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I.

PROXY STATEMENT, LETTER TO SHAREHOLDERS

June 14, 2017
MERGER PROPOSAL—YOUR VOTE IS VERY IMPORTANT
Dear Reynolds American Inc. Shareholders:
British American Tobacco p.l.c., referred to as BAT, and Reynolds American Inc., referred
to as RAI, have entered into an Agreement and Plan of Merger, dated as of January 16, 2017, as
it and the plan of merger contained therein were amended as of June 8, 2017, and as it and the
plan of merger contained therein may be further amended from time to time, referred to as the
merger agreement, under which an indirect, wholly owned subsidiary of BAT will be merged
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with and into RAI, and RAI will continue as the surviving corporation in the merger and an
indirect, wholly owned subsidiary of BAT, referred to as the merger. If the merger is completed,
RAI shareholders (other than BAT and its subsidiaries and excluded holders, as defined in the
accompanying proxy statement/prospectus) will receive, in exchange for each share of RAI
common stock owned immediately prior to the merger, (1) a number of BAT American
Depositary Shares, referred to as BAT ADSs, representing 0.5260 of a BAT ordinary share plus
(2) $29.44 in cash, without interest, collectively referred to as the merger consideration. Based
on the number of shares of RAI common stock and BAT ordinary shares (excluding treasury
shares) outstanding as of June 12, 2017, and the total number of shares of RAI common stock
issuable under outstanding RAI equity awards that are expected to be settled for BAT ADSs in
connection with the merger, it is expected that, immediately after completion of the merger,
former RAI shareholders (other than BAT and its subsidiaries) will own approximately 19% of
BAT’s share capital. The currently outstanding BAT ADSs have unlisted trading privileges on
the New York Stock Exchange MKT, referred to as the NYSE MKT, where they trade under the
trading symbol “BTI” (but, at or prior to the completion of the merger, all BAT ADSs will be
listed on the New York Stock Exchange, referred to as the NYSE, for trading under the symbol
“BTI”), and the shares of RAI common stock are currently listed on the NYSE, under the trading
symbol “RAI.”
RAI will hold a special meeting of its shareholders to vote on certain matters in connection
with the merger. Attendance at the special meeting will be limited as more fully described in the
accompanying proxy statement/prospectus. Admittance tickets will be required for the special
meeting.
RAI shareholders are cordially invited to attend the special meeting of RAI shareholders. The
special meeting will be held at 9:00 a.m. (Eastern Time), on July 19, 2017, in the Reynolds
American Plaza Building Auditorium at RAI’s corporate offices, 401 North Main Street,
Winston-Salem, North Carolina 27101. At the special meeting, RAI shareholders will be asked
to vote on the approval of the merger agreement, including the plan of merger contained therein.
In addition, RAI shareholders will be asked to vote on the approval of, on a non-binding,
advisory basis, the compensation payments that will or may be paid by RAI or BAT to RAI’s
named executive officers and that are based on or otherwise relate to the merger and the
agreements and understandings pursuant to which such compensation may be paid or become
payable, referred to as the transaction-related named executive officer compensation, and to vote
on the approval of the adjournment of the special meeting, if necessary or appropriate, to solicit
additional proxies if there are not sufficient votes to approve the merger agreement.
The exchange of the merger consideration for RAI common stock in the merger generally
will be a taxable transaction to U.S. holders (as defined in “Special Factors Relating to RAI
Proposal I: Approval of the Merger Agreement—Material U.S. Federal Income Tax
Consequences”) for U.S. federal income tax purposes and may also be taxable under state, local
and non-U.S. income and other tax laws. We encourage RAI shareholders to carefully review the
information under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Material U.S. Federal Income Tax Consequences” beginning on page 137 of the
accompanying proxy statement/prospectus for a description of material U.S. federal income tax
consequences of the merger.
BAT currently holds approximately 42% of RAI’s outstanding common stock through its
wholly owned subsidiaries, Brown & Williamson Holdings, Inc., a Delaware corporation and
2

indirect, wholly owned subsidiary of BAT, referred to as B&W, and Louisville Securities
Limited, a private limited company incorporated under the laws of England and Wales and an
indirect, wholly owned subsidiary of BAT, referred to as Louisville. As described in “Special
Factors Relating to RAI Proposal I: Approval of the Merger Agreement—Position of BAT and
Merger Sub as to the Fairness of the Merger” BAT does not believe it controls RAI for purposes
of North Carolina corporate law.
We cannot complete the merger without the approval of the merger agreement by RAI
shareholders, including approval by holders of a majority of the outstanding shares of RAI
common stock entitled to vote and present (in person or by proxy) and voting at the special
meeting that are not owned by BAT or its subsidiaries or RAI’s subsidiaries. The Series B
preferred stock of RAI, all of which is owned by a wholly owned subsidiary of RAI, is not
entitled to vote. It is important that your shares of RAI common stock be represented and
voted regardless of the size of your holdings. Whether or not you plan to attend the special
meeting, we urge you to submit a proxy to have your shares of RAI common stock voted in
advance of the special meeting by using one of the methods described in the accompanying
proxy statement/prospectus.
RAI, BAT and B&W are parties to a governance agreement pursuant to which entry into the
transactions contemplated by the merger agreement, including the merger, requires the approval
of a majority of the independent directors of RAI other than directors designated for nomination
by B&W. In furtherance of this requirement, on October 28, 2016, the RAI board of directors
appointed a transaction committee, consisting of all of the independent directors of RAI at that
time other than directors designated for nomination by B&W, referred to as the Transaction
Committee, to review and evaluate the merger and RAI’s other available strategic alternatives.
Following extensive arm’s-length negotiations with BAT, the Transaction Committee
unanimously approved, adopted and authorized the merger agreement and determined that the
merger is fair to and in the best interests of RAI and its shareholders (other than BAT and its
affiliates) and recommended that the RAI board of directors approve, adopt and authorize the
merger agreement, including the merger and the other transactions contemplated thereby.
The RAI board of directors recommends that RAI shareholders vote “FOR” the
approval of the merger agreement, “FOR” the approval, on a non-binding, advisory basis,
of the transaction-related named executive officer compensation and “FOR” the
adjournment of the special meeting, if necessary or appropriate, to solicit additional
proxies if there are not sufficient votes to approve the merger agreement.
The accompanying proxy statement/prospectus provides important information regarding the
special meeting and a detailed description of the merger agreement, the merger and the matters to
be presented at the special meeting. We urge you to read the accompanying proxy
statement/prospectus, including all documents incorporated by reference into the
accompanying proxy statement/prospectus, and its annexes carefully and in their entirety.
Please pay particular attention to “Risk Factors” beginning on page 154 of the
accompanying proxy statement/prospectus.
We hope to see you at the special meeting and look forward to the successful completion of
the merger.
Sincerely,
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Susan M. Cameron
Chairman of the Board
Reynolds American Inc.

II.
PROXY DISCUSSION OF BASIC INFORMATION ON THE TRANSACTION,
INCLUDING A SUMMARY

A.
ABOUT THIS PROXY STATEMENT/PROSPECTUS (YOU MAY WANT
TO REFER TO THIS SECTION WHEN READING THE SUMMARY UNDER
1.2.B, BELOW)
This proxy statement/prospectus, which forms part of the registration statement on Form F4 filed by BAT with the U.S. Securities and Exchange Commission, constitutes a prospectus of
BAT under Section 5 of the Securities Act of 1933, as amended, with respect to the BAT
ordinary shares (which will be represented by BAT ADSs) to be issued to RAI shareholders as
the stock portion of the merger consideration. This proxy statement/prospectus also constitutes a
proxy statement for RAI under Section 14(a) of the Securities Exchange Act of 1934, as
amended. In addition, it constitutes a notice of meeting with respect to the special meeting of
RAI shareholders.
You should rely only on the information contained in or incorporated by reference into this
proxy statement/prospectus. No one has been authorized to provide you with information that is
different from that contained in, or incorporated by reference into, this proxy
statement/prospectus. This proxy statement/prospectus is dated June 14, 2017. You should not
assume that the information contained in this proxy statement/prospectus is accurate as of any
date other than that date. You should not assume that the information incorporated by reference
into this proxy statement/prospectus is accurate as of any date other than the date of such
information. The mailing of this proxy statement/prospectus to RAI shareholders shall not create
any implication to the contrary.
This proxy statement/prospectus shall not constitute an offer to sell, or the solicitation
of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or
from any person to whom it is unlawful to make any such offer or solicitation. Information
contained in this proxy statement/prospectus regarding BAT has been provided by BAT
and information contained in this proxy statement/prospectus regarding RAI has been
provided by RAI.
This proxy statement/prospectus is not a prospectus published in accordance with the
Prospectus Rules made under Part VI of the United Kingdom Financial Services and
Markets Act 2000 (as set out in the Financial Conduct Authority Handbook), referred to as
the UK Prospectus Rules. BAT intends to publish a prospectus as required by the UK
Prospectus Rules, in connection with its proposed issue of BAT ordinary shares, and
application for admission to list such shares on the premium listing segment of the Official
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List of the UKLA and to trading on the main market for listed securities of the LSE. A
copy of such prospectus may be obtained at BAT’s website (www.bat.com) following
approval by the UKLA. BAT also intends to mail to BAT shareholders a shareholder
circular relating to the general meeting of BAT’s shareholders to be held for the purpose of
obtaining the approval of holders of BAT ordinary shares of the merger agreement and the
applicable transactions contemplated thereby, and authorization for directors of BAT to
allot and issue the BAT ordinary shares underlying the BAT ADSs constituting the stock
portion of the merger consideration. The web address of BAT has been included as an
inactive textual reference only. The BAT prospectus, circular and website are not
incorporated by reference into, and do not form a part of, this proxy statement/prospectus.
Unless otherwise indicated or as the context otherwise requires, all references in this proxy
statement/prospectus to:
• “acquisition facility” refer to the term loan facilities agreement, dated as of January 16,
2017, among B.A.T. International Finance p.l.c. and B.A.T Capital Corporation, as
original borrowers, BAT, as guarantor, HSBC Bank plc, as agent, HSBC Bank USA,
National Association, as U.S. agent and the lenders and financial institutions party
thereto, providing for unsecured and unsubordinated term loan facilities in an aggregate
principal amount of up to $25.0 billion for the purpose of financing the merger, paying
related taxes, fees, costs and expenses and refinancing an existing revolving credit
facility of RAI;
• “ADRs” refer to American depositary receipts that evidence ADSs;
• “ADSs” refer to American depositary shares;
• “Amended and Restated Omnibus Plan” refer to the Reynolds American Inc. Amended
and Restated 2009 Omnibus Incentive Compensation Plan;

• “B&W” refer to Brown & Williamson Holdings, Inc., f/k/a Brown & Williamson
Tobacco Corporation, a Delaware corporation and indirect, wholly owned subsidiary of
BAT;
• “B&W business combination” refer to the combination of the U.S. assets, liabilities and
operations, other than certain specified assets and liabilities, of BAT’s wholly owned
subsidiary, B&W, with RJR Tobacco Company in July 2004;
• “BAT” refer to British American Tobacco p.l.c., a public limited company incorporated
under the laws of England and Wales;
• “BAT ADSs” refer to BAT’s American depositary shares, each of which represents one
BAT ordinary share and may be evidenced by ADRs;
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• “BAT ADS ratio change” refer to the change from each BAT ADS representing two
BAT ordinary shares to each BAT ADS representing one BAT ordinary share as of
February 14, 2017;
• “BAT board of directors” refer to the board of directors of BAT;
• “BAT circular” refer to the shareholder circular relating to the general meeting of BAT’s
shareholders to be held for the purpose of obtaining the approval of holders of BAT
ordinary shares of the merger agreement and the applicable transactions contemplated
thereby, and authorization for directors of BAT to allot and issue the BAT ordinary
shares underlying the BAT ADSs constituting the stock portion of the merger
consideration, in each case on a poll by the holders of not less than a majority of BAT
ordinary shares, present in person or by proxy who are entitled to vote at such BAT
general meeting;
• “BATGET” refer to the BAT Group Employee Trust;
• “BAT Group” refer collectively to BAT and its subsidiaries;
• “BAT Group management board” refer to the members of the management board of the
BAT Group as described in “Business of BAT—Directors and Management Board—BAT
Group Management Board” beginning on page 276 of this proxy statement/prospectus;
• “BAT ordinary shares” refer to ordinary shares, nominal value 25 pence per share, of
BAT;
• “BAT parties” refer to BAT, Louisville, B&W, BATUS and Merger Sub;
• “BAT pension fund” refer to the British American Tobacco p.l.c. Pension Fund;
• “BAT prospectus” refer to the BAT prospectus relating to the admission of the BAT
ordinary shares underlying the BAT ADSs constituting the stock portion of the merger
consideration to the premium listing segment of the Official List of the UKLA and to
trading on the main market for listed securities of the LSE;
• “BAT shareholder approval” refer to the approval of holders of BAT ordinary shares of
the merger agreement and the applicable transactions contemplated thereby as a Class 1
transaction and authorization for directors of BAT to allot and issue the BAT ordinary
shares underlying the BAT ADSs constituting the stock portion of the merger
consideration, in each case, on a poll by the holders of not less than a majority of BAT
ordinary shares, present in person or by proxy who are entitled to vote at the BAT
shareholders’ meeting;
• “BATUS” refer to BATUS Holdings Inc.;
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• “cash-out RSU” refer to each RAI RSU and each RAI performance share, in each case,
that was granted prior to the date of the merger agreement, other than RAI retention
RSUs;
• “cash in lieu of fractional BAT ADSs” refer to the cash payment that holders of RAI
common stock are entitled to receive in lieu of fractional BAT ADSs. Under the terms of
the merger agreement such cash payment equals the product obtained by multiplying
(1) the amount of the net proceeds (less any commissions, transfer taxes and out-ofpocket costs and expenses of the exchange agent) from the sale on the NYSE of the
excess of (a) the aggregate number of BAT ADSs (rounded up to the nearest whole
number) to be issued as the stock portion of the merger consideration over (b) the
aggregate whole number of BAT ADSs to be distributed to holders of shares of RAI
common stock by (2) a fraction, the

numerator of which is the amount of the fractional BAT ADSs to which such holder of
shares of RAI common stock is entitled (after taking into account all shares of RAI
common stock exchanged by such holder) and the denominator of which is the aggregate
amount of fractional BAT ADSs to which all applicable holders of RAI common stock
are entitled;
• “Centerview” refer to Centerview Partners UK LLP;
• “Class 1 transaction” refer to a transaction for a listed company, the size of which results
in a 25% threshold being reached under any one of the class tests set out in the UK
Listing Rules;
• “Code” refer to the U.S. Internal Revenue Code of 1986, as amended;
• “combined company” refer to the BAT Group after the completion of the merger;
• “completion date” refer to the completion date of the merger;
• “continuing employee” refer to employees of the RAI Group that remain as employees of
the BAT Group (including RAI and its subsidiaries) following the completion of the
merger;
• “DCP” refer to the Deferred Compensation Plan for Directors of Reynolds American
Inc.;
• “depositary bank” refer to Citibank, N.A., as depositary bank for the BAT ADSs;
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• “deposit agreement” refer to the Amended and Restated Deposit Agreement, dated as of
December 1, 2008, and amended as of February 14, 2017, and as further amended from
time to time, among BAT, Citibank, N.A., as depositary bank, and all holders and
beneficial owners from time to time of BAT ADSs issued thereunder;
• “Deutsche Bank” refer to Deutsche Bank AG, London Branch;
• “Divestiture” refer to the acquisition by a wholly owned subsidiary, n/k/a ITG Brands,
LLC, of Imperial Brands, PLC, f/k/a Imperial Tobacco Group, PLC, on June 12, 2015, of
certain assets (1) owned by certain RAI subsidiaries or affiliates relating to the cigarette
brands WINSTON, KOOL and SALEM, and (2) owned by certain Lorillard subsidiaries
or affiliates relating to the cigarette brand MAVERICK and the “e-vapor” brand BLU
(including SKYCIG), as well as Lorillard’s owned and leased real property, and certain
transferred employees, together with associated liabilities;
• “DOJ” refer to the U.S. Department of Justice;
• “DSBS” refer to the British American Tobacco p.l.c. Deferred Annual Share Bonus
Scheme;
• “EIAP” refer to the Equity Incentive Award Plan for Directors of Reynolds American
Inc.;
• “ESP” refer to the Reynolds American Inc. Executive Severance Plan;
• “EURIBOR” refer to Euro Interbank Offered Rate;
• “EV” refer to enterprise value;
• “Exchange Act” refer to the U.S. Securities Exchange Act of 1934, as amended;
• “exchange agent” refer to Citibank, N.A., as exchange agent for the merger;
• “excluded holders” refer to holders of shares of RAI common stock who have not voted,
or caused or permitted to be voted, any shares of RAI common stock in favor of the
approval of the merger agreement at the special meeting and who have properly asserted
(and not lost or effectively withdrawn) their rights of appraisal in accordance with Article
13 of NCBCA (however, in the case of the RAI Savings Plan and the Puerto Rico SIP,
the trustee of the RAI Savings Plan and the custodian of the Puerto Rico SIP shall be
treated as excluded holders with respect to shares of RAI common stock as to which such
trustee or custodian has exercised appraisal rights even though such trustee or custodian
may have voted other shares in the applicable plan in favor of approval of the merger
agreement);
• “FCA” refer to the UK Financial Conduct Authority;

8

• “FDA” refer to the U.S. Food and Drug Administration;

• “FII GLO” refer to Franked Investment Income Group Litigation Order;
• “foreign private issuer” refer to a foreign company that qualifies as a “foreign private
issuer” as defined in Rule 3b-4(c) of the Exchange Act and Rule 405 of the Securities
Act—a company ceases to be a “foreign private issuer” at such time as more than 50% of
its outstanding voting securities are directly or indirectly held of record by U.S. residents
and any of the following circumstances applies: (1) the majority of its executive officers
or directors are U.S. citizens or residents, (2) more than 50% of its assets are located in
the United States or (3) its business is administered principally in the United States;
• “FSMA” refer to the UK Financial Services Market Act 2000;
• “FTC” refer to the U.S. Federal Trade Commission;
• “FTSE” refer to Financial Times Stock Exchange;
• “global drive brands” refer to DUNHILL, KENT, LUCKY STRIKE, PALL MALL and
ROTHMANS, collectively;
• “governance agreement” refer to the governance agreement, dated as of July 30, 2004, as
amended, among RAI, BAT and B&W;
• “Goldman Sachs” refer to Goldman Sachs & Co. LLC, f/k/a Goldman, Sachs & Co.;
• “HSR Act” refer to the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended;
• “HM Revenue & Customs” refer to Her Majesty’s Revenue and Customs of the United
Kingdom;
• “IEIS” refer to the British American Tobacco p.l.c. International Executive Incentive
Scheme;
• “IFRS” refer to International Financial Reporting Standards as issued by the International
Accounting Standards Board;
• “IFRS (EU)” refer to International Financial Reporting Standards as adopted by the
European Union;
• “J.P. Morgan” refer to J.P. Morgan Securities LLC;
• “JSE” refer to Johannesburg Stock Exchange;
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• “Key Markets” refer to Americas, Western Europe, Eastern Europe, Middle East, Asia
and Asia-Pacific;
• “key strategic brands” refer to STATE EXPRESS 555 and SHUANG XI;
• “Lazard” refer to Lazard Frères & Co. LLC;
• “LIBOR” refer to London Interbank Offered Rate;
• “Lorillard” refer to Lorillard, LLC, a Delaware limited liability company and a wholly
owned subsidiary of RAI, f/k/a Lorillard, Inc., a Delaware corporation;
• “Lorillard merger” refer to the acquisition by RAI of Lorillard on June 12, 2015, in a
cash and stock transaction;
• “Louisville” refer to Louisville Securities Limited, a private limited company
incorporated under the laws of England and Wales and an indirect, wholly owned
subsidiary of BAT;
• “LSE” refer to London Stock Exchange plc;
• “LTIP” refer to the applicable British American Tobacco p.l.c. Long-Term Incentive
Plan;
• “menthol regulatory action” refer to any law, judgment or action enacted, promulgated,
proposed or threatened by the FDA or any other governmental entity that could have the
effect of banning or materially restricting the use of menthol in any product sold or
distributed by RAI or BAT or any of their respective subsidiaries;

• “merger” refer to the merger of Merger Sub with and into RAI; as a result of the merger,
the separate corporate existence of Merger Sub will cease, and RAI will continue as the
surviving corporation in the merger and an indirect, wholly owned subsidiary of BAT.
Upon the completion of the merger, all of the title to all real estate and other property
owned by each of RAI and Merger Sub will vest in RAI as the surviving corporation, and
all liabilities of RAI and Merger Sub will become the liabilities of RAI as the surviving
corporation;
• “merger agreement” refer to the Agreement and Plan of Merger, dated as of January 16,
2017, as it and the plan of merger contained therein were amended as of June 8, 2017,
and as it and the plan of merger contained therein may be further amended from time to
time, among BAT, BATUS, RAI and Merger Sub, a copy of which is attached as Annex
A to this proxy statement/prospectus;
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• “merger consideration” refer to the consideration, per share of RAI common stock, to be
received in the merger by RAI shareholders (other than the BAT Group and excluded
holders), consisting of:
•

a number of BAT ADSs representing 0.5260 of a BAT ordinary share (the “stock
portion of the merger consideration”), plus

•

$29.44 in cash, without interest (the “cash portion of the merger consideration”);

• “Merger Sub” refer to Flight Acquisition Corporation, a North Carolina corporation and
an indirect, wholly owned subsidiary of BAT;
• “MSA” refer to the Master Settlement Agreement, dated as of November 23, 1998,
among 46 U.S. states, the District of Columbia and five U.S. territories listed on the
signature pages thereto, Philip Morris Incorporated, RJR Tobacco Company, B&W,
Lorillard Tobacco Company, LLC, f/k/a Lorillard Tobacco Company, and various
subsequent participating manufacturers listed on the National Association of Attorneys
General’s list of “Participating Manufacturers,” as amended, supplemented or replaced;
• “NCBCA” refer to the North Carolina Business Corporation Act;
• “next generation products” refer, in relation to BAT’s view of such products, to any
tobacco or nicotine product developed to offer adult tobacco consumers potentially less
risky alternatives to smoking conventional cigarettes and include (1) vapor products
(such as e-cigarettes), which are battery powered electronic devices which heat a solution
to create a vapor which can be inhaled, and (2) tobacco heating products, which are
battery powered electronic devices that operate with specifically designed consumables
containing tobacco, to deliver a real tobacco taste and aroma, and, in relation to RAI’s
view of such products, to the above-mentioned products as well as (a) any device that
employs a chemical reaction or combustible, carbonaceous fuel source for heat
generation to produce an aerosol from a physically separate source and (b) products that
contain nicotine for therapeutic purposes (such as products characterized as gums,
lozenges and inhalers that are intended to be nicotine replacement therapy, referred to as
NRT, products, and products characterized as devices that are intended to be used for
NRT purposes);
• “NYSE” refer to the New York Stock Exchange;
• “NYSE MKT” refer to the NYSE MKT;
• “Other Directors” refer to the independent directors, as defined in the governance
agreement, of RAI (other than any independent directors designated for nomination by
B&W), and references to Other Directors comprising the Transaction Committee refer to
such independent directors of RAI as of October 28, 2016 and cease to include Thomas
C. Wajnert following his retirement from the RAI board of directors effective as of the
close of business on December 31, 2016;
11

• “PCAOB” refer to the U.S. Public Company Accounting Oversight Board;
• “plan of merger” refer to the plan of merger contained in the merger agreement;
• “Puerto Rico SIP” refer to the Puerto Rico Savings & Investment Plan sponsored by
RAI;
• “RAI” refer to Reynolds American Inc., a North Carolina corporation;

• “RAI-Lorillard merger agreement” refer to the Agreement and Plan of Merger, dated as
of July 15, 2014, among Lorillard, RAI and Lantern Acquisition Co., a Delaware
corporation and wholly owned subsidiary of RAI;
• “RAI articles of incorporation” refer to the Restated Articles of Incorporation of RAI,
effective as of May 5, 2016;
• “RAI board of directors” refer to the board of directors of RAI;
• “RAI bylaws” refer to the Amended and Restated Bylaws of Reynolds American Inc.,
dated December 1, 2016;
• “RAI change in control” refer to a “change in control” or “change of control” (or other
similar phrase) within the meaning of the RAI severance and equity incentive
arrangements;
• “RAI common stock” refer to RAI common stock, par value $0.0001 per share;
• “RAI DSU” refer to each RAI deferred stock unit that is payable in shares of RAI
common stock or the value of which is determined with reference to the value of shares
of RAI common stock;
• “RAI governance committee” refer to the RAI board of directors’ Corporate Governance
and Nominating Committee;
• “RAI Group” refer collectively to RAI and its subsidiaries;
• “RAI’s financial advisors” refer to J.P. Morgan and Lazard;
• “RAI performance share” refer to any RAI performance share award subject to
performance-based vesting, payable in shares of RAI common stock;
• “RAI record date” refer to the close of business on June 12, 2017;
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• “RAI retention RSU” refer to three RAI RSU grants that were made prior to the date of
the merger agreement that will be assumed, and will not vest and settle upon the
completion of the merger;
• “RAI RSU” refer to any RAI restricted stock unit award subject solely to time-based
vesting and not performance-based vesting (other than performance-based vesting only
for purposes of Section 162(m) of the Code), payable in shares of RAI common stock;
• “RAI Savings Plan” refer to the RAI 401k Savings Plan;
• “RAI shareholder approvals” refer to (1) the approval of the merger agreement by the
affirmative vote of the holders of a majority of the outstanding shares of RAI capital
stock entitled to vote as of the RAI record date and (2) the unaffiliated shareholder
approval;
• “Remuneration Committee” refer to the Remuneration Committee of the BAT board of
directors;
• “Remuneration Policy” refer to the forward-looking remuneration policy for BAT
directors and former directors, as approved at the 2016 annual general meeting of BAT;
• “RJR Tobacco Company” refer to R. J. Reynolds Tobacco Company, a North Carolina
corporation and an indirect, wholly owned subsidiary of RAI;
• “rollover RSU” refer to each RAI RSU or RAI performance share that, in either case, is
not a cash-out RSU;
• “RSU exchange ratio” refer to the sum of (1) 0.5260 plus (2) the quotient of (a) $29.44
over (b) the closing price of one BAT ADS on the last trading date preceding the
completion date as reported on the NYSE MKT;
• “SEC” refer to the U.S. Securities and Exchange Commission;
• “Securities Act” refer to the U.S. Securities Act of 1933, as amended;
• “SFNTC” refer to Santa Fe Natural Tobacco Company, Inc.;
• “share issuance” refer to the issuance of BAT ordinary shares represented by BAT ADSs
to holders of RAI common stock (other than the BAT Group or excluded holders) as the
stock portion of the merger consideration;
• “share repurchase agreement” refer to the Share Repurchase Agreement, dated as of
July 25, 2016, as it may be amended from time to time, among B&W, Louisville and
RAI;
• “Sharesave Scheme” refer to the British American Tobacco p.l.c. Sharesave Scheme;
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• “SIP” refer to the British American Tobacco p.l.c. Employee Share Ownership Plan;
• “special meeting” refer to the special meeting that RAI will hold for its shareholders to
vote on certain matters in connection with the merger, and is the meeting to which this
proxy statement/prospectus relates;
• “State Settlement Agreements” refer to the MSA, together with settlement agreements
with the states of Mississippi, Florida, Texas and Minnesota;
• “tobacco litigation” refer to United States v. Philip Morris, et al., No. 99-02496
(D.D.C.), and any other actions or judgments regarding any health or other impacts or
alleged health or other impacts, including impacts cognizable under the Racketeer
Influenced and Corrupt Organizations Act, from the development, manufacture,
distribution, sale, advertising, marketing and/or use of any tobacco product (including
products that are derived from tobacco, such as products containing tobacco-derived
nicotine), including for the avoidance of doubt any and all actions or judgments
regarding the presence of or exposure to smoke from any tobacco product;
• “Transaction Committee” refer to the special committee formed by the RAI board of
directors, initially formed to review and evaluate BAT’s initial October 20, 2016
proposal, the merger and RAI’s other available strategic alternatives consisting of all of
the Other Directors as of October 28, 2016, but which ceased to include Thomas C.
Wajnert following his retirement from the RAI board of directors effective as of the close
of business on December 31, 2016;
• “transaction-related named executive officer compensation” refer to the compensation
payments that will or may be paid by RAI or BAT to RAI’s named executive officers
and that are based on or otherwise relate to the merger and the agreements and
understandings pursuant to which such compensation may be paid or become payable;
• “Transaction Committee’s financial advisor” refer to Goldman Sachs;
• “Treasury” refer to the U.S. Department of the Treasury;
• “UBS” refer to UBS Limited;
• “UKLA” refer to the FCA acting in its capacity as the competent authority for the
purposes of Part VI of FSMA;
• “unaffiliated shareholder approval” refer to the approval of the merger agreement by the
affirmative vote of the holders of a majority of the shares of RAI common stock that are
entitled to vote as of the RAI record date and present (in person or by proxy) and voting
at the special meeting and that are not owned by the BAT Group or any of RAI’s
subsidiaries;
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• “Unaffiliated Shareholders” refer to the holders of RAI capital stock other than the BAT
Group, RAI’s subsidiaries, the members of the RAI board of directors and RAI’s
officers;
• “UK Regulations” refer to the Large and Medium-size Companies and Group (Accounts
and Reports) (Amendment) Regulations 2013;
• “U.S. GAAP” refer to U.S. Generally Accepted Accounting Principles; and
• “UURBS” refer to the unfunded approved retirement benefit scheme sponsored by BAT.
All brands, unless otherwise noted, referred to herein are trademarks owned or licensed by the
BAT Group or the RAI Group, as applicable.
When used in describing aspects of the BAT Group’s business, reference to volume is an
unaudited operating measure and is calculated as the total global cigarette volume of the BAT
Group’s brands sold by its subsidiaries.
References to the price of the BAT ADSs prior to February 14, 2017 are adjusted to give effect
to the BAT ADS ratio change unless otherwise indicated.
References to “ton” refer to metric tonnes.
Presentation of Financial Information
This proxy statement/prospectus contains or is accompanied by:
• the unaudited consolidated financial statements of BAT for the year ended December 31,
2014, prepared on the basis of IFRS;
• the audited consolidated financial statements of BAT as of December 31, 2016 and 2015
and for each of the years in the two-year period ended December 31, 2016, prepared on
the basis of IFRS (together with the unaudited consolidated financial statements of BAT
for the year ended December 31, 2014, referred to in this proxy statement/prospectus as
the BAT Group’s consolidated financial statements);
• the unaudited condensed consolidated financial statements of RAI as of March 31, 2017,
and for the three months ended March 31, 2017 and 2016, prepared on the basis of U.S.
GAAP (referred to in this proxy statement/prospectus as the RAI Group’s unaudited
condensed consolidated financial statements); and
• the audited consolidated financial statements of RAI as of December 31, 2016 and 2015
and for each of the years in the three-year period ended December 31, 2016, prepared on
the basis of U.S. GAAP (referred to in this proxy statement/prospectus as the RAI
Group’s consolidated financial statements).
Unless indicated otherwise, financial data presented in this proxy statement/prospectus has
been taken from the BAT Group’s consolidated financial statements, the RAI Group’s
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consolidated financial statements and the RAI Group’s unaudited condensed consolidated
financial statements included in and attached to, respectively, this proxy statement/prospectus.
BAT’s financial statements for 2014, which were prepared in accordance with IFRS (EU),
are included on BAT’s website and can be found at http://www.bat.com/bat2014financials.
These financial statements start on page 121 and the audit report can be found on page 120.
These financial statements, which were prepared in accordance with IFRS (EU), are the same as
those that would be prepared using IFRS (IASB). They were audited by PricewaterhouseCoopers
LLP, referred to as PwC, in accordance with International Standards on Auditing (UK and
Ireland). PwC issued its report on those statements on February 25, 2015. At the time its report
was issued, PwC was independent under the Financial Reporting Council’s Ethical Standards
and the International Ethics Standards Board for Accountants’ Code of Ethics. PwC is no longer
independent under such standards. Accordingly, PwC could neither issue nor consent to the
issuance of an audit report on the financial statements of BAT for 2014. These financial
statements and the audit report thereon, included on BAT’s website, are not incorporated by
reference into this proxy statement/prospectus and should not be considered to be part of this
proxy statement/prospectus.
This proxy statement/prospectus also contains the unaudited pro forma condensed
combined financial information of BAT as of and for the year ended December 31, 2016 after
giving effect to the merger, referred to in this proxy statement/prospectus as Pro Forma Financial
Information. See “BAT Unaudited Pro Forma Condensed Combined Financial Information”
beginning on page 351 of this proxy statement/prospectus.
The financial information set forth in this proxy statement/prospectus has been rounded for
ease of presentation. Accordingly, in certain cases, the sum of the numbers in a column in a table
may not conform to the total figure given for that column.
For additional information on the presentation of financial information in this proxy
statement/prospectus, see the BAT Group’s consolidated financial statements beginning on page
FIN-1 of this proxy statement/prospectus and the RAI Group’s consolidated financial statements
and the RAI Group’s unaudited condensed consolidated financial statements, attached as Annex
G and Annex H to this proxy statement/prospectus, respectively.
Exchange Rates
BAT publishes its consolidated financial statements in pounds sterling, while RAI publishes
its consolidated financial statements in U.S. dollars. In this proxy statement/prospectus,
references to “$,” “U.S. dollars” or “USD” are to the lawful currency of the United States of
America, references to “£,” “pounds sterling,” “pence” or “GBP” are to the lawful currency of
the United Kingdom, references to “Cdn$” and “Canadian dollars” are to the lawful currency of
Canada, references to “€” or “euro” are to the single currency adopted by participating member
states of the European Union, referred to as the EU, relating to Economic and Monetary Union,
references to “Swiss franc” and “CHF” are to the lawful currency of Switzerland, references to
“R$” and “Brazilian real” are to the lawful currency of Brazil, references to “South African
rand” are to the lawful currency of South Africa and references to “Korean Won” are to the
lawful currency of South Korea.
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References to the “Sterling-Dollar exchange rate” refer to the pound sterling—U.S. dollar
exchange rate as quoted by the Bloomberg Composite Rate on such date at the time of LSE
market close, except (1) in relation to October 20, 2016 where it refers to the pound sterling—
U.S. dollar exchange rate as quoted by the Bloomberg Composite Rate on such date at 9:00 p.m.
UK time and (2) where another time is specified, in which case it refers to the pound sterling—
U.S. dollar exchange rate as quoted by the Bloomberg Composite Rate on such date at such
specified time.
The following table sets forth the high and low noon buying rates of each month of the last
six months, as certified for customs purposes by the Federal Reserve Bank of New York, for the
pound sterling expressed in U.S. dollars per pound sterling.
Period
December 2016
January 2017
February 2017
March 2017
April 2017
May 2017

High
1.2708
1.2620
1.2643
1.2583
1.2938
1.3018

Low
1.2222
1.2118
1.2427
1.2152
1.2398
1.2795

The following table sets forth for each year the average of the noon buying rates on the last
business day of each month of that year, as certified for customs purposes by the Federal Reserve
Bank of New York, for the pound sterling expressed in U.S. dollars per pound sterling for each
of the five most recent fiscal years.
Period
Year ended December 31, 2012
Year ended December 31, 2013
Year ended December 31, 2014
Year ended December 31, 2015
Year ended December 31, 2016

Average
1.5924
1.5668
1.6461
1.5250
1.3444

On June 9, 2017, the latest practicable date prior to this filing, the noon buying rate was
£1.00 = $1.2737.
The rates presented above may differ from the actual rates used in preparation of financial
information appearing in this proxy statement/prospectus. The presentation of such rates is not
meant to suggest that the U.S. dollar amounts actually represent the pound sterling amounts or
that such amounts could have been converted to U.S. dollars at any particular rate.
Industry Data
References to market share are the BAT Group’s estimates based on the latest available data
from a number of internal and external sources.
U.S. industry shipment volume and retail market share data that appear in this proxy
statement/prospectus have been obtained from Management Science Associates, Inc., referred to
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as MSAi. This information is included in this proxy statement/prospectus because it is used
primarily as an indicator of the relative performance of industry participants, brands and market
trends. All U.S. market share results that appear, except as noted otherwise, in this document are
based on U.S. cigarette (or smokeless tobacco products, as applicable) shipments to retail outlets,
referred to as STR data, based on information submitted by wholesale locations and processed
and managed by MSAi. However, you should not rely on the STR data reported by MSAi as
being a precise measurement of actual market share as the shipments to retail outlets do not
reflect actual consumer sales and do not track all volume and trade channels. Accordingly, the
STR data of the U.S. tobacco industry as reported by MSAi may overstate or understate actual
market share. Moreover, you should be aware that in a product market experiencing overall
declining consumption, a particular product can experience increasing market share relative to
competing products, yet still be subject to declining consumption volumes.
B.

SUMMARY
SUMMARY

This summary highlights selected information from this proxy statement/prospectus. It may
not contain all of the information that is important to you. You are urged to read this entire
proxy statement/prospectus and the other documents referred to or incorporated by reference
into this proxy statement/prospectus in order to fully understand the merger and the merger
agreement. See “Where You Can Find More Information” beginning on page 445 of this proxy
statement/prospectus. Each item in this summary refers to the beginning page of this proxy
statement/prospectus on which that subject is discussed in more detail.
The Companies (See page 198)
British American Tobacco p.l.c.
BAT is the parent holding company of the BAT Group, a global tobacco and next
generation products group with brands sold in over 200 markets. According to the BAT Group’s
internal estimates, the BAT Group is a market leader in more than 55 countries by volume,
producing the cigarette chosen by one in eight of the world’s one billion smokers. The BAT
Group, excluding the BAT Group’s associated undertakings, is organized into four regions: AsiaPacific, Americas, Western Europe and Eastern Europe, Middle East and Africa, referred to as
EEMEA.
The BAT Group manufactures and sells traditional tobacco products, which are composed
of cigarettes, fine cut (roll-your-own and make-your-own tobacco), Swedish-style snus and
cigars, alongside next generation products, including vapor products and tobacco heating
products. The BAT Group’s five global drive brands are DUNHILL, KENT, LUCKY STRIKE,
PALL MALL and ROTHMANS. The BAT Group’s cigarette portfolio also includes other
international and local brands, such as VOGUE, VICEROY, KOOL, PETER STUYVESANT,
CRAVEN A, BENSON & HEDGES, JOHN PLAYER GOLD LEAF, STATE EXPRESS 555
and SHUANG XI.
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BAT has had a significant global presence in the tobacco industry for over 100 years. The
British-American Tobacco Company Ltd., referred to as BAT Ltd., was incorporated in 1902,
when the Imperial Tobacco Company and the American Tobacco Company agreed to form a
joint venture company. BAT Ltd. inherited companies and quickly expanded into major markets,
including India and Ceylon, Egypt, Malaya, Northern Europe and East Africa. In 1927, BAT Ltd.
expanded into the U.S. market through its acquisition of B&W. During the 1960s, 1970s and
1980s, the BAT Group diversified its business under the umbrella of B.A.T Industries p.l.c., with
acquisitions in the paper, cosmetics, retail and financial services industries, among others.
Various business reorganizations followed as the business was eventually refocused on the BAT
Group’s core cigarette, cigars and tobacco products businesses with British American Tobacco
p.l.c. becoming a separately listed entity on the LSE in 1998.
In July 2004, the U.S. assets, liabilities and operations, other than certain specified assets
and liabilities, of BAT’s wholly owned subsidiary, B&W, were combined with RJR Tobacco
Company. RAI was previously formed as a new holding company for these combined
businesses. In connection with the B&W business combination, B&W acquired beneficial
ownership of approximately 42% of RAI’s outstanding common stock. In June 2015, in
connection with the Lorillard merger, the BAT Group invested $4.7 billion to maintain its
approximate 42% equity position in RAI following the Lorillard merger.
BAT’s ordinary shares are listed on the LSE under the trading symbol “BATS” and are
classified as a premium listing. BAT ordinary shares also have a secondary listing on the JSE
under the abbreviated name “BATS” and the trading symbol “BTI.”
BAT ordinary shares trade in the form of BAT ADSs in the United States. The currently
outstanding BAT ADSs have unlisted trading privileges on the NYSE MKT where they trade
under the trading symbol “BTI.” None of BAT’s securities are currently listed on any U.S.
securities exchange or registered pursuant to the securities laws of the United States.
BAT’s principal executive offices are located at Globe House, 4 Temple Place, London
WC2R 2PG, United Kingdom, and its telephone number is +44 (0) 207 845 1000. BAT’s
website address is www.bat.com. The web address of BAT has been included as an inactive
textual reference only. BAT’s website and the information contained therein or connected thereto
are not intended to be incorporated into this proxy statement/prospectus.
Flight Acquisition Corporation
Flight Acquisition Corporation, referred to as Merger Sub, is a North Carolina corporation
and an indirect, wholly owned subsidiary of BAT. Merger Sub was incorporated on January 12,
2017, solely for the purpose of effecting the merger. It has not carried on any activities to date,
except for activities incidental to its formation and activities undertaken in connection with the
transactions contemplated by the merger agreement. Merger Sub’s principal executive offices are
located at Wells Fargo Capitol Center, Suite 2300, 150 Fayetteville Street, Raleigh, North
Carolina 27601, and its telephone number is (919) 821-6731.
Reynolds American Inc.
RAI, the parent company of the RAI Group, is a holding company whose wholly owned
operating subsidiaries include the second largest tobacco company in the United States, RJR
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Tobacco Company; SFNTC, the manufacturer and marketer of the NATURAL AMERICAN
SPIRIT brand of cigarettes and other tobacco products in the United States; the second largest
smokeless tobacco products manufacturer in the United States, American Snuff Company, LLC;
R. J. Reynolds Vapor Company, referred to as RJR Vapor, a marketer of digital vapor cigarettes
in the United States; Niconovum USA, Inc. and Niconovum AB, marketers of nicotine
replacement therapy products in the United States and Sweden, respectively; and until their sale
on January 13, 2016, SFR Tobacco International GmbH, referred to as SFRTI, and various
foreign subsidiaries affiliated with SFRTI, distributors and marketers of the NATURAL
AMERICAN SPIRIT brand of cigarettes and other tobacco products outside the United States.
RAI’s reportable operating segments include the RJR Tobacco segment, the Santa Fe
segment and the American Snuff segment:
• The RJR Tobacco segment consists of the primary operations of RJR Tobacco Company
and includes three of the top four best-selling cigarettes in the United States:
NEWPORT, CAMEL and PALL MALL. These brands, and RJR Tobacco’s other
brands, including DORAL, MISTY and CAPRI, are manufactured in a variety of styles
and marketed in the United States. As part of its total tobacco strategy, RJR Tobacco
offers a smokeless tobacco product, CAMEL Snus. RJR Tobacco manages contract
manufacturing of cigarettes and tobacco products through arrangements with BAT
affiliates, and manages the export of tobacco products to U.S. territories, U.S. duty-free
shops and U.S. overseas military bases. In the United States, RJR Tobacco also manages
the premium cigarette brands DUNHILL, which RJR Tobacco Company licenses from
the BAT Group, and STATE EXPRESS 555, which RJR Tobacco Company licenses
from CTBAT International Co. Ltd., referred to as CTBAT, a joint venture between the
BAT Group and China National Tobacco Corporation, referred to as CNTC.
• The Santa Fe segment consists of the primary operations of SFNTC and includes the
manufacturing and marketing of premium cigarettes and other tobacco products under
the NATURAL AMERICAN SPIRIT brand in the United States.
• The American Snuff segment consists of the primary operations of American Snuff
Company, LLC. American Snuff is the second largest smokeless tobacco products
manufacturer in the United States,
and offers adult tobacco consumers a range of differentiated smokeless tobacco products,
primarily moist snuff. The moist snuff category is divided into premium, price-value and
popular-price brands. American Snuff’s primary brands include its largest selling moist
snuff brands, GRIZZLY, in the price-value category, and KODIAK, in the premium
category.
Included in All Other, among other RAI subsidiaries, are RJR Vapor, Niconovum USA,
Inc., Niconovum AB, and until their sale on January 13, 2016, SFRTI and various foreign
subsidiaries affiliated with SFRTI.
RAI was incorporated in the State of North Carolina on January 2, 2004, and its common
stock is listed on the NYSE under the trading symbol “RAI.” RAI’s headquarters are located at
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401 North Main Street, Winston-Salem, North Carolina 27101, and its telephone number is
(336) 741-2000. RAI’s website address is www.reynoldsamerican.com. The web address of RAI
has been included as an inactive textual reference only. RAI’s website and the information
contained therein or connected thereto are not intended to be incorporated into this proxy
statement/prospectus.
Special Meeting (See page 200)
General
The special meeting will be held at 9:00 a.m. (Eastern Time), on July 19, 2017, in the
Reynolds American Plaza Building Auditorium at RAI’s corporate offices, 401 North Main
Street, Winston-Salem, North Carolina 27101. At the special meeting, RAI shareholders will be
asked to vote on the approval of the merger agreement. In addition, RAI shareholders will be
asked to vote on the approval of, on a non-binding, advisory basis, the transaction-related named
executive officer compensation and to vote on the approval of the adjournment of the special
meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes
to approve the merger agreement.
The approval of the merger agreement by RAI shareholders, including the unaffiliated
shareholder approval, is a condition to the obligations of BAT and RAI to complete the merger.
The approval, on a non-binding, advisory basis, of the transaction-related named executive
officer compensation is not a condition to the obligations of BAT or RAI to complete the merger.
The approval of the adjournment of the special meeting, if necessary or appropriate, to solicit
additional proxies if there are not sufficient votes to approve the merger agreement also is not a
condition to the obligations of BAT or RAI to complete the merger.
Record Date
The RAI board of directors has fixed the close of business on June 12, 2017, as the RAI
record date, for determination of the RAI shareholders entitled to vote at the special meeting and
any adjournment or postponement thereof. Only RAI record holders on the RAI record date are
entitled to receive notice of, and to vote at, the special meeting or any adjournment or
postponement thereof.
As of the RAI record date, there were 1,426,422,676 shares of RAI common stock
outstanding and entitled to vote at the special meeting, held by approximately 11,529 record
holders. As of the RAI record date, there were 1,000,000 shares of Series B preferred stock of
RAI, all of which is owned by a wholly owned subsidiary of RAI and are not entitled to vote. Of
the 1,426,422,676 shares of RAI common stock outstanding and entitled to vote at the special
meeting, 825,054,505 shares are not owned, directly or indirectly, by the BAT Group or any of
RAI’s subsidiaries. Pursuant to the terms of the merger agreement, BAT has agreed to cause all
shares of RAI common stock held by the BAT Group to be voted in favor of approval of the
merger agreement and the other proposals to be considered at the special meeting. However,
while the shares of RAI common stock held by the BAT Group will be included for purposes of
determining whether, as required by law, a majority of the outstanding shares of RAI capital
stock have approved the merger agreement, completion of the merger also requires receipt of the
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unaffiliated shareholder approval. Each outstanding share of RAI common stock is entitled to
one vote. The number of shares you own is reflected on your proxy card.

Quorum
A quorum of shareholders is necessary to hold a valid meeting. The record holders, present
in person or by proxy at the special meeting, of a majority of the shares of RAI common stock
entitled to vote constitute a quorum. Abstentions and broker non-votes will be counted in
determining the existence of a quorum.
Required Vote
Item
RAI Proposal I

Approval of the Merger Agreement

Vote Necessary*
Approval requires the affirmative vote,
in person or by proxy, of holders of a
majority of the outstanding shares of
RAI capital stock entitled to vote as of
the RAI record date. The Series B
preferred stock of RAI, all of which is
owned by a wholly owned subsidiary
of RAI, is not entitled to vote.
Approval also requires obtaining the
unaffiliated shareholder approval,
which requires the affirmative vote of
a majority of the outstanding shares of
RAI common stock that are entitled to
vote as of the RAI record date and
present (in person or by proxy) and
voting at the special meeting that are
not owned by the BAT Group or any
of RAI’s subsidiaries.

RAI Proposal II Non-Binding, Advisory Vote on
Approval requires the affirmative vote
Transaction-Related Named Executive of holders of a majority of the shares
Officer Compensation
of RAI common stock that are entitled
to vote as of the RAI record date and
present (in person or by proxy) and
voting at the special meeting.
RAI Proposal III Adjournment of Special Meeting

Approval requires the affirmative vote
of holders of a majority of the shares
of RAI common stock that are entitled
to vote as of the RAI record date and
present (in person or by proxy) and
voting at the special meeting.
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* Under the rules of the NYSE, if you hold your shares of RAI common stock in street name,
your nominee or intermediary may not vote your shares without instructions from you. Without
your voting instructions, a broker non-vote will occur on RAI Proposal I, RAI Proposal II and
RAI Proposal III. Abstentions from voting and broker non-votes will have the same effect as a
vote “AGAINST” approval of the merger agreement by holders of a majority of the
outstanding shares of RAI capital stock entitled to vote as of the RAI record date; however,
abstentions from voting and broker non-votes will have no effect on determining whether the
unaffiliated shareholder approval is obtained. Abstentions and broker non-votes will have no
effect on RAI Proposal II or RAI Proposal III.
Share Ownership of and Voting by RAI Directors and Executive Officers
At the RAI record date, RAI’s directors and executive officers and their affiliates
beneficially owned and had the right to vote 1,648,567 shares of RAI common stock at the
special meeting, which represents less than 1.00% of the shares of RAI common stock entitled to
vote at the special meeting.
RAI’s directors and executive officers intend to vote their shares “FOR” the approval of the
merger agreement, “FOR” the approval, on a non-binding, advisory basis, of the transactionrelated named executive officer compensation and “FOR” the approval of the adjournment of
the special meeting, if necessary or appropriate, to solicit additional proxies if there are not
sufficient votes to approve the merger agreement.
The Merger and the Merger Agreement (See page 207)
The merger agreement provides that, on the terms and subject to the conditions in the
merger agreement, and in accordance with the NCBCA, upon the completion of the merger,
Merger Sub will merge with and into RAI. As a result of the merger, the separate corporate
existence of Merger Sub will cease, and RAI will continue as the surviving corporation in the
merger and an indirect, wholly owned subsidiary of BAT. The merger will not be completed
without the approval of the merger agreement by RAI shareholders, including the unaffiliated
shareholder approval.
A copy of the merger agreement is attached as Annex A to this proxy statement/prospectus.
You are urged to read the merger agreement in its entirety because it is the legal document
that governs the merger. See “Special Factors Relating to RAI Proposal I: Approval of the
Merger Agreement” and “The Merger Agreement” beginning on pages 41 and 207, respectively,
of this proxy statement/prospectus.
Assuming the satisfaction (or, to the extent legally permissible, waiver) of the conditions to
BAT’s and RAI’s obligations to complete the merger, BAT and RAI expect the merger to be
completed on or about July 25, 2017. However, the merger is subject to various conditions, and it
is possible that factors outside the control of BAT and RAI could result in the merger being
completed at a later time, or not at all. An end date of December 31, 2017, after which the parties
may terminate the merger agreement, has been set for the completion of the merger, subject to an
extension of five business days if, on December 31, 2017, BAT has not completed all or any
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portion of the financing it needs to fund the merger and the transactions contemplated by the
merger agreement. Financing, however, is not a condition to the completion of the merger.
What RAI Shareholders Will Receive in the Merger (See page 208)
If the merger is completed, each share of RAI common stock (other than shares of RAI
common stock owned by the BAT Group or excluded holders) automatically will be converted
into the right to receive the merger consideration, consisting of (1) a number of BAT ADSs
representing 0.5260 of a BAT ordinary share plus (2) $29.44 in cash, without interest. No
fractional BAT ADSs will be issued in the merger, and RAI shareholders will receive cash in
lieu of fractional BAT ADSs.
Based on the closing price of a BAT ordinary share of £47.63 and the Sterling-Dollar
exchange rate of 1.2056, in each case, on January 16, 2017, the last trading day of the BAT
ordinary shares before the public announcement of the merger agreement, the merger
consideration represented approximately $59.64 in value per share of RAI common stock. Based
on the closing price of a BAT ordinary share of £54.62 and the Sterling-Dollar exchange rate of
1.2662, in each case, on June 12, 2017, the most recent practicable trading day prior to the date
of this proxy statement/prospectus, the merger consideration represented approximately $65.82
in value for each share of RAI common stock. Because the merger agreement provides for a
fixed number of BAT ADSs and BAT ordinary shares underlying those BAT ADSs to be
issued as part of the consideration payable in exchange for each share of RAI common
stock, the value of the merger consideration that RAI shareholders will receive will depend
on the market price of BAT ordinary shares underlying such BAT ADSs and the SterlingDollar exchange rate at the time the merger is completed. As a result, the value of the
merger consideration that RAI shareholders will receive upon the completion of the merger
could be greater than, less than or the same as the value of the merger consideration on the
date of this proxy statement/prospectus or at the time of the special meeting.

BAT’s Purposes and Reasons for the Merger (See page 54)
For the factors considered by the BAT board of directors in approving the merger
agreement, see “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—BAT’s Purposes and Reasons for the Merger” beginning on page 54 of this proxy
statement/prospectus.
RAI’s Purposes and Reasons for the Merger; Recommendation of the Transaction
Committee; Recommendation of the RAI Board of Directors (See page 62)
The Transaction Committee, after extensive negotiations with BAT, unanimously
(1) determined that entering into the merger agreement and completing the merger and the other
transactions contemplated by the merger agreement are fair to and in the best interests of RAI
and its shareholders (other than BAT and its affiliates), (2) approved, adopted and authorized the
merger agreement, including the merger and the other transactions contemplated thereby,
(3) recommended to the RAI board of directors that the RAI board of directors approve, adopt
and authorize the merger agreement, including the merger and the other transactions
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contemplated thereby, (4) recommended that RAI shareholders approve the merger agreement
and (5) declared the merger agreement and the merger advisable.
The RAI board of directors (other than Mr. Abelman and Mr. Oberlander, who recused
themselves from all discussion and consideration of the merger), having received the unanimous
approval and recommendation of the Transaction Committee, (1) adopted the merger agreement,
including the merger and the other transactions contemplated thereby, (2) determined that the
terms of the merger and the other transactions contemplated by the merger agreement are fair to
and in the best interests of RAI and its shareholders (other than BAT and its affiliates),
(3) recommended that RAI shareholders approve the merger agreement and (4) declared that the
merger agreement and the merger are advisable.
The RAI board of directors recommends that RAI shareholders vote “FOR” the approval of
the merger agreement. For the factors considered by the RAI board of directors in reaching this
decision, see “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
RAI’s Purposes and Reasons for the Merger; Recommendation of the Transaction Committee;
Recommendation of the RAI Board of Directors” beginning on page 62 of this proxy
statement/prospectus.
In addition, the RAI board of directors recommends that RAI shareholders vote “FOR” the
approval, on a non-binding, advisory basis, of the transaction-related named executive officer
compensation and “FOR” the approval of the adjournment of the special meeting, if necessary or
appropriate, to solicit additional proxies if there are not sufficient votes to approve the merger
agreement. See “RAI Proposal II: Non-Binding, Advisory Vote on Transaction-Related Named
Executive Officer Compensation” and “RAI Proposal III: Adjournment of Special Meeting”
beginning on pages 349 and 350, respectively, of this proxy statement/prospectus for a more
detailed discussion of the recommendation.
Opinion of the Transaction Committee’s Financial Advisor (See page 70)
The Transaction Committee retained Goldman Sachs as its financial advisor in connection
with the merger. In connection with this engagement, the Transaction Committee requested that
Goldman Sachs deliver the opinion described below.
Opinion of Goldman Sachs
On January 16, 2017, Goldman Sachs rendered its oral opinion, which was subsequently
confirmed in writing, to the RAI board of directors and the Transaction Committee that, as of
January 16, 2017, and based upon and subject to the factors and assumptions set forth therein,
the consideration, consisting of (1) a number of
BAT ADSs (each BAT ADS representing, as of the date of the opinion, two BAT ordinary
shares and currently representing one BAT ordinary share) equal to 0.5260 divided by the ADS
Ratio (as defined in the merger agreement), plus (2) $29.44 in cash, to be paid to the holders of
shares of RAI common stock (other than the BAT Group) pursuant to the merger agreement was
fair from a financial point of view to such holders, the amounts in (1) and (2) collectively
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referred to as the merger consideration throughout this section and in other instances where the
opinion of Goldman Sachs is referenced.
The full text of the written opinion of Goldman Sachs, dated January 16, 2017, which
sets forth the assumptions made, procedures followed, matters considered and limitations
on the review undertaken in connection with the opinion, is attached as Annex B to this
proxy statement/prospectus. The summary of the Goldman Sachs opinion provided in this
proxy statement/prospectus is qualified in its entirety by reference to the full text of
Goldman Sachs’ written opinion. Goldman Sachs’ advisory services were provided for the
information and assistance of the Transaction Committee and Goldman Sachs’ opinion was
provided for the information and assistance of the RAI board of directors and the
Transaction Committee, in each case in connection with their consideration of the merger.
The Goldman Sachs opinion is not a recommendation as to how any holder of shares of
RAI common stock should vote with respect to the merger or any other matter.
The full text of Goldman Sachs’ written opinion, dated January 16, 2017, should be
read carefully and in its entirety for a description of the assumptions made, procedures
followed, matters considered and qualifications and limitations on the opinion and the
review undertaken by Goldman Sachs in connection with rendering its opinion.
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval
of the Merger Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion
of Goldman Sachs” beginning on page 70 of this proxy statement/prospectus, which is qualified
in its entirety by reference to the full text of Goldman Sachs’ written opinion.
Opinions of RAI’s Financial Advisors (See page 80)
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in
connection with the merger. In connection with this engagement, the RAI board of directors
requested that RAI’s financial advisors deliver the opinions described below.
Opinion of J.P. Morgan
On January 16, 2017, at the meeting of the RAI board of directors at which the merger
agreement was approved, J.P. Morgan rendered to the RAI board of directors an oral opinion,
subsequently confirmed by delivery to the RAI board of directors of a written opinion, dated
January 16, 2017, to the effect that, as of such date and based upon and subject to the factors,
procedures, qualifications, assumptions and any limitations set forth in its written opinion, the
consideration per share of RAI common stock, consisting of (1) a number of BAT ADSs
representing 0.5260 of a BAT ordinary share as of the effective time of the proposed merger plus
(2) $29.44 in cash, taken together, to be paid to the holders of RAI common stock (other than the
BAT Group) in the proposed merger was fair, from a financial point of view, to such holders (the
consideration described in (1) and (2) is being collectively referred to as the merger
consideration throughout this section).
The full text of J.P. Morgan’s written opinion, dated January 16, 2017, is attached as Annex
C to this proxy statement/prospectus and is incorporated herein by reference. The full text of the
opinion contains a discussion of, among other things, the assumptions made, procedures
26

followed, matters considered and qualifications and any limitations on the opinion and the
review undertaken by J.P. Morgan in connection with rendering its
opinion. The summary of the opinion of J.P. Morgan set forth in this proxy
statement/prospectus is qualified in its entirety by reference to the full text of such opinion.
RAI shareholders are urged to read J.P. Morgan’s opinion attached as Annex C and the
summary beginning on page 81 of this proxy statement/prospectus carefully and in their
entirety. J.P. Morgan’s opinion was addressed to the RAI board of directors (in its capacity as
such) in connection with and for the purposes of its evaluation of the merger, was directed only
to the fairness, from a financial point of view, of the merger consideration to be paid to the
holders of RAI common stock (other than the BAT Group) in the merger and did not address any
other aspect of the merger. J.P. Morgan was not authorized to and did not solicit any expressions
of interest from any other parties with respect to the sale of all or any part of RAI or any other
alternative transaction. J.P. Morgan expressed no opinion as to the fairness of any consideration
to be paid in connection with the merger to the holders of any other class of securities, creditors
or other constituencies of RAI or as to the underlying decision by RAI to engage in the merger.
The issuance of J.P. Morgan’s opinion was approved by a fairness committee of J.P. Morgan.
The opinion does not constitute a recommendation to any shareholder of RAI as to how such
shareholder should vote with respect to the merger or any other matter. The full text of J.P.
Morgan’s written opinion, dated January 16, 2017, should be read carefully and in its
entirety for a description of the assumptions made, procedures followed, matters
considered and qualifications and any limitations on the opinion and the review
undertaken by J.P. Morgan in connection with rendering its opinion.
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval
of the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of J.P. Morgan”
beginning on page 81 of this proxy statement/prospectus, which is qualified in its entirety by
reference to the full text of J.P. Morgan’s written opinion.
Opinion of Lazard
On January 16, 2017, at a meeting of the RAI board of directors held to evaluate the
merger, Lazard rendered to the RAI board of directors an oral opinion, which was confirmed by
delivery of a written opinion dated January 16, 2017, to the effect that, as of that date and based
upon and subject to the matters described in its opinion, the merger consideration per share of
RAI common stock, consisting of (1) a number of BAT ADSs representing 0.5260 of a BAT
ordinary share plus (2) $29.44 in cash to be paid to holders of shares of RAI common stock,
other than the BAT Group and holders of shares of RAI common stock who have not voted, or
caused or permitted to be voted, any shares of RAI common stock in favor of the adoption of the
plan of merger, as defined in the merger agreement, at the special meeting and who have
properly asserted (and not lost or effectively withdrawn) their rights of appraisal in accordance
with Article 13 of the NCBCA, was fair, from a financial point of view, to such holders.
The full text of Lazard’s written opinion, dated January 16, 2017, to the RAI board of
directors which sets forth, among other things, the procedures followed, assumptions made,
matters considered and limitations on the scope of review undertaken, is attached to this proxy
statement/prospectus as Annex D and is incorporated into this proxy statement/prospectus by
reference. The summary of Lazard’s opinion set forth in this proxy statement/prospectus is
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qualified in its entirety by reference to the full text of Lazard’s written opinion attached as Annex
D. You are encouraged to read Lazard’s opinion and this section carefully and in their entirety.
Lazard’s opinion was for the benefit of the RAI board of directors (in its capacity as such)
and Lazard’s opinion was rendered to the RAI board of directors in connection with its
evaluation of the merger. Lazard’s opinion was not intended to and does not constitute a
recommendation to any RAI shareholder as to how such shareholder should vote or act
with respect to the merger or any matter relating thereto.
The full text of Lazard’s written opinion, dated January 16, 2017, should be read
carefully and in its entirety for a description of the procedures followed, assumptions
made, matters considered and limitations on the scope of the review undertaken by Lazard
in connection with its opinion.
For a summary of the opinion, see “Special Factors Relating to RAI Proposal I: Approval
of the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of Lazard”
beginning on page 96 of this proxy statement/prospectus, which is qualified in its entirety by
reference to the full text of Lazard’s written opinion.
Financing of the Merger (See page 113)
BAT currently intends to finance the cash portion of the merger consideration, which is
estimated to be $24.4 billion, and related fees and expenses with drawings under the acquisition
facility.
On January 16, 2017, B.A.T. International Finance p.l.c. and B.A.T Capital Corporation,
each a wholly owned subsidiary of BAT, as original borrowers, and BAT, as guarantor, entered
into an acquisition facility with HSBC Bank plc, as agent, HSBC Bank USA, National
Association, as U.S. agent, and the financial institutions party thereto, as mandated lead
arrangers and banks. Under the acquisition facility, the lenders are providing unsecured and
unsubordinated term loan facilities in an aggregate principal amount of up to $25.0 billion,
available for the purpose of financing the merger, paying related taxes, fees, costs and expenses
and refinancing an existing revolving credit facility of RAI.
The acquisition facility consists of four credit facilities: (1) a $15.0 billion bridge facility
which, subject to two six-month extension options exercisable at BAT’s option, matures on the
date falling 12 months after the earlier of (a) the date that the merger is completed and (b) the
business day falling six months after January 16, 2017 (the earlier of (a) and (b) being referred to
as the start date), (2) a $5.0 billion bridge facility which, subject to two six-month extension
options exercisable at BAT’s option, matures on the date falling 24 months after the start date,
(3) a $2.5 billion term loan which matures on the date falling 36 months after the start date and
(4) a $2.5 billion term loan which matures on the date falling 60 months after January 16, 2017.
It is currently expected that the funded acquisition facility will be refinanced by bond issuances
in due course. As an alternative to drawing on the acquisition facility, BAT may issue new bonds
to finance a portion of the cash portion of the merger consideration. BAT has not entered into
any definitive documentation with respect to any such bond issuances. There can be no assurance
that any replacement, supplemental or refinance financing will be available at all or on
acceptable terms.
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See “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Financing of the Merger” beginning on page 113 of this proxy statement/prospectus.
Interests of Certain RAI Directors and Executive Officers (See page 115)
When considering the recommendation of the RAI board of directors that RAI shareholders
approve the merger agreement, you should be aware that certain RAI directors and executive
officers have interests in the merger that are different from, or in addition to, those of RAI
shareholders generally. These interests may present such directors and executive officers with
actual or potential conflicts of interest. The RAI board of directors and the Transaction
Committee were aware of these interests during their deliberations on the merits of the merger
and in deciding to recommend that RAI shareholders vote to approve the merger agreement at
the special meeting.
These interests include:
• Treatment of Equity Awards for RAI Executive Officers. RAI’s executive officers have
been granted RAI RSUs and RAI performance shares. Under the terms of the merger
agreement, upon the completion of the merger, (1) each outstanding cash-out RSU will
be canceled and converted into the right of the holder to receive the merger consideration
for each share of RAI common stock subject to such cash-out RSU, subject to applicable
proration, plus any accrued dividend equivalents earned in respect of such cash-out RSU,
in each case, less any required withholding taxes; and (2) each outstanding rollover RSU
will continue to be subject to substantially the same terms and conditions as were
applicable immediately prior to the completion of the merger and will be converted into a
restricted stock unit of BAT with respect to a target number of BAT ADSs (rounded
down to the nearest whole BAT ADS and with any fractional BAT ADSs settled in cash)
equal to the product of (a) the target number of shares of RAI common stock subject to
the rollover RSU immediately prior to the completion of the merger and (b) the RSU
exchange ratio, subject to adjustment as provided in the merger agreement to prevent
dilution.

29

• Treatment of Equity Awards for RAI Directors. Certain RAI directors hold RAI DSUs.
Under the terms of the merger agreement, upon the completion of the merger, (1) each
outstanding RAI DSU attributable to the DCP will be converted into a number of
deferred stock units tracking the value of BAT ADSs, determined by multiplying such
RAI DSU by the RSU exchange ratio, and the resulting deferred stock units will be
payable in accordance with the terms of the DCP and applicable existing deferral
elections, (2) each outstanding RAI DSU attributable to an initial stock award, a pro rata
annual stock award or an annual stock award under the EIAP will be converted into the
right of the holder to receive, as soon as practicable upon the completion of the merger,
either (a) cash equal in value to the merger consideration, (b) BAT ADSs, with the
number of BAT ADSs received based on the RSU exchange ratio, or (c) the merger
consideration, in all cases pursuant to each director’s election, less any applicable
withholding taxes, and (3) each outstanding RAI DSUs attributable to a quarterly equity
award under the EIAP will be converted into the right of the holder to receive cash equal
in value to the merger consideration, payable as soon as practicable upon the completion
of the merger, less any applicable withholding taxes.
• Treatment of Bonuses under Annual Incentive Award Program. RAI’s executive officers
are eligible to receive bonuses under the annual incentive award program. Under the
terms of the merger agreement, the 2017 annual bonuses will be calculated and paid in
the ordinary course of business consistent with past practice. In the event the completion
of the merger occurs prior to December 31, 2017, BAT and RAI will work together in
good faith to specify the process for determining the achievement of performance goals
with respect to the 2017 annual bonuses. Under the terms of the merger agreement, the
2017 annual bonuses will not vest or pay out upon the completion of the merger;
however, if an executive officer experiences an involuntary termination of employment
in 2017 where such executive officer is eligible for and accepts severance benefits, the
executive officer would be entitled to receive a pro-rated 2017 annual bonus payment
based on actual performance, with such proration based on the number of months,
rounded up to the nearest whole month, that have elapsed in fiscal year 2017 through the
termination date.
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• RAI Change in Control and Termination Benefits. RAI maintains two types of severance
arrangements with its executive officers that provide severance benefits upon certain
terminations of employment: (1) a standard form of severance agreement between certain
executive officers and RAI, referred to as a severance agreement, and (2) the ESP. The
severance agreements provide an executive officer party to such an agreement with
severance and other benefits following any such executive officer’s termination of
employment without cause or a termination of employment during the 24-month period
following an RAI change in control for “change of control good reason,” estimated at a
total of $34,141,559 for all executive officers who are party to a severance agreement as
a group, assuming the completion of the merger occurred on June 6, 2017 (the latest
practicable date, determined pursuant to Item 402(t) of Regulation S-K) and all such
executive officers were terminated without cause on such date. The ESP provides a
participating executive officer with severance and other benefits following such
executive officer’s termination of employment without cause or with “change in control
good reason” within the 24 months following an RAI change in control, or a termination
without cause during the 12-month period prior to an RAI change in control, estimated at
a total of $18,067,438 for all executive officers who are participants in the ESP as a
group, assuming the completion of the merger occurred on June 6, 2017 and all such
executive officers were terminated without cause on such date. The severance
arrangements applicable to certain of RAI’s executive officers have been modified in
connection with the merger as described below.
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• Retention Agreements and Severance Modifications. RAI has entered into arrangements
with certain of its executive officers, consisting of a retention agreement with each such
executive officer and modifications to the RAI severance arrangement applicable to the
executive officer described above. Pursuant to the retention agreement, each such
executive officer will be entitled to receive payment of a cash retention award if he or she
remains employed until either December 31, 2019 (with respect to Ms. Crew) or
December 31, 2020 (with respect to Mr. Fragnito and all other executive officers who are
party to a retention agreement). The total amount of retention awards that may become
payable to RAI’s executive officers, assuming employment until the applicable retention
date, is $4,950,000. In the event Ms. Crew’s, Mr. Fragnito’s or any other executive
officer’s employment is terminated for any reason prior to December 31, 2019 or
December 31, 2020, as applicable, the retention award for such executive officer will be
forfeited. Pursuant to the modifications to the severance arrangement applicable to him
or her, the severance payments and benefits available to each such executive officer
under the severance agreement or the ESP, as applicable and calculated as if the
executive officer had terminated employment on the date of the completion of the
merger, will be provided to such executive officer upon any termination of employment
other than for cause during the period beginning on the date of the completion of the
merger and ending on December 31, 2020 (with respect to Ms. Crew) or December 31,
2022 (with respect to Mr. Fragnito and all other executive officers subject to the
modified version of the severance agreement or the ESP, as applicable). Any termination
of employment other than for cause during the applicable period will also be considered a
termination of employment entitling the executive officer to severance benefits for
purposes of any annual bonus or equity arrangement of RAI, or any affiliate or successor
to RAI, that provides for special benefits upon such a termination.
• Indemnification and Insurance. RAI’s directors and executive officers are entitled to
continued indemnification and, for a period of six years following the completion of the
merger, insurance coverage through a “tail” directors’ and officers’ liability insurance
policy purchased by RAI or BAT.
Assuming the completion of the merger occurred on June 6, 2017 and all of RAI’s
executive officers experienced a vesting termination and a qualifying termination, or a modified
severance termination, as applicable, (each as defined below in “Special Factors Relating to RAI
Proposal I: Approval of the Merger Agreement—Interests of Certain RAI Directors and
Executive Officers”) on such date, (1) RAI’s named executive officers would potentially be
entitled to payments and other benefits with the following values: Susan M. Cameron - $0 (with
respect to her service as a named executive officer of RAI); Debra A. Crew - $25,640,634;
Andrew D. Gilchrist - $19,283,890; Martin L. Holton III - $10,417,090; Joseph P. Fragnito $6,158,886; and Jeffery S. Gentry - $2,498,272; and (2) RAI’s other executive officers as a
group would potentially be entitled to payments and other benefits with an aggregate value equal
to $53,694,634. Assuming the completion of the merger occurred on June 6, 2017 and a
complete payment under the DCP occurred at such time, RAI’s non-employee directors would be
entitled to payment of the following amounts with respect to RAI DSUs: Jerome B. Abelman $0; John A. Boehner - $853,478; Susan M. Cameron - $297,469 (with respect to her service on
the RAI board of directors in 2013 and 2014 prior to her re-reappointment as President and Chief
Executive Officer of RAI); Martin D. Feinstein - $9,025,127; Luc Jobin - $1,352,017; Murray S.
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Kessler - $89,867; Holly Keller Koeppel - $8,176,385; Robert Lerwill - $0; Jean-Marc Lévy $22,930; Nana Mensah - $3,490,767; Lionel L. Nowell, III - $11,230,609; Ricardo Oberlander $0; Ronald S. Rolfe - $689,349; Thomas C. Wajnert - $0; and John J. Zillmer - $1,615,969.
These interests may cause the directors and executive officers of RAI to view the proposals
relating to the merger differently and more favorably than RAI shareholders generally may view
them. For more information on the interests of RAI’s directors and executive officers in the
merger, including the individual components of and the assumptions underlying such payments
and benefits, see “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Interests of Certain RAI Directors and Executive Officers” beginning on page 115
of this proxy statement/prospectus.

Board of Directors of BAT Following the Merger (See page 135)
Pursuant to the merger agreement, BAT will take all actions necessary to cause three
directors serving on the RAI board of directors (other than directors designated for nomination
by B&W) immediately prior to completion of the merger to be appointed as members of the
BAT board of directors upon completion of the merger. Such directors will be selected by BAT
prior to the completion of the merger after consultation with the Transaction Committee. See
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—Board of
Directors of BAT Following the Merger” on page 135 of this proxy statement/prospectus.
Regulatory Approvals for the Merger (See page 136)
Completion of the merger is conditioned upon the expiration or termination of the waiting
period relating to the merger under the HSR Act and the earlier of the expiration of the waiting
period required by the Japanese merger control regulations and the receipt of clearance from the
Japan Fair Trade Commission.
Pursuant to the requirements of the HSR Act, BAT and RAI filed Notification and Report
Forms with respect to the merger with the FTC and DOJ on February 6, 2017 and requested early
termination of the HSR Act waiting period. The applicable HSR Act waiting period for the
merger expired on March 8, 2017.
On March 23, 2017, BAT and RAI filed notifications for the merger with the Japan Fair
Trade Commission. Approval from the Japan Fair Trade Commission was received on April 4,
2017. As a result of the foregoing, the conditions related to antitrust approvals required as part of
the closing conditions to the merger have now been satisfied.
There can be no assurances as to the absence of any litigation challenging regulatory
approvals received.
See “Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Regulatory Approvals for the Merger” beginning on page 136 of this proxy
statement/prospectus.
Material U.S. Federal Income Tax Consequences (See page 137)
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The receipt of BAT ADSs and cash in exchange for RAI common stock in the merger
generally will be a taxable transaction to U.S. holders (as defined in “Special Factors Relating to
RAI Proposal I: Approval of the Merger Agreement—Material U.S. Federal Income Tax
Consequences”) for U.S. federal income tax purposes. A U.S. holder of RAI common stock that
receives BAT ADSs and cash in the merger generally will recognize capital gain or loss equal to
the difference, if any, between (1) the sum of the fair market value of BAT ADSs and cash,
including any cash in lieu of fractional BAT ADSs, received in the merger, and (2) such holder’s
adjusted tax basis in such holder’s RAI common stock exchanged therefor. The determination of
the actual tax consequences of the merger to a holder of RAI common stock will depend on the
holder’s specific situation. Holders of RAI common stock should consult their own tax advisors
as to the tax consequences of the merger in their particular circumstances, including the
applicability and effect of the alternative minimum tax and any state, local, foreign or other tax
laws and of changes in those laws. See “Special Factors Relating to RAI Proposal I: Approval of
the Merger Agreement—Material U.S. Federal Income Tax Consequences” beginning on page
137 of this proxy statement/prospectus.
Material UK Tax Consequences (See page 142)
The receipt of BAT ADSs and cash in exchange for RAI common stock in the merger
generally will be a taxable transaction for UK tax purposes. A UK holder of RAI common stock
who receives BAT ADSs and cash in the merger generally will recognize a capital gain or loss
equal to the difference, if any, between (1) the sum of the fair market value of BAT ADSs and
cash, including any cash in lieu of fractional BAT ADSs, received in the
merger, and (2) such holder’s base cost for UK tax purposes in such holder’s RAI common stock
exchanged thereunder. The determination of the actual tax consequences of the merger for a UK
holder of RAI common stock will depend on the holder’s specific situation. Holders of RAI
common stock should consult their own tax advisors as to the tax consequences of the merger in
their particular circumstances, including the applicability and effect of any UK and foreign tax
laws and of changes in those laws. See “Special Factors Relating to RAI Proposal I: Approval of
the Merger Agreement—Material UK Tax Consequences” beginning on page 142 of this proxy
statement/prospectus.
Accounting Treatment (See page 145)
The merger will be accounted for as a business combination using the acquisition method of
accounting in accordance with IFRS under IFRS 3, Business Combinations, which requires that
one of the two companies in the merger be designated as the acquirer for accounting purposes
based on the evidence available. BAT will be treated as the accounting acquirer, and
accordingly, will record assets acquired, including identifiable intangible assets, and liabilities
assumed from RAI at their respective fair values at the date of completion of the merger. Any
excess of the purchase price over the net fair value of such assets and liabilities will be recorded
as goodwill. See “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Accounting Treatment” beginning on page 145 of this proxy statement/prospectus.
Treatment of RAI Equity Awards (See page 146)
Cash-Out RSUs
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Upon the completion of the merger, each outstanding cash-out RSU will be canceled and
converted into the right to receive (1) the merger consideration for each share of RAI common
stock subject to such cash-out RSU, subject to applicable proration, and (2) cash for any accrued
dividend equivalent right in respect of such cash-out RSU, in each case, less any required
withholding taxes. If a cash-out RSU is also an RAI performance share, the number of shares of
RAI common stock deemed subject to such cash-out RSU will be determined by the RAI board
of directors (or a committee of the RAI board of directors) prior to the completion of the merger
in accordance with the applicable award agreement and after reasonable consultation with BAT.
RAI DSUs
Upon the completion of the merger, each outstanding RAI DSU attributable to the DCP will
be converted into a number of deferred stock units tracking the value of BAT ADSs, determined
by multiplying such RAI DSU by the RSU exchange ratio, and the resulting deferred stock units
will be payable in accordance with the terms of the DCP and applicable existing deferral
elections. Upon the completion of the merger, each outstanding RAI DSU attributable to an
initial stock award, a pro rata annual stock award or an annual stock award under the EIAP will
be converted into the right of the holder to receive, as soon as practicable upon the completion of
the merger, either (1) cash equal in value to the merger consideration, (2) BAT ADSs, with the
number of BAT ADSs received based on the RSU exchange ratio, or (3) the merger
consideration, in all cases pursuant to each director’s election, less any applicable withholding
taxes. Upon the completion of the merger, each outstanding RAI DSU attributable to a quarterly
equity award under the EIAP will be converted into the right of the holder to receive cash equal
in value to the merger consideration, payable as soon as practicable upon the completion of the
merger, less any applicable withholding taxes.
Rollover RSUs
Upon the completion of the merger, each outstanding rollover RSU will be converted into a
restricted stock unit of BAT with respect to a target number of BAT ADSs (rounded down to the
nearest whole BAT ADS and with any fractional BAT ADSs settled in cash) equal to the product
of (1) the target number of shares of RAI
common stock subject to the rollover RSU immediately prior to the completion of the merger
and (2) the RSU exchange ratio, subject to adjustment as provided in the merger agreement to
prevent dilution (each referred to as an adjusted RSU). Each adjusted RSU will be subject to
substantially the same terms and conditions applicable to the related rollover RSU immediately
prior to the completion of the merger, except that the form of payment upon vesting and
settlement will be in BAT ADSs. If the rollover RSU was subject to performance-based vesting
prior to the completion of the merger, then the adjusted RSU will continue to provide for
performance-based vesting following the completion of the merger based on performance
metrics agreed upon by BAT and RAI.
Listing of BAT Ordinary Shares, Listing of BAT ADSs and Delisting and Deregistration of
RAI Common Stock (See page 148)
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Under the terms of the merger agreement, BAT is required to use its reasonable best efforts
to cause (1) the BAT ordinary shares underlying the BAT ADSs constituting the stock portion of
the merger consideration to be approved for admission to the premium listing segment of the
Official List of the UKLA and to trading on the main market for listed securities of the LSE,
subject only to the issue of such BAT ordinary shares upon completion of the merger, and (2) the
BAT ADSs to be issued as the stock portion of the merger consideration to be approved for
listing on the NYSE, subject to official notice of issuance, each prior to the completion of the
merger. It is a condition to both parties’ obligations to complete the merger that such approvals
are obtained. Accordingly, application will be made to have the BAT ordinary shares underlying
the BAT ADSs constituting the stock portion of the merger consideration approved for listing by
the UKLA and to trading on the main market for listed securities on the LSE and for the BAT
ADSs to be issued as the stock portion of the merger consideration approved for listing on the
NYSE. Application will also be made to have BAT ordinary shares underlying the BAT ADSs
constituting the stock portion of the merger consideration to be listed on the JSE.
As a result of the registration of BAT’s ordinary shares with the SEC pursuant to the
registration statement of which this proxy statement/prospectus forms a part, BAT will become
subject to the periodic reporting requirements under the Exchange Act and BAT’s ADR
program, including the existing BAT ADSs issued as part of that program, will be automatically
converted to a Level 3 ADR program upon completion of the merger with no action required by
the holders of existing BAT ADSs. Following the completion of the merger, existing BAT ADSs
will be fungible with the BAT ADSs to be issued as the stock portion of the merger
consideration.
If the merger is completed, there will no longer be any publicly held shares of RAI common
stock. Accordingly, RAI common stock will be delisted from the NYSE and will be deregistered
under the Exchange Act as soon as practicable following the completion of the merger, and RAI
will no longer be required to file periodic reports with the SEC in respect of RAI common stock.
Periodic Reporting under United States Securities Laws
Under the Exchange Act, for so long as BAT continues to qualify as a foreign private
issuer, BAT will be required to publicly file with the SEC an annual report on Form 20-F within
four months of the end of the financial year covered by the report. As a foreign private issuer,
BAT will also be required to publicly furnish to the SEC current reports on Form 6-K promptly
after the occurrence of specified significant events, including material information that it makes
or is required to make public pursuant to English law, files or is required to file with any stock
exchange on which BAT ordinary shares trade and which was made public by that exchange, or
is otherwise distributed or required to be distributed to shareholders of BAT. As a foreign private
issuer listed on the NYSE, BAT will also be required to submit semi-annual financial statements
on Form 6-K to the SEC within six months of the end of the relevant second quarter.
If BAT no longer qualified as a foreign private issuer, BAT would be required to publicly
file with the SEC an annual report on Form 10-K within 90, 75 or 60 days of the end of the
financial year covered by the report,
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with the time period determined based on BAT’s aggregate worldwide market value, the period
of time for which it has been subject to SEC reporting requirements and certain other factors. In
addition, BAT would be required to publicly file with the SEC quarterly reports on Form 10-Q
within 45 or 40 days (depending on the same factors) of the end of the applicable financial
quarter. BAT would also be required to publicly file with the SEC current reports on Form 8-K
typically within four business days after the occurrence of specified significant events, and under
Regulation FD, BAT would be required to simultaneously or promptly make public disclosure of
any material nonpublic information shared with securities market professionals or shareholders
of BAT who are reasonably likely to trade on the basis of the information. Further, BAT would
be subject to certain disclosure and procedural requirements applicable to proxy solicitations
under Section 14 of the Exchange Act, and members of the BAT board of directors, the BAT
Group management board and principal shareholders of BAT would be subject to the disclosure
and other requirements of Section 16 of the Exchange Act in respect of their ownership of, and
transactions in, BAT securities.
NYSE Rules
For so long as the BAT ADSs will be listed on the NYSE, BAT will be required to meet
certain requirements relating to ongoing communication and disclosure to holders of BAT ADSs,
including a requirement to make any annual report filed with the SEC simultaneously available
on or through BAT’s website and to comply with the timely alert policy of the NYSE with
respect to earnings and dividend announcements, combination transactions, tender offers, stock
splits, major management changes and any substantive items of an unusual or non-recurrent
nature. Subject to certain exceptions, the rules of the NYSE permit a foreign private issuer to
follow its home country practice in lieu of the corporate governance requirements of the NYSE,
including, for example, certain board, committee and director independence requirements.
Foreign private issuers are, however, required to comply with the audit committee independence
requirements imposed by Section 10A-3 of the Exchange Act. BAT will be required to disclose
any significant ways in which its corporate governance practices differ from those followed by
U.S. domestic companies under NYSE listing standards in its annual report on Form 20-F filed
with the SEC or on its website.
Merger Fees and Expenses (See page 153)
Generally, all fees and expenses incurred in connection with the merger and the other
transactions contemplated by the merger agreement will be paid by the party incurring such fees
and expenses, whether or not the merger is completed. See “Special Factors Relating to RAI
Proposal I: Approval of the Merger Agreement—Merger Fees and Expenses” beginning on page
153 of this proxy statement/prospectus. In certain circumstances, BAT or RAI may be required
to pay a termination fee to the other party.
Certain Effects of the Merger (See page 150)
If the conditions to the completion of the merger are either satisfied or, to the extent legally
permissible, waived, Merger Sub will be merged with and into RAI. As a result of the merger,
the separate corporate existence of Merger Sub will cease, and RAI will continue as the
surviving corporation in the merger and an indirect, wholly owned subsidiary of BAT. Upon the
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completion of the merger, each share of RAI common stock (other than shares of RAI common
stock owned by the BAT Group or excluded holders) will be automatically converted into the
right to receive the merger consideration, consisting of (1) a number of BAT ADSs representing
0.5260 of a BAT ordinary share plus (2) $29.44 in cash, without interest. No fractional BAT
ADSs will be issued in the merger, and RAI shareholders will receive cash in lieu of fractional
BAT ADSs. Following completion of the merger, RAI common stock will no longer be publicly
traded, and shareholders will cease to have any ownership interest in RAI.
No Solicitation of Takeover or Alternative Proposals (See page 216)
RAI has agreed, except as otherwise provided in the merger agreement, not to, and not to
authorize or permit any of its subsidiaries or any of its or their respective officers, directors,
employees or representatives to, directly or indirectly:
• solicit, initiate, knowingly encourage, induce or facilitate, or furnish or disclose nonpublic information in furtherance of, any “company takeover proposal,” as defined under
“The Merger Agreement—No Solicitation of Takeover or Alternative Proposals”
beginning on page 216 of this proxy statement/prospectus, or any inquiry or proposal that
would reasonably be expected to result in or lead to a company takeover proposal;
• enter into any agreement with respect to any company takeover proposal (except certain
confidentiality agreements in accordance with the merger agreement); or
• enter into, participate in or continue any discussions or negotiations with any person
(other than its representatives) regarding, or furnish or disclose to any person any nonpublic information with respect to, or otherwise cooperate in any way with any person
(whether or not a person making a company takeover proposal) with respect to, any
company takeover proposal or any inquiry or proposal that would reasonably be expected
to result in or lead to a company takeover proposal.
Additionally, RAI has agreed to (1) immediately cease and cause to be terminated all
discussions or negotiations with any person conducted prior to the date of the merger agreement
with respect to a company takeover proposal or any inquiry or proposal that would reasonably be
expected to result in or lead to a company takeover proposal, (2) promptly request each person, if
any, that has executed a confidentiality agreement in the last 12 months in respect of a company
takeover proposal to return or destroy all information RAI or its subsidiaries or representatives
have furnished to such person or its representatives and (3) reasonably promptly terminate all
physical and electronic data room access previously granted to any such person or its
representatives.
Notwithstanding these restrictions, the merger agreement provides that at any time prior to
obtaining the RAI shareholder approvals, RAI and its representatives may, in response to a
written company takeover proposal that the RAI board of directors or the Transaction Committee
determines in good faith (after consultation with its outside legal counsel and financial advisor)
is bona fide and constitutes, or is reasonably expected to result in or lead to, a “superior
proposal,” as defined under “The Merger Agreement—No Solicitation of Takeover or Alternative
Proposals” beginning on page 216 of this proxy statement/prospectus, and which was
38

unsolicited, was made after the date of the merger agreement and did not otherwise result from a
breach of the non-solicitation obligations described above, subject to compliance with the
provisions of the merger agreement described in the following paragraph, take the following
actions:
• furnish information to the person making such company takeover proposal and its
representatives (provided that all such information has been or is provided to BAT prior
to or substantially concurrent with the time it is provided to such person) pursuant to a
confidentiality agreement that meets certain requirements set forth in the merger
agreement; and
• participate in discussions regarding the terms of such company takeover proposal and the
negotiation of such terms with, and only with, the person or group of persons making
such company takeover proposal and its representatives,
in each case, if and so long as the RAI board of directors or the Transaction Committee, as
applicable, determines in good faith after consultation with its outside legal counsel that
providing such information or engaging in such negotiations or discussions is reasonably likely
to be required for the directors to comply with their fiduciary duties under applicable law.
The merger agreement also requires RAI to (1) promptly, and in any event within 24 hours,
advise BAT in writing of any company takeover proposal or any request for non-public
information or inquiry that would reasonably be expected to result in, lead to or that
contemplates a company takeover proposal, the identity of the person making such company
takeover proposal, request or inquiry and the material terms of such company takeover proposal,
request or inquiry, (2) keep BAT informed in all material respects on a reasonably current basis
of the status, including any change to the material terms of such company takeover proposal, and
(3) provide BAT copies of any draft definitive agreements or term sheets sent or provided to or
by RAI from or to any third party in connection with a company takeover proposal as soon as
practicable after receipt or delivery of the same.
BAT has agreed, except as otherwise provided in the merger agreement, not to, and not to
authorize or permit any of its subsidiaries or any of its or their respective officers, directors,
employees or representatives to, directly or indirectly:
• solicit, initiate, knowingly encourage, induce or facilitate, or furnish or disclose nonpublic information in furtherance of, an “alternative proposal,” as defined under “The
Merger Agreement—No Solicitation of Takeover or Alternative Proposals” beginning on
page 216 of this proxy statement/prospectus, or any inquiry or proposal that would
reasonably be expected to result in or lead to an alternative proposal;
• enter into any agreement with respect to any alternative proposal (except certain
confidentiality agreements in accordance with the merger agreement); or
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• enter into, participate in or continue any discussions or negotiations with any person
(other than its representatives) regarding, or furnish or disclose to any person any nonpublic information with respect to, or otherwise cooperate in any way with any person
(whether or not a person making an alternative proposal) with respect to, any alternative
proposal or any inquiry or proposal that would reasonably be expected to result in or lead
to an alternative proposal.
Additionally, BAT has agreed to (1) immediately cease and cause to be terminated all
discussions or negotiations with any person conducted prior to the date of the merger agreement
with respect to an alternative proposal or any inquiry or proposal that would reasonably be
expected to result in or lead to an alternative proposal, (2) promptly request each person, if any,
that has executed a confidentiality agreement in the last 12 months in respect of an alternative
proposal to return or destroy all information BAT or its subsidiaries or representatives have
furnished to such person or its representatives and (3) reasonably promptly terminate all physical
and electronic data room access previously granted to any such person or its representatives.
Notwithstanding these restrictions, the merger agreement provides that at any time prior to
obtaining the BAT shareholder approval, BAT and its representatives may, in response to a
written alternative proposal that the BAT board of directors determines in good faith (after
consultation with its outside legal counsel and financial advisor) is bona fide and constitutes, or
is reasonably expected to result in or lead to, a “superior alternative proposal,” as defined under
“The Merger Agreement—No Solicitation of Takeover or Alternative Proposals” beginning on
page 216 of this proxy statement/prospectus, and which was unsolicited, was made after the date
of the merger agreement and did not otherwise result from a breach of the non-solicitation
obligations described above, subject to compliance with the provisions of the merger agreement
described in the following paragraph, take the following actions:
• furnish information to the person making such alternative proposal and its representatives
(provided that all such information has been or is provided to RAI prior to or
substantially concurrent with the time it is provided to such person) pursuant to a
confidentiality agreement that meets certain requirements set forth in the merger
agreement; and
• participate in discussions regarding the terms of such alternative proposal and the
negotiation of such terms with, and only with, the person or group of persons making
such alternative proposal and its representatives,

in each case, if and so long as the BAT board of directors determines in good faith after
consultation with its outside legal counsel that providing such information or engaging in such
negotiations or discussions is reasonably likely to be required for the directors to comply with
their fiduciary duties under applicable law.
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The merger agreement also requires BAT to (1) promptly, and in any event within 24 hours,
advise RAI in writing of any alternative proposal or any request for non-public information or
inquiry that would reasonably be expected to result in or lead to or that contemplates an
alternative proposal, the identity of the person making such alternative proposal, request or
inquiry and the material terms of such alternative proposal, request or inquiry, (2) keep RAI
informed in all material respects on a reasonably current basis of the status, including any change
to the material terms of such alternative proposal, and (3) provide RAI copies of any draft
definitive agreements or term sheets sent or provided to or by such party from or to any third
party in connection with an alternative proposal as soon as practicable after receipt or delivery of
the same.
Completion of the Merger is Subject to Certain Conditions (See page 227)
The obligations of each of BAT and RAI to complete the merger are subject to the
satisfaction or, to the extent legally permissible (and except with respect to the condition
described in the second bullet below, which shall not be waivable) waiver on or prior to the
completion date of the following conditions:
• the approval of the merger agreement by holders of a majority of the outstanding shares
of capital stock of RAI entitled to vote as of the RAI record date (the Series B preferred
stock of RAI, all of which is owned by a wholly owned subsidiary of RAI, is not entitled
to vote);
• receipt of the unaffiliated shareholder approval;
• receipt of the BAT shareholder approval;
• the approval for listing of the BAT ADSs issuable as the stock portion of the merger
consideration on the NYSE (subject to official notice of issuance);
• the approval for admission of the BAT ordinary shares underlying the BAT ADSs
constituting the stock portion of the merger consideration on the premium listing
segment of the Official List of the UKLA and to trading on the main market for listed
securities of the LSE subject only to the issue of such BAT ordinary shares upon the
completion of the merger;
• the expiration or termination of the applicable waiting period under the HSR Act and the
earlier of the expiration of the waiting period required by the Japanese merger control
regulations and the receipt of clearance from the Japan Fair Trade Commission;
• the absence of any legal restraints that prevent, make illegal or prohibit the completion of
the merger or the issuance of the BAT ordinary shares underlying the BAT ADSs
constituting the stock portion of the merger consideration;
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• declaration by the SEC of the effectiveness of the registration statement filed on Form F4 of which this proxy statement/prospectus forms a part and of the registration statement
on Form F-6 relating to the BAT ADSs to be issued as the stock portion of the merger
consideration (and the absence of any stop order suspending the effectiveness of such
registration statements or any proceedings seeking such a stop order);
• the filing of the BAT prospectus and BAT circular with the UKLA, the approval of such
prospectus and circular by the UKLA and the mailing of the BAT circular and the
publishing of the BAT prospectus, in each case, in accordance with applicable rules and
regulations;
• the other party having performed in all material respects all obligations required to be
performed by it under the merger agreement that are required to be performed on or prior
to the completion date and each party having received a certificate signed by the chief
executive officer, chief financial officer or the finance director of the other party, as
applicable, certifying that such condition has been satisfied;
• the representations and warranties of the other party relating to organization, standing
and power, capital structure, authority, execution and delivery, enforceability, and, in the
case of RAI, the representations and warranties relating to brokers, schedules of fees and
expenses and opinions of financial advisors being true and correct in all material respects
as of the date of the merger agreement and as of the completion date (except to the extent
expressly made as of an earlier date, in which case, as of such earlier date);
• the representation and warranty of the other party relating to the absence of a material
adverse effect on the other party being true and correct in all respects as of the date of the
merger agreement and as of the completion date;
• each other representation and warranty of the other party being true and correct (ignoring
any “materiality” or “material adverse effect” qualifiers) as of the date of the merger
agreement and as of the completion date (except to the extent expressly made as of an
earlier date, in which case, as of such earlier date), except where the failure of such
representations and warranties to be so true and correct, individually and in the
aggregate, has not had and would not reasonably be expected to have a material adverse
effect; and
• receipt of an officer’s certificate executed by the chief executive officer, chief financial
officer or the finance director of the other party certifying that the three preceding
conditions have been satisfied.
In addition, the obligations of BAT and Merger Sub to complete the merger are conditioned
on the absence of any antitrust restriction, as defined under “The Merger Agreement—Efforts to
Complete the Merger” beginning on page 223 of this proxy statement/prospectus.
Termination of the Merger Agreement (See page 229)
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The merger agreement may be terminated at any time prior to the completion of the merger,
whether before or after receipt of the RAI shareholder approvals or the BAT shareholder
approval, under the following circumstances:
• by mutual written consent of BAT and RAI (in the case of RAI, acting through or on the
recommendation of the Transaction Committee); or
• by either BAT or RAI (in the case of RAI, acting through or on the recommendation of
the Transaction Committee) in the event that:
•

the merger is not completed by the end date, except that no party may terminate the
merger agreement if the merger is not completed by the end date if such party has
breached a representation, warranty or covenant in the merger agreement and such
breach has been a principal cause of or resulted in the failure of the transactions
contemplated by the merger agreement to be completed on or before the end date
(and, in the event all conditions to the completion of the merger have been satisfied
but the end date, by its terms, would occur before the expiration of the five business
days contemplated in the merger agreement (related to the completion of the
financing of the merger), the end date will be extended by the number of days
necessary to provide BAT with such five business day period);

•

a legal restraint that prevents, makes illegal or prohibits the completion of the
merger or the issuance of the BAT ordinary shares underlying the BAT ADSs
constituting the stock portion of the merger consideration has become final and
nonappealable, as long as the terminating party has complied in all material respects
with its obligations to use its reasonable best efforts to complete the merger and the
other transactions contemplated by the merger agreement as promptly as practicable
(as described in “The Merger Agreement—Efforts to Complete the Merger”
beginning on page 223 of this proxy statement/prospectus);
the RAI shareholders vote on and fail to approve the merger agreement at the
special meeting;

•
•

BAT shareholders vote on and fail to approve the merger agreement or to authorize
the BAT directors to allot and issue the BAT ordinary shares underlying the BAT
ADSs to be issued as the stock portion of the merger consideration at the general
meeting;
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•

the other party breaches or fails to perform any of its covenants or agreements in the
merger agreement, or if the other party’s representations or warranties fail to be true
and correct, in either case, such that the applicable conditions to the terminating
party’s obligations to complete the merger would not then be satisfied and such
breach is not capable of being cured by the end date or has not been cured within 30
days after giving written notice to the other party of such breach, except that no
party may terminate the merger agreement for this reason if such party is then in
material breach of any covenant or agreement in the merger agreement or if such
party’s representations or warranties are not true and correct such that the applicable
conditions to the other party’s obligations to complete the merger would not then be
satisfied; or

•

prior to obtaining the approval of the other party’s shareholders required to
complete the merger, the board of directors of the other party (or any committee
thereof) (1) withholds, withdraws, modifies or qualifies (in a manner adverse to the
terminating party) or proposes publicly to withhold, withdraw, modify or qualify (in
a manner adverse to the terminating party), its recommendation to its shareholders
to vote in favor of approving the merger agreement and in the case of BAT, the
share issuance, or (2) approves, recommends or declares advisable or proposes
publicly to approve, recommend or declare advisable an alternative proposal, as
defined under “The Merger Agreement—No Solicitation of Takeover or Alternative
Proposals” beginning on page 216 of this proxy statement/prospectus, in the case of
BAT, or a company takeover proposal, as defined under “The Merger Agreement—
No Solicitation of Takeover or Alternative Proposals” beginning on page 216 of this
proxy statement/prospectus, in the case of RAI.

If the merger agreement is terminated, the merger agreement will become void and have no
effect, without any liability or obligation on the part of any party, except in the case of a willful
and material breach of the merger agreement and except that certain provisions of the merger
agreement, including those relating to confidentiality, the indemnification obligations of BAT in
connection with the financing, fees and expenses (including termination fees), effect of
termination and certain other general provisions, will survive termination of the merger
agreement. If either party receives any payments for damages from another party as a result of a
breach of the merger agreement and also receives a termination fee, the amount of such
payments for damages made by the applicable party as a result of any such breaches will be
reduced by the amount of such termination fee.
Expenses and Termination Fees Under the Merger Agreement (See page 230)
Except as described below, each party will pay all fees and expenses incurred by it in
connection with the merger agreement and the transactions contemplated by the merger
agreement.
If the merger agreement is terminated, BAT will be entitled to receive a termination fee of
$1.0 billion from RAI in the event that:
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• the RAI board of directors or any committee thereof changes its recommendation and
either (1) the merger agreement is terminated because the RAI shareholder approvals are
not obtained at the special meeting or no special meeting is held prior to the end date or
(2) BAT terminates the merger agreement as a result of such change in recommendation;
or
• (1) the merger agreement is terminated (or in certain circumstances could have been
terminated) because the merger has not occurred by the end date (and at such time all
antitrust approvals have been
obtained and no legal restraint preventing the completion of the merger is in effect), the
RAI shareholder approvals are not obtained at the special meeting or RAI breached its
obligations under the merger agreement, (2) prior to such termination, shareholder vote
or breach, as applicable, and after the date of the merger agreement, a company takeover
proposal that contemplates acquiring a majority of the capital stock or assets of RAI was
made or made known to RAI or its shareholders and (3) within 12 months after such
termination, RAI or any of its subsidiaries enters into a definitive agreement with respect
to, or completes, such company takeover proposal.
If the merger agreement is terminated, RAI will be entitled to receive a termination fee of
$1.0 billion from BAT in the event that:
• the BAT board of directors or any committee thereof changes its recommendation and
either (1) the merger agreement is terminated because the BAT shareholder approval is
not obtained at the general meeting or no general meeting is held prior to the end date or
(2) RAI terminates the merger agreement as a result of such change in recommendation;
or
• (1) the merger agreement is terminated (or in certain circumstances could have been
terminated) because the merger has not occurred by the end date (and at such time all
antitrust approvals have been obtained, no legal restraint preventing the completion of
the merger is in effect and no antitrust restriction is in effect), the BAT shareholder
approval is not obtained at the general meeting or BAT breached its obligations under the
merger agreement, (2) prior to such termination, shareholder vote or breach, as
applicable, and after the date of the merger agreement, an alternative proposal that
contemplates acquiring a majority of the capital stock or assets of BAT is publicly
proposed or announced and (3) within 12 months after such termination, BAT enters into
a definitive agreement with respect to, or completes, such alternative proposal.
In addition, the merger agreement provides that RAI will be entitled to receive a
termination fee of $500.0 million from BAT in the event that the merger agreement is terminated
because the merger has not occurred by the end date and at the time of termination (1) all
antitrust approvals that are conditions to completion of the merger have not been obtained, a
legal restraint attributable to an antitrust law is in effect that prevents the completion of the
merger or an antitrust restriction is in effect and (2) all other conditions to completion of the
merger have been satisfied (or, in the case of any condition that by its nature is to be satisfied at
completion, would be satisfied if the completion were to occur on the date of such termination).
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The conditions related to antitrust approvals required as part of the conditions to completion of
the merger have been satisfied. RAI will also be entitled to receive a termination fee of $500.0
million from BAT in the event that the merger agreement is terminated because a legal restraint
attributable to an antitrust law that prevents the completion of the merger has become final and
nonappealable. BAT will not be required to pay the termination fees described in this paragraph
if RAI has not complied with its obligation to use reasonable best efforts to complete the merger
as promptly as practicable. See “The Merger Agreement—Efforts to Complete the Merger”
beginning on page 223 of this proxy statement/prospectus for details on the efforts RAI is
required to use to complete the merger.
Comparison of Shareholder Rights (See page 391)
RAI shareholders will have different rights once they become BAT shareholders due to
differences between the organizational documents of BAT and RAI and differences between
North Carolina law, where RAI is incorporated, and the laws of England and Wales, where BAT
is incorporated. See “Comparison of Shareholder Rights” beginning on page 391 of this proxy
statement/prospectus.
Appraisal Rights (See page 416 and Annex E)
Under North Carolina law, holders of shares of RAI common stock on the RAI record date
who (1) are entitled to vote on the proposal to approve the merger agreement, (2) do not vote in
favor of the proposal to
approve the merger agreement, (3) properly deliver notice of their intent to demand payment for
their shares of RAI common stock and (4) who otherwise comply with the requirements of
Article 13 of the NCBCA will be entitled to seek appraisal for, and obtain payment in cash for
the “fair value” of, their shares of RAI common stock (plus interest) in lieu of receiving the
merger consideration if the merger is completed. These rights are occasionally referred to as
appraisal rights in this proxy statement/prospectus. In addition, a participant in the RAI Savings
Plan or the Puerto Rico SIP, as applicable, who instructs the trustee of the RAI Savings Plan or
the custodian of the Puerto Rico SIP, as applicable, to not vote the shares of RAI common stock
that are considered allocated to such participant’s account in favor of the proposal to approve the
merger agreement may further instruct the trustee of the RAI Savings Plan or the custodian of the
Puerto Rico SIP, as applicable, to exercise appraisal rights in connection with the merger under
Article 13 of the NCBCA. The relevant provisions of the NCBCA are attached as Annex E to this
proxy statement/prospectus. You are encouraged to read these provisions carefully and in their
entirety.
A shareholder who properly asserts appraisal rights has no assurance that such holder will
receive an amount more than the merger consideration and, in fact, may receive an amount the
same as or even less than the merger consideration. This also applies to a participant in the RAI
Savings Plan or the Puerto Rico SIP, as applicable, who instructs the trustee of the RAI Savings
Plan or the custodian of the Puerto Rico SIP, as applicable, to exercise appraisal rights in
connection with the merger under Article 13 of the NCBCA. A beneficial owner may assert
appraisal rights only if such beneficial owner also submits to RAI the record holder’s written
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consent to such assertion not later than the “Demand Deadline” and may assert appraisal rights
only with respect to all shares of RAI common stock of which it is the beneficial owner.
To assist you in your determination of whether to assert your appraisal rights, copies of the
RAI Group’s consolidated financial statements (together with the report of RAI’s independent
registered public accounting firm regarding such statements) contained in RAI’s Annual Report
on Form 10-K for the year ended December 31, 2016, and the RAI Group’s unaudited condensed
consolidated financial statements contained in RAI’s Quarterly Report on Form 10-Q for the
quarter ended March 31, 2017, are attached as Annex G and Annex H, respectively, to this proxy
statement/prospectus. See “Where You Can Find More Information” beginning on page 445 of
this proxy statement/prospectus.
Multiple steps must be taken to properly assert and perfect appraisal rights. Moreover, due
to the complexity of the procedures for asserting the right to seek appraisal, shareholders who are
considering asserting such rights are encouraged to seek the advice of legal counsel. Failure to
comply strictly with these provisions may result in loss of the right of appraisal. Voting against
or abstaining from voting on the proposal to approve the merger agreement is not enough to
satisfy the requirements of the NCBCA. A shareholder must also comply with all of the
conditions relating to the separate written notice of intent to assert appraisal rights with respect to
the merger and the other requirements set forth in Article 13 of the NCBCA.
III.

GOLDMAN’S OPINION TO TRANSACTION COMMITTEE OF RAI BOARD
A.

PROXY DISCUSSION OF OPINION OF GOLDMAN

Opinion of the Transaction Committee’s Financial Advisor
The Transaction Committee retained Goldman Sachs as its financial advisor in connection
with the merger. In connection with this engagement, the Transaction Committee requested that
Goldman Sachs deliver the opinion described below.
Opinion of Goldman Sachs
On January 16, 2017, Goldman Sachs rendered its oral opinion, which was subsequently
confirmed in writing, to the RAI board of directors and the Transaction Committee that, as of
January 16, 2017, and based upon and subject to the factors and assumptions set forth therein,
the consideration, consisting of (1) a number of BAT ADSs (each BAT ADS representing, as of
the date of the opinion, two BAT ordinary shares and currently representing one BAT ordinary
share) equal to 0.5260 divided by the ADS Ratio (as defined in the merger agreement), plus
(2) $29.44 in cash, to be paid to the holders of shares of RAI common stock (other than the BAT
Group) pursuant to the merger agreement was fair from a financial point of view to such holders,
the amounts in (1) and (2) collectively referred to as the merger consideration throughout this
section and in other instances where the opinion of Goldman Sachs is referenced.
The full text of the written opinion of Goldman Sachs, dated January 16, 2017, which
sets forth the assumptions made, procedures followed, matters considered and limitations
on the review undertaken in connection with the opinion, is attached as Annex B to this
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proxy statement/prospectus. The summary of the Goldman Sachs opinion provided in this
proxy statement/prospectus is qualified in its entirety by reference to the full text of
Goldman Sachs’ written opinion. Goldman Sachs’ advisory services were provided for the
information and assistance of the Transaction Committee and Goldman Sachs’ opinion was
provided for the information and assistance of the RAI board of directors and the
Transaction Committee, in each case in connection with their consideration of the merger.
The Goldman Sachs opinion is not a recommendation as to how any holder of shares of
RAI common stock should vote with respect to the merger or any other matter.
In connection with rendering the opinion described above and performing its related
financial analyses, Goldman Sachs reviewed, among other things:
• the merger agreement;
• the Amended and Restated Deposit Agreement, dated as of December 1, 2008, by and
among BAT, the depositary and the holders and beneficial owners of the BAT ADSs
issued thereunder;
• annual reports to RAI shareholders and Annual Reports on Form 10-K of RAI for the
five fiscal years ended December 31, 2015, and annual reports to shareholders of BAT
for the five fiscal years ended December 31, 2015;
• certain interim reports to RAI shareholders and Quarterly Reports on Form 10-Q of RAI,
and certain interim reports to shareholders of BAT;
• certain other communications from RAI and BAT to their respective shareholders;
• certain publicly available research analyst reports for RAI and BAT;
• certain financial information for BAT prepared by its management; and
• certain internal financial analyses and forecasts for RAI and BAT prepared by RAI
management, in each case, as approved for Goldman Sachs’ use by RAI (which are
referred to in this section of the proxy statement/prospectus as the Forecasts and, in the
case of the RAI Forecasts, which are described below in the section entitled “—RAI
Unaudited Prospective Financial Information” beginning on page 108 of this proxy
statement/prospectus), including certain operating synergies projected by
RAI management to result from the merger, as approved for Goldman Sachs’ use by RAI
(referred to in this section of the proxy statement/prospectus as the Synergies).
Goldman Sachs also held discussions with members of the senior managements of RAI and
BAT regarding their assessment of the strategic rationale for, and the potential benefits of, the
merger and the past and current business operations, financial condition and future prospects of
RAI and BAT; reviewed the reported price and trading activity for the shares of RAI common
stock, the BAT ordinary shares and the BAT ADSs; compared certain financial and stock market
information for RAI and BAT with similar information for certain other companies the securities
of which are publicly traded; reviewed the financial terms of certain recent business
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combinations in the tobacco industry and in other industries; and performed such other studies
and analyses, and considered such other factors, as Goldman Sachs deemed appropriate.
For purposes of rendering its opinion described above, Goldman Sachs, with the consent of
RAI, relied upon and assumed the accuracy and completeness of all of the financial, legal,
regulatory, tax, accounting and other information provided to, discussed with or reviewed by
Goldman Sachs, without assuming any responsibility for independent verification thereof. In that
regard, Goldman Sachs assumed, with the consent of RAI, that the Forecasts, including the
Synergies, were reasonably prepared on a basis reflecting the best available estimates and
judgments of the management of RAI as of the date that Goldman Sachs rendered its opinion.
Goldman Sachs did not make an independent evaluation or appraisal of the assets and liabilities
(including any contingent, derivative or other off-balance-sheet assets and liabilities) of RAI or
BAT or any of their respective subsidiaries, nor was any such evaluation or appraisal furnished
to Goldman Sachs. Goldman Sachs assumed that all governmental, regulatory or other consents
and approvals necessary for the consummation of the merger will be obtained without any
adverse effect on RAI or BAT or on the expected benefits of the merger in any way meaningful
to its analysis. Goldman Sachs has also assumed that the merger will be consummated on the
terms set forth in the merger agreement, without the waiver or modification of any term or
condition the effect of which would be in any way meaningful to its analysis.
Goldman Sachs’ opinion does not address the underlying business decision of RAI to
engage in the merger, or the relative merits of the merger as compared to any strategic
alternatives that may be available to RAI; nor does it address any legal, regulatory, tax or
accounting matters. Goldman Sachs was not requested to solicit, and did not solicit, interest from
other parties with respect to an acquisition of, or other business combination with, RAI or any
other alternative transaction. Goldman Sachs’ opinion addresses only the fairness from a
financial point of view to the holders (other than the BAT Group) of shares of RAI common
stock, as of the date of the opinion, of the consideration to be paid to such holders pursuant to the
merger agreement. Goldman Sachs opinion does not express any view on, and does not address,
any other term or aspect of the merger agreement or the merger or any term or aspect of any
other agreement or instrument contemplated by the merger agreement or entered into or amended
in connection with the merger, including the fairness of the merger to, or any consideration
received in connection therewith by, the holders of any other class of securities, creditors, or
other constituencies of RAI; nor as to the fairness of the amount or nature of any compensation
to be paid or payable to any of the officers, directors or employees of RAI, or class of such
persons, in connection with the merger, whether relative to the consideration to be paid to the
holders (other than the BAT Group) of shares of RAI common stock pursuant to the merger
agreement or otherwise. Goldman Sachs does not express any opinion as to the prices at which
the BAT ADSs or the BAT ordinary shares will trade at any time or as to the impact of the
merger on the solvency or viability of RAI or BAT or the ability of RAI or BAT to pay their
respective obligations when they come due. Goldman Sachs’ opinion was necessarily based on
economic, monetary, market and other conditions as in effect on, and the information made
available to Goldman Sachs as of, the date of the opinion and Goldman Sachs assumed no
responsibility for updating, revising or reaffirming its opinion based on circumstances,
developments or events occurring after the date of its opinion. Goldman Sachs’ advisory services
were provided for the information and assistance of the Transaction Committee and Goldman
Sachs’ opinion was provided for the information and assistance of the RAI board of directors and
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the Transaction Committee, in each case in connection with their consideration of the merger,
and Goldman Sachs’ opinion does not constitute a recommendation as to how any holder of
shares of RAI common stock should vote with respect to the merger or any other matter.
Goldman Sachs’ opinion was approved by a fairness committee of Goldman Sachs.
Summary of Financial Analyses
The following is a summary of the material financial analyses delivered by Goldman Sachs
to the RAI board of directors and the Transaction Committee in connection with rendering the
opinion described above. The following summary, however, does not purport to be a complete
description of the financial analyses performed by Goldman Sachs, nor does the order of
analyses described represent relative importance or weight given to those analyses by Goldman
Sachs. Some of the summaries of the financial analyses include information presented in tabular
format. The tables must be read together with the full text of each summary and are alone not a
complete description of Goldman Sachs’ financial analyses. Except as otherwise noted, the
following quantitative information, to the extent that it is based on market data, is based on
market data as it existed on or before January 16, 2017 and is not necessarily indicative of
current market conditions.
Summary of the Merger Consideration. To calculate the implied value of the BAT ADSs to
be issued as part of the consideration to be paid to the holders (other than the BAT Group) of
shares of RAI common stock pursuant to the merger agreement, Goldman Sachs used a BAT
ADS to BAT ordinary share exchange ratio of 0.2630 (calculated by dividing the ordinary share
exchange ratio of 0.5260 by 2.0 since each BAT ADS represented two BAT ordinary shares as of
the date of the merger agreement, which was prior to the effective date of the BAT ADS ratio
change) and the closing price per BAT ADS on January 13, 2017 of $115.21 (before giving
effect to the BAT ADS ratio change). Goldman Sachs then calculated (1) the implied
consideration; (2) the premium represented by such implied consideration as compared to the
closing price per share of RAI common stock as of October 20, 2016, the last trading day prior to
BAT’s announcement of a proposal to merge with RAI; and (3) the total illustrative equity value
and EV implied by such implied consideration, calculated using the number of fully diluted
outstanding shares of RAI common stock, as per the merger agreement, and the net debt of RAI
as of December 31, 2016, as provided by RAI management. The following table presents a
summary of these calculations:
Cash Consideration
Ordinary Share Exchange Ratio
ADS Exchange Ratio(1)
Implied Stock Consideration as of
January 13, 2017
Implied Merger Consideration as of
January 13, 2017
Implied Premium to October 20, 2016
Illustrative Implied Equity Value
Illustrative Implied EV

$

29.44
0.5260x
0.2630x

$

30.30

$

59.74
26.6%
$ 85,608 million
$ 96,507 million
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(1) Calculated by dividing the ordinary share exchange ratio of 0.5260 by 2.0 since each BAT
ADS represented two BAT ordinary shares as of the date of the merger agreement, which
was prior to the effective date of the BAT ADS ratio change.
Illustrative Public Market Present Value of Future Share Price Analysis. Goldman Sachs
performed an illustrative analysis of the implied present value of the potential future value per
share of RAI common stock at the year-end of each of calendar years 2017 through 2020.
Goldman Sachs multiplied the one-year forward estimated earnings per share estimates for
calendar years 2018 through 2021, respectively, as set forth in the Forecasts, by forward price to
earnings per share multiples ranging from 16.5x to 20.2x. The calculation was adjusted for the
present value of shares of RAI common stock repurchased and estimated dividends per share of
common stock paid, as per the RAI Forecasts. Goldman Sachs then discounted these values for
calendar years 2017 through 2020 back to December 31, 2016 using a discount rate of 6.5%,
reflecting an estimate of RAI’s cost of equity. The following table presents the results of
Goldman Sachs’ analysis:
Illustrative Present Value
of Future Share Price
$45.03 – $54.69
$47.34 – $57.09
$51.20 – $61.38
$54.72 – $65.24

Dec-2017
Dec-2018
Dec-2019
Dec-2020

Illustrative Discounted Cash Flow Analysis. Using the Forecasts, Goldman Sachs
performed an illustrative discounted cash flow analysis on RAI. Utilizing illustrative discount
rates ranging from 5.0% to 6.5%, reflecting estimates of RAI’s weighted average cost of capital,
Goldman Sachs, using mid-year convention, discounted to present value as of December 31,
2016 (1) estimates of the projected cash flows of RAI for the fiscal years ending December 31,
2017 through December 31, 2021, as per the RAI Forecasts, and (2) a range of illustrative
terminal values for RAI as of December 31, 2021, which were calculated by applying perpetuity
growth rates ranging from (0.5)% to 0.5% to a terminal year estimate of the projected cash flows
of RAI, as reflected in the Forecasts. Goldman Sachs then derived ranges of illustrative
enterprise values for RAI by adding together the ranges of present values it derived above.
Goldman Sachs then subtracted from such range of illustrative enterprise values the net debt of
RAI as of December 31, 2016 of $10,899 million, as provided by RAI management, to derive a
range of implied equity values for RAI. Goldman Sachs then divided the range of implied equity
values it derived by the number of fully diluted outstanding shares of RAI common stock, as per
the merger agreement, to derive a range of implied equity values per share of RAI common stock
of $45.16 to $72.17.
Selected Transactions Analysis. Goldman Sachs analyzed certain information relating to the
following selected transactions in the tobacco industry from 2005 through 2015 that, in the
experience and professional judgment of Goldman Sachs, involve companies that are engaged in
businesses analogous to RAI’s and BAT’s businesses.

Date of Announcement Acquirer

Target

EV (dollars EV / LTM
in billions) EBITDA
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June 2015
March 2015
July 2014
May 2012

BAT
BAT
RAI
Japan
Tobacco Inc.
BAT

May 2011
June 2009
September 2008
February 2008
February 2008
November 2007
July 2007
February 2007
December 2006
April 2006

TDR d.o.o.
Souza Cruz S.A.
Lorillard, Inc.
Gryson NV

$0.6
$14.2
$27.6
$0.6

Productora Tabacalera de
Colombia, S.A.S. (Protabaco)
BAT
PT Bentoel Internasional
Investama Tbk
Altria Group, UST Inc.
Inc.
BAT
Skandinavisk
Tobakskompagni A/S
BAT
Tekel
Altria Group, John Middleton, Inc.
Inc.
Imperial
Altadis S.A.
Brands PLC
Imperial
Commonwealth Brands, Inc.
Brands PLC
Japan
Gallaher Group PLC
Tobacco Inc.
RAI
Conwood Company, LP,
Conwood Sales Co., LP,
Rosswil LLC and Scott
Tobacco LLC

12.5x
16.0x
13.9x
12.3x

$0.5 11.3x
$0.7 14.0x
$11.7 12.0x
$4.0 11.2x
$1.7 11.4x
$2.9 15.0x
$22.4 14.2x
$1.9 10.9x
$18.5 13.0x
$3.5 13.6x

While none of the companies (other than RAI) that participated in the selected transactions
is directly comparable to RAI, the companies that participated in the selected transactions are
companies with operations that, for purposes of analysis, may be considered similar to certain
aspects of the RAI Group’s results, market size and product profile.
For each of the selected transactions, Goldman Sachs calculated and compared the EV of
the target at the applicable offer price as a multiple of the target’s publicly disclosed last twelve
months (referred to in this section as LTM) EBITDA at the time of announcement. The
calculation of the median value excluded the multiple applicable to the acquisition of Lorillard,
Inc. by RAI announced in July 2014, which represented an EV / LTM EBITDA multiple of
13.9x, which was referenced for information purposes, but the multiple for this transaction was
excluded from the calculation of the median, as such transaction involved significant geographic
overlap and was not deemed to be comparable to the proposed transaction. The following table
presents the results of this analysis:
Selected Transactions
High
Median
Low

EV / LTM EBITDA
16.0x
12.5x
10.9x
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Goldman Sachs applied the range of EV / LTM EBITDA ratios of 10.9x to 16.0x in respect
of the selected transactions to the estimated EBITDA of RAI for fiscal year 2016 as per the
Forecasts. After dividing by the number of fully diluted shares of RAI common stock
outstanding, as per the merger agreement, Goldman Sachs calculated a range of implied equity
values per share of RAI common stock of $38.12 to $59.51.
Selected Historical Premia Analysis. Goldman Sachs reviewed and analyzed the acquisition
premia for the selected transactions in the tobacco industry described above. Although none of
the companies (other than RAI) that participated in the selected transactions is directly
comparable to RAI, the companies that participated in the selected transactions are companies
with operations that, for purposes of analysis, may be considered similar to certain aspects of the
RAI Group’s results, market size and product profile. The following table presents the results of
this analysis:
Premium
29%
22%
15%

(1)

High
Median(1)
Low
(1) Does not include RAI’s acquisition of Lorillard, Inc.

Goldman Sachs also reviewed and analyzed the acquisition premia for all announced
transactions greater than $250 million from 2004 through 2016 and which involved the
acquisition of a U.S.-based target, using information obtained from Thomson Reuters as of
December 31, 2016. Announced premia were calculated relative to the target’s closing share
price one day prior to announcement. The following table presents the results of this analysis:

Year (No. of Deals)
2004 (37 cash-stock; 122 total)
2005 (47 cash-stock; 155 total)
2006 (36 cash-stock; 211 total)
2007 (47 cash-stock; 229 total)
2008 (21 cash-stock; 88 total)
2009 (18 cash-stock; 65 total)
2010 (22 cash-stock; 129 total)
2011 (27 cash-stock; 123 total)
2012 (19 cash-stock; 101 total)
2013 (23 cash-stock; 109 total)
2014 (40 cash-stock; 129 total)
2015 (53 cash-stock; 153 total)
2016 (46 cash-stock; 168 total)

Median 1-Day
Premia on CashStock
Transactions
15.1%
16.9%
16.3%
22.2%
11.7%
32.5%
34.4%
31.1%
33.4%
17.9%
26.0%
27.3%
31.6%

Median 1Day
Premia on
All
Transactions
19.6%
21.6%
20.6%
21.2%
28.6%
31.5%
33.4%
32.3%
31.1%
24.5%
26.3%
25.3%
28.1%
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Precedent Transactions Median
(for all years)

26.0%

26.3%

Finally, Goldman Sachs reviewed and analyzed the acquisition premia for all announced
transactions greater than $1.0 billion from 2005 through 2016 and which involved the acquisition
of a U.S.-based target by an existing significant shareholder, using information obtained from
Deal Point Data. The following table presents the results of this analysis:
Premium
29.4%
30.1%

Median
Average

Using a range of premia on the selected precedent tobacco transactions described above of
15% to 29%, the median premia on cash-stock transactions described above of 26.0%, and the
average of premia on transactions involving significant shareholders described above of 30.1%,
Goldman Sachs applied a range of 15% to 30% acquisition premia to the closing price per share
of RAI common stock as of October 20, 2016, the last trading day prior to BAT’s announcement
of a proposal to merge with RAI, to calculate a range of implied equity values per share of RAI
common stock of $54.25 to $61.32.
Implied Value of the Consideration Based on Present Value of Pro Forma Future Share
Price. Goldman Sachs also performed an illustrative analysis of the implied present value of the
consideration to be paid to the holders (other than the BAT Group) of shares of RAI common
stock pursuant to the merger agreement based on the cash portion of the consideration and the
present value of the potential future value of the BAT ADSs to be issued as part of the
consideration at December 31, 2020. Goldman Sachs multiplied the one-year forward estimated
earnings per share for the pro forma combined company for the calendar year 2021, as set forth
in the Forecasts, including the Synergies, by forward price to earnings per share multiples
ranging from 15.6x to 18.8x. The calculation was adjusted for the present value of estimated
dividends per share paid during calendar years 2017 through 2020, as per the Forecasts.
Goldman Sachs then discounted these values back to December 31, 2016 using discount rates
ranging from 6.5% to 8.5%, reflecting an estimate of the pro forma combined company’s cost of
equity. This analysis resulted in a range of implied present values of the consideration to be paid
to the holders (other than the BAT Group) of shares of RAI common stock pursuant to the
merger agreement ranging from $61.80 to $70.62.
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General
The preparation of a fairness opinion is a complex process and is not necessarily susceptible
to partial analysis or summary description. Selecting portions of the analyses or of the summary
set forth above, without considering the analyses as a whole, could create an incomplete view of
the processes underlying Goldman Sachs’ opinion. In arriving at its fairness determination,
Goldman Sachs considered the results of all of its analyses and did not attribute any particular
weight to any factor or analysis considered by it. Rather, Goldman Sachs made its determination
as to fairness on the basis of its experience and professional judgment after considering the
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results of all of its analyses. No company (other than RAI) or transaction used in the above
analyses as a comparison is directly comparable to RAI or BAT or the merger.
Goldman Sachs prepared these analyses for purposes of Goldman Sachs providing its
opinion to the RAI board of directors and the Transaction Committee as to the fairness from a
financial point of view of the consideration to be paid to the holders (other than the BAT Group)
of RAI common stock pursuant to the merger agreement. These analyses do not purport to be
appraisals nor do they necessarily reflect the prices at which businesses or securities actually
may be sold. Analyses based upon forecasts of future results are not necessarily indicative of
actual future results, which may be significantly more or less favorable than suggested by these
analyses. Because these analyses are inherently subject to uncertainty, being based upon
numerous factors or events beyond the control of the parties or their respective advisors, none of
RAI, BAT, Goldman Sachs or any other person assumes responsibility if future results are
materially different from those forecast.
The consideration to be paid to the holders (other than the BAT Group) of RAI common
stock pursuant to the merger agreement was determined through arm’s-length negotiations
between the Transaction Committee and BAT and was approved by the RAI board of directors,
after recommendation and approval by the Transaction Committee. Goldman Sachs provided
advice to the Transaction Committee during these negotiations. Goldman Sachs did not,
however, recommend any specific consideration to RAI, the RAI board of directors or the
Transaction Committee or that any specific consideration constituted the only appropriate
consideration for the merger.
As described above, Goldman Sachs’ opinion to the RAI board of directors and the
Transaction Committee was one of many factors taken into consideration by the Transaction
Committee in making its recommendation to the RAI board of directors to approve the merger
agreement and by the RAI board of directors in making its determination to approve the merger
agreement. The foregoing summary does not purport to be a complete description of the analyses
performed by Goldman Sachs in connection with the fairness opinion and is qualified in its
entirety by reference to the written opinion of Goldman Sachs attached as Annex B to this proxy
statement/prospectus.
Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing,
principal investing, sales and trading, research, investment management and other financial and
non-financial activities and services for various persons and entities. Goldman Sachs and its
affiliates and employees, and funds or other entities they manage or in which they invest or have
other economic interests or with which they co-invest, may at any time purchase, sell, hold or
vote long or short positions and investments in securities, derivatives, loans, commodities,
currencies, credit default swaps and other financial instruments of RAI, BAT, any of their
respective affiliates and third parties, or any currency or commodity that may be involved in the
merger. Goldman Sachs acted as financial advisor to the Transaction Committee in connection
with, and participated in certain of the negotiations leading to, the merger. Goldman Sachs has
provided certain financial advisory and/or underwriting services to RAI and/or its affiliates from
time to time for which the Investment Banking Division of Goldman Sachs has received, and
may receive, compensation, including having acted as a joint book-running manager with respect
to a public offering of RAI’s 2.300% Senior Notes due 2018 (aggregate principal amount
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$1,250,000,000), 3.250% Senior Notes due 2020 (aggregate principal amount $1,250,000,000),
4.000% Senior Notes due 2022 (aggregate principal amount $1,000,000,000), 4.450% Senior
Notes due 2025 (aggregate principal amount $2,500,000,000), 5.700% Senior Notes due 2035
(aggregate principal amount $750,000,000) and 5.850% Senior Notes due 2045
(aggregate principal amount $2,250,000,000) in June 2015; as a lead dealer manager in
connection with a tender offer for RAI’s 4.750% Senior Notes due 2042, 3.250% Senior Notes
due 2022, 3.750% Senior Notes due 2023, 3.250% Senior Notes due 2020, 4.000% Senior Notes
due 2022, 4.450% Senior Notes due 2025 and 4.850% Senior Notes due 2023 (aggregate
principal amount $7,873,689,000) in February 2016; and as a participant in RAI’s 364-day senior
unsecured term loan bridge facility (aggregate principal amount $9,000,000,000) in September
2014. During the two-year period ended January 16, 2017, Goldman Sachs has received
compensation for financial advisory and/or underwriting services provided by its Investment
Banking Division to RAI and/or its affiliates of approximately $11 million. During the two-year
period ended January 16, 2017, Goldman Sachs has not been engaged by BAT to provide
financial advisory and/or underwriting services for which it has received compensation.
Goldman Sachs may also in the future provide financial advisory and/or underwriting services to
RAI, BAT and their respective affiliates for which the Investment Banking Division of Goldman
Sachs may receive compensation.
The Transaction Committee selected Goldman Sachs as its financial advisor because
Goldman Sachs is an internationally recognized investment banking firm that has substantial
experience in transactions similar to the merger. Pursuant to a letter agreement dated
November 21, 2016, the Transaction Committee engaged Goldman Sachs to act as its financial
advisor in connection with the possible sale of all or a portion of the stock or assets of RAI.
Pursuant to the terms of this engagement letter, RAI has agreed to pay Goldman Sachs a
transaction fee of 0.085% of the merger consideration, that is estimated, based on the
information available as of the date of announcement of the merger agreement, at approximately
$42 million, approximately $4 million of which has been paid and the remainder of which is
contingent upon consummation of the merger. In addition, RAI has agreed to reimburse
Goldman Sachs for certain of its expenses, including attorneys’ fees and disbursements, and to
indemnify Goldman Sachs and related persons various liabilities, including certain liabilities
under the federal securities law.
Other Presentations by Goldman Sachs
In addition to the presentation made to the RAI board of directors and the Transaction
Committee on January 16, 2017 described under “Special Factors Relating to RAI Proposal I:
Approval of the Merger Agreement—Opinion of the Transaction Committee’s Financial
Advisor—Opinion of Goldman Sachs,” Goldman Sachs also made written and oral preliminary
presentations to the Transaction Committee, and, in some cases, the RAI board of directors, on
October 28, 2016, November 4, 2016, November 8, 2016, November 23, 2016, December 7,
2016, December 20, 2016, January 5, 2017, January 10, 2017 and January 14, 2017. Copies of
these written materials have been attached as exhibits to the Schedules 13E-3 filed with the SEC
in connection with the merger. These written presentations will be available to any interested
shareholder of RAI (or any representative of a shareholder who has been so designated in
writing) to inspect and copy at RAI’s principal executive offices during regular business hours.
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None of these other written and oral preliminary presentations by Goldman Sachs, alone or
together, constitute, or form the basis of, an opinion of Goldman Sachs with respect to the
merger consideration. Information contained in these other written and oral preliminary
presentations is substantially similar to the information provided in Goldman Sachs’ written
presentation to the RAI board of directors and to the Transaction Committee on January 16,
2017, as described under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Opinion of the Transaction Committee’s Financial Advisor.” A summary of these
other preliminary presentations is provided below. The following summary, however, does not
purport to be a complete description of these preliminary presentations or of the preliminary
financial analyses performed by Goldman Sachs.
• The October 28, 2016 materials presented to the Transaction Committee and the RAI
board of directors contained, among other information, a review of BAT’s October 20
Proposal and preliminary process considerations.

• The November 4, 2016 materials presented to the Transaction Committee included,
among other information, an updated review of BAT’s October 20 Proposal, a summary
of preliminary financial projections, including synergies, then provided by RAI
management, a review of process considerations, and a preliminary financial analysis of
the then implied proposed merger consideration as a multiple of (1) RAI’s LTM EV /
EBITDA, using RAI EBITDA for the twelve-month period ended September 30, 2016,
based on information provided by RAI management, (2) RAI’s next twelve months
(referred to in this section as NTM) EV / EBITDA, using the preliminary financial
projections provided by RAI management that had been approved for Goldman Sachs’
use by RAI management, (3) NTM price to earnings (referred to in this section as P / E),
using the preliminary financial projections provided by RAI management that had been
approved for Goldman Sachs’ use by RAI management, and (4) 2017 year-end P / E,
using the preliminary financial projections provided by RAI management that had been
approved for Goldman Sachs’ use by RAI management. Goldman Sachs then compared
these preliminary calculated multiples to the corresponding multiples for BAT, certain
selected transactions and/or certain selected companies in the tobacco industry. The
following table presents a summary of these preliminary calculations:
LTM EV / EBITDA
RAI(1)
Selected Transactions(2)

15.4x
12.0x – 15.1x

NTM EV / EBITDA
RAI(1)
BAT
Selected Companies(3)

14.7x
11.6x
12.3x

NTM P / E
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RAI(1)
BAT
Selected Companies(3)

22.7x
16.6x
18.7x

2017E P / E
RAI(1)

22.2x
(1) Implied by BAT’s October 20 Proposal.
(2) Includes the following selected transactions in the tobacco industry: BAT’s
acquisition of Souza Cruz S.A. (announced in March 2015), RAI’s acquisition of
Lorillard (announced in July 2014), Altria Group, Inc.’s acquisition of UST Inc.
(announced in September 2008), Imperial Brands PLC’s acquisition of Altadis S.A.
(announced in July 2007) and Japan Tobacco Inc.’s acquisition of Gallaher Group
PLC (announced in December 2006).
(3) Includes the following publicly traded corporations in the tobacco industry: Altria
Group, Inc., Imperial Brands PLC, ITC Limited, Japan Tobacco Inc. and Philip
Morris International Inc.

• The November 8, 2016 materials presented to the Transaction Committee and the RAI
board of directors included, among other information, an updated review of BAT’s
October 20 Proposal, a summary of preliminary financial projections, including
synergies, then provided by RAI management, and the following preliminary financial
analyses:
•

A preliminary illustrative public market present value of future share price analysis
similar to that described above under “Special Factors Relating to RAI Proposal I:
Approval of the Merger Agreement—Opinion of the Transaction Committee’s
Financial Advisor—Opinion of Goldman Sachs—Summary of Financial Analyses—
Illustrative Public Market Present Value of Future Share Price Analysis,” using the
preliminary financial projections provided by RAI management

that had been approved for Goldman Sachs’ use by RAI management, applying the
same 16.5x to 20.2x forward price to earnings per share multiples and using a
discount rate of 5.9% as an estimate of RAI’s cost of equity. On the basis of such
preliminary analysis, Goldman Sachs calculated a preliminary illustrative range of
the implied present value of the potential future value per share of RAI common
stock on December 31, 2020 of $55.98 to $66.57.
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•

A preliminary illustrative discounted cash flow analysis similar to that described
above under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion
of Goldman Sachs—Summary of Financial Analyses—Illustrative Discounted Cash
Flow Analysis,” using the preliminary financial projections provided by RAI
management that had been approved for Goldman Sachs’ use by RAI management,
applying the same perpetuity growth rates ranging from (0.5)% to 0.5% and
utilizing illustrative discount rates ranging from 5.0% to 6.0%, reflecting estimates
of RAI’s weighted average cost of capital. On the basis of such preliminary analysis,
Goldman Sachs derived a preliminary illustrative range of implied equity values per
share of RAI common stock of $48.86 to $71.67.

•

A preliminary selected transactions analysis similar to that described above under
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Opinion of the Transaction Committee’s Financial Advisor—Opinion of Goldman
Sachs—Summary of Financial Analyses—Selected Transactions Analysis,” using
RAI EBITDA for the twelve-month period ended September 30, 2016. On the basis
of such preliminary analysis, Goldman Sachs calculated a preliminary illustrative
range of implied equity values per share of RAI common stock of $37.82 to $59.18.

•

A preliminary selected historical premia analysis similar to that described above
under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion
of Goldman Sachs—Summary of Financial Analyses—Selected Historical Premia
Analysis,” which indicated the same preliminary illustrative range of implied equity
values per share of RAI common stock of $54.25 to $61.32.

• The November 23, 2016 materials presented to the Transaction Committee included,
among other information, an updated review of BAT’s October 20 Proposal and a
summary of selected news and commentary relating to the transaction.
• The December 7, 2016 materials presented to the Transaction Committee included,
among other information, an updated review of BAT’s October 20 Proposal and
December 5 Proposal, a summary of selected news and commentary relating to the
Transaction, a summary of preliminary financial projections, including synergies, then
provided by RAI management, a review of process considerations, and the following
preliminary financial analyses:
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•

A preliminary illustrative public market present value of future share price analysis
similar to that described above under “Special Factors Relating to RAI Proposal I:
Approval of the Merger Agreement—Opinion of the Transaction Committee’s
Financial Advisor—Opinion of Goldman Sachs—Summary of Financial Analyses—
Illustrative Public Market Present Value of Future Share Price Analysis,” using the
preliminary financial projections provided by RAI management that had been
approved for Goldman Sachs’ use by RAI management, applying the same 16.5x to
20.2x forward price to earnings per share multiples and using a discount rate of
6.5% as an estimate of RAI’s cost of equity. On the basis of such preliminary
analysis, Goldman Sachs calculated a preliminary illustrative range of the implied
present value of the potential future value per share of RAI common stock on
December 31, 2020 of $54.82 to $65.16.

•

A preliminary illustrative discounted cash flow analysis similar to that described
above under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Opinion of the

Transaction Committee’s Financial Advisor—Opinion of Goldman Sachs—
Summary of Financial Analyses—Illustrative Discounted Cash Flow Analysis,”
using the preliminary financial projections provided by RAI management that had
been approved for Goldman Sachs’ use by RAI management, applying the same
perpetuity growth rates ranging from (0.5)% to 0.5% and utilizing illustrative
discount rates ranging from 5.0% to 6.5%, reflecting estimates of RAI’s weighted
average cost of capital. On the basis of such preliminary analysis, Goldman Sachs
derived a preliminary illustrative range of implied equity values per share of RAI
common stock of $44.76 to $71.67.
•

A preliminary selected transactions analysis similar to that described above under
“Special Factors Relating to RAI Proposal I: Approval of the Merger Agreement—
Opinion of the Transaction Committee’s Financial Advisor—Opinion of Goldman
Sachs—Summary of Financial Analyses—Selected Transactions Analysis,” using
RAI EBITDA for the twelve-month period ended September 30, 2016. On the basis
of such analysis, Goldman Sachs calculated a preliminary illustrative range of
implied equity values per share of RAI common stock of $37.82 to $59.18.

•

A preliminary selected historical premia analysis similar to that described above
under “Special Factors Relating to RAI Proposal I: Approval of the Merger
Agreement—Opinion of the Transaction Committee’s Financial Advisor—Opinion
of Goldman Sachs—Summary of Financial Analyses—Selected Historical Premia
Analysis,” which indicated the same preliminary illustrative range of implied equity
values per share of RAI common stock of $54.25 to $61.32.
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• The December 20, 2016 materials presented to the Transaction Committee included,
among other information, an updated review of BAT’s October 20 Proposal, December 5
Proposal and December 20 Proposal.
• The January 5, 2017 materials presented to the Transaction Committee included, among
other information, an updated review of BAT’s October 20 Proposal, December 5
Proposal and December 20 Proposal and the Transaction Committee’s December 20
Counterproposal, an overview of accretion and dilution modeling assumptions and a
summary of preliminary financial projections, including synergies, then provided by RAI
management.
• The January 10, 2017 materials presented to the Transaction Committee and the RAI
board of directors included, among other information, an illustrative analysis of the effect
of different exchange ratios based on the cash portion of the merger consideration.
• The January 14, 2017 materials presented to the Transaction Committee and the RAI
board of directors included, among other information, an updated review of BAT’s
October 20 Proposal and January 10 Proposal.
The preliminary financial analyses in these other written and oral preliminary presentations
were based on market, economic and other conditions as they existed as of the dates of the
respective presentations as well as other information that was available at those times.
Accordingly, the results of the financial analyses differed due to changes in those conditions.
Among other things, the results of certain analyses changed as RAI’s financial results changed as
well as projections made by management of RAI were revised or adjusted. Finally, Goldman
Sachs continued to refine various aspects of its financial analyses with respect to RAI and BAT
over time.
B.
ANNEX B TO PROXY STATEMENT, FAIRNESS OPINION OF
GOLDMAN

Annex B
200 West Street | New York, NY 10282-2198
Tel: 212-902-1000 | Fax: 212-902-3000

PERSONAL AND CONFIDENTIAL
January 16, 2017
Board of Directors
Transaction Committee of the Board of Directors
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Reynolds American Inc.
401 North Main Street
Winston Salem, NC 27101
Ladies and Gentlemen:
You have requested our opinion as to the fairness from a financial point of view to the holders
(other than British American Tobacco p.l.c. (“BAT”) and its subsidiaries) of the outstanding
shares of common stock, par value $0.0001 per share (the “Shares”), of Reynolds American Inc.
(the “Company”) of the Consideration (as defined below) to be paid to such holders pursuant to
the Agreement and Plan of Merger, dated as of January 16, 2017 (the “Agreement”), by and
among BAT, BATUS Holdings, Inc., an indirect wholly owned subsidiary of BAT, Flight
Acquisition Corporation, an indirect wholly owned subsidiary of BAT (“Acquisition Sub”), and
the Company. The Agreement provides that Acquisition Sub will be merged with and into the
Company (the “Merger”) and each outstanding Share (other than Dissenting Shares (as defined
in the Agreement) and Shares held by BAT or its subsidiaries) will be converted into $29.44 in
cash (the “Cash Consideration”), and that number of American depositary shares (“BAT ADS”)
of BAT (each BAT ADS representing, as of the date of the Agreement, two ordinary shares, par
value £0.25 per share (“BAT Ordinary Shares”) of BAT), equal to 0.5260 divided by the ADS
Ratio (as defined in the Agreement) (the “Stock Consideration”; together with the Cash
Consideration, the “Consideration”).
Goldman, Sachs & Co. and its affiliates are engaged in advisory, underwriting and financing,
principal investing, sales and trading, research, investment management and other financial and
non-financial activities and services for various persons and entities. Goldman, Sachs & Co. and
its affiliates and employees, and funds or other entities they manage or in which they invest or
have other economic interests or with which they co-invest, may at any time purchase, sell, hold
or vote long or short positions and investments in securities, derivatives, loans, commodities,
currencies, credit default swaps and other financial instruments of the Company, BAT, any of
their respective affiliates and third parties, or any currency or commodity that may be involved in
the transaction contemplated by the Agreement (the “Transaction”). We have acted as financial
advisor to the Transaction Committee of the Board of Directors of the Company (the
“Transaction Committee”) in connection with, and have participated in certain of the
negotiations leading to, the Transaction. We expect to receive fees for our services in connection
with the Transaction, the principal portion of which is contingent upon consummation of the
Transaction, and the Company has agreed to reimburse certain of our expenses arising, and
indemnify us against certain liabilities that may arise, out of our engagement. We have provided
certain financial advisory and/or underwriting services to the Company and/or its affiliates from
time to time for which our Investment Banking Division has received, and may receive,
compensation, including having acted as a joint book-running manager with respect to a public
offering of the Company’s 2.300% Senior Notes due 2018 (aggregate principal amount
$1,250,000,000), 3.250% Senior Notes due 2020 (aggregate principal amount $1,250,000,000),
4.000% Senior Notes due 2022 (aggregate principal amount $1,000,000,000), 4.450% Senior
Notes due 2025 (aggregate principal amount $2,500,000,000), 5.700% Senior Notes due 2035
(aggregate principal amount $750,000,000) and 5.850% Senior Notes due 2045 (aggregate
principal amount $2,250,000,000) in June 2015; as a lead dealer manager in connection with a
tender offer for the Company’s 4.750% Senior Notes due 2042, 3.250% Senior Notes due 2022,
62

3.750% Senior Notes due 2023, 3.250% Senior Notes due 2020, 4.000% Senior Notes due 2022,
4.450% Senior Notes due 2025 and 4.850% Senior Notes due 2023 (aggregate principal amount
$7,873,689,000) in February 2016; and as a participant in the Company’s 364-day senior
unsecured term loan bridge facility (aggregate principal amount $9,000,000,000) in September
2014. We may also in the future provide financial advisory and/or underwriting services to the
Company, BAT and their respective affiliates for which our Investment Banking Division may
receive compensation.
In connection with this opinion, we have reviewed, among other things, the Agreement; the
Amended and Restated Deposit Agreement, dated as of December 1, 2008, by and among BAT,
Citibank, N.A., as Depositary, and the holders and beneficial owners of the BAT ADSs issued
thereunder; annual reports to stockholders and Annual Reports on Form 10-K of the Company
for the five fiscal years ended December 31, 2015, and annual reports to shareholders of BAT for
the five fiscal years ended December 31, 2015; certain interim reports to stockholders and
Quarterly Reports on Form 10-Q of the Company, and certain interim reports to shareholders of
BAT; certain other communications from the Company and BAT to their stockholders and
shareholders, respectively; certain publicly available research analyst reports for the Company
and BAT; certain financial information for BAT prepared by its management; and certain
internal financial analyses and forecasts for the Company and BAT prepared by the Company’s
management, in each case, as approved for our use by the Company (the “Forecasts”), including
certain operating synergies projected by the management of the Company to result from the
Transaction, as approved for our use by the Company (the “Synergies”). We have also held
discussions with members of the senior managements of the Company and BAT regarding their
assessment of the strategic rationale for, and the potential benefits of, the Transaction and the
past and current business operations, financial condition and future prospects of the Company
and BAT; reviewed the reported price and trading activity for the Shares, the BAT Ordinary
Shares and the BAT ADSs; compared certain financial and stock market information for the
Company and BAT with similar information for certain other companies the securities of which
are publicly traded; reviewed the financial terms of certain recent business combinations in the
tobacco industry and in other industries; and performed such other studies and analyses, and
considered such other factors, as we deemed appropriate.
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the
accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other
information provided to, discussed with or reviewed by, us, without assuming any responsibility
for independent verification thereof. In that regard, we have assumed with your consent that the
Forecasts, including the Synergies, have been reasonably prepared on a basis reflecting the best
currently available estimates and judgments of the management of the Company. We have not
made an independent evaluation or appraisal of the assets and liabilities (including any
contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or BAT or
any of their respective subsidiaries and we have not been furnished with any such evaluation or
appraisal. We have assumed that all governmental, regulatory or other consents and approvals
necessary for the consummation of the Transaction will be obtained without any adverse effect
on the Company or BAT or on the expected benefits of the Transaction in any way meaningful to
our analysis. We have assumed that the Transaction will be consummated on the terms set forth
in the Agreement, without the waiver or modification of any term or condition the effect of
which would be in any way meaningful to our analysis.
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Our opinion does not address the underlying business decision of the Company to engage in the
Transaction, or the relative merits of the Transaction as compared to any strategic alternatives
that may be available to the Company; nor does it address any legal, regulatory, tax or
accounting matters. We were not requested to solicit, and did not solicit, interest from other
parties with respect to an acquisition of, or other business combination with, the Company or any
other alternative transaction. This opinion addresses only the fairness from a financial point of
view to the holders (other than BAT and its subsidiaries) of Shares, as of the date hereof, of the
Consideration to be paid to such holders pursuant to the Agreement. We do not express any view
on, and our opinion does not address, any other term or aspect of the Agreement or Transaction
or any term or aspect of any other agreement or instrument contemplated by the Agreement or
entered into or amended in connection with the Transaction, including, the fairness of the
Transaction to, or any consideration received in connection therewith by, the holders of any other
class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the
amount or nature of any compensation to be paid or payable to any of the officers, directors or
employees of the Company, or class of such persons, in connection with the Transaction,
whether relative to the Consideration to be paid to the holders (other than BAT and its
subsidiaries) of Shares pursuant to the Agreement or otherwise. We are not expressing any
opinion as to the prices at which the BAT ADSs or the BAT Ordinary Shares will trade at any
time or as to the impact of the Transaction on the solvency or viability of the Company or BAT
or the ability of the Company or BAT to pay their respective obligations when they come due.
Our opinion is necessarily based on economic, monetary, market and other conditions as in effect
on, and the information made available to us as of, the date hereof and we assume no
responsibility for updating, revising or reaffirming this opinion based on circumstances,
developments or events occurring after the date hereof. Our advisory services and the opinion
expressed herein are provided for the information and assistance of the Transaction Committee
and the Board of Directors of the Company in connection with its consideration of the
Transaction and such opinion does not constitute a recommendation as to how any holder of
Shares should vote with respect to the Transaction or any other matter. This opinion has been
approved by a fairness committee of Goldman, Sachs & Co.
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the
Consideration to be paid to the holders (other than BAT and its subsidiaries) of Shares pursuant
to the Agreement is fair from a financial point of view to such holders.
Very truly yours,
/s/ Goldman, Sachs & Co.
(GOLDMAN, SACHS & CO.)

IV.

JP MORGAN’S OPINION TO RAI’S BOARD
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A.

PROXY DISCUSSION OF OPINION OF JP MORGAN

Opinions of RAI’s Financial Advisors
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in
connection with the merger. In connection with this engagement, the RAI board of directors
requested that RAI’s financial advisors deliver the opinions described below.
Opinion of J.P. Morgan
On January 16, 2017, at the meeting of the RAI board of directors at which the merger
agreement was approved, J.P. Morgan rendered to the RAI board of directors an oral opinion,
subsequently confirmed by delivery to the RAI board of directors of a written opinion, dated
January 16, 2017, to the effect that, as of such date and based upon and subject to the factors,
procedures, qualifications, assumptions and any limitations set forth in its written opinion, the
consideration per share of RAI common stock, consisting of (1) a number of BAT ADSs
representing 0.5260 of a BAT ordinary share as of the effective time of the proposed merger plus
(2) $29.44 in cash, taken together, to be paid to the holders of RAI common stock (other than the
BAT Group) in the proposed merger was fair, from a financial point of view, to such holders (the
consideration described in (1) and (2) is being collectively referred to as the merger
consideration throughout this section, “Special Factors Relating to RAI Proposal I: Approval of
the Merger Agreement—Opinions of RAI’s Financial Advisors—Opinion of J.P. Morgan”).
The full text of J.P. Morgan’s written opinion, dated January 16, 2017, which sets forth,
among other things, the assumptions made, procedures followed, matters considered and
qualifications and any limitations on the opinion and the review undertaken by J.P. Morgan in
connection with rendering its opinion, is attached as Annex C to this proxy statement/prospectus
and is incorporated herein by reference. The summary of the opinion of J.P. Morgan set forth
in this proxy statement/prospectus is qualified in its entirety by reference to the full text of
such opinion, and RAI shareholders are urged to read J.P. Morgan’s opinion attached as
Annex C carefully and in its entirety. J.P. Morgan’s opinion was addressed to the RAI board of
directors (in its capacity as such) in connection with and for the purposes of its evaluation of the
merger, was directed only to the fairness, from a financial point of view, of the merger
consideration to be paid to the holders of RAI common stock (other than the BAT Group) in the
merger and did not address any other aspect of the merger. J.P. Morgan was not authorized to
and did not solicit any expressions of interest from any other parties with respect to the sale of all
or any part of RAI or any other alternative transaction. J.P. Morgan expressed no opinion as to
the fairness of any consideration to be paid in connection with the merger to the holders of any
other class of securities, creditors or other constituencies of RAI or as to the underlying decision
by RAI to engage in the merger. The issuance of J.P. Morgan’s opinion was approved by a
fairness committee of J.P. Morgan. The opinion does not constitute a recommendation to any
shareholder of RAI as to how such shareholder should vote with respect to the merger or any
other matter.
In arriving at its opinion, J.P. Morgan, among other things:
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• reviewed a draft dated January 16, 2017 of the merger agreement;
• reviewed certain publicly available business and financial information concerning RAI
and BAT and the industries in which they operate;
• compared the proposed financial terms of the merger with the publicly available financial
terms of certain transactions involving companies J.P. Morgan deemed relevant and the
consideration paid for such companies;
• compared the financial and operating performance of RAI and BAT with publicly
available information concerning certain other companies J.P. Morgan deemed relevant
and reviewed the current and historical market prices of RAI common stock, BAT
ordinary shares and BAT ADSs and certain publicly traded securities of such other
companies;
• reviewed certain internal financial analyses and forecasts prepared by the management of
RAI relating to the businesses of each of RAI (referred to in this section of the proxy
statement/prospectus as the RAI projections) and BAT (which, in the case of the
forecasts for BAT, were based in part on certain financial information for BAT prepared
by the management of BAT and provided to RAI, and which are referred to in this
section of the proxy statement/prospectus as the RAI projections for BAT), as well as the
estimated amount and timing of the cost savings and related expenses and synergies
expected to result from the merger (referred to in this section of the proxy
statement/prospectus as the synergies); and

• performed such other financial studies and analyses and considered such other
information as J.P. Morgan deemed appropriate for the purposes of its opinion.
In addition, J.P. Morgan held discussions with certain members of the management of RAI
and BAT with respect to certain aspects of the merger, and the past and current business
operations of RAI and BAT, the financial condition and future prospects and operations of RAI
and BAT, the effects of the merger on the financial condition and future prospects of RAI and
BAT, and certain other matters J.P. Morgan believed necessary or appropriate to its inquiry.
In giving its opinion, J.P. Morgan relied upon and assumed the accuracy and completeness
of all information that was publicly available or was furnished to or discussed with J.P. Morgan
by RAI and BAT or otherwise reviewed by or for J.P. Morgan, and J.P. Morgan did not
independently verify (and, pursuant to its engagement letter with RAI, did not assume any
obligation to undertake any such independent verification) any such information or its accuracy
or completeness. J.P. Morgan did not conduct and was not provided with any valuation or
appraisal of any assets or liabilities, nor did J.P. Morgan evaluate the solvency, of RAI or BAT,
BATUS or Merger Sub under any state or federal laws relating to bankruptcy, insolvency or
similar matters. In relying on financial analyses and forecasts provided to J.P. Morgan or derived
therefrom, including the synergies, J.P. Morgan assumed that they had been reasonably prepared
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based on assumptions reflecting the best currently available estimates and judgments by
management as to the expected future results of operations and financial condition of RAI and
BAT to which such analyses or forecasts relate. J.P. Morgan expressed no view as to such
analyses or forecasts (including the synergies) or the assumptions on which they were based.
J.P. Morgan also assumed that the merger and the other transactions contemplated by the merger
agreement would have the tax consequences described in discussions with, and materials
furnished to J.P. Morgan by, representatives of RAI, and would be consummated as described in
the draft merger agreement, and that the definitive merger agreement would not differ in any
material respects from the draft thereof furnished to J.P. Morgan. J.P. Morgan also assumed that
the representations and warranties made by RAI and BAT, BATUS and Merger Sub in the
merger agreement and the related agreements were and would be true and correct in all respects
material to J.P. Morgan’s analysis. J.P. Morgan is not a legal, regulatory or tax expert and relied
on the assessments made by advisors to RAI with respect to such issues. J.P. Morgan further
assumed that all material governmental, regulatory or other consents and approvals necessary for
the consummation of the merger would be obtained without any adverse effect on RAI or BAT
or on the contemplated benefits of the merger.
J.P. Morgan’s opinion was necessarily based on economic, market and other conditions as
in effect on, and the information made available to J.P. Morgan as of, the date of such opinion.
J.P. Morgan’s opinion noted that subsequent developments may affect J.P. Morgan’s opinion,
and that J.P. Morgan does not have any obligation to update, revise, or reaffirm such opinion.
J.P. Morgan’s opinion is limited to the fairness, from a financial point of view, of the merger
consideration to be paid to the holders of RAI common stock (other than the BAT Group) in the
proposed merger, and J.P. Morgan has expressed no opinion as to the fairness of any
consideration to be paid in connection with the merger to the holders of any other class of
securities, creditors or other constituencies of RAI or as to the underlying decision by RAI to
engage in the merger. Furthermore, J.P. Morgan expressed no opinion with respect to the amount
or nature of any compensation to any officers, directors, or employees of any party to the merger,
or any class of such persons relative to the merger consideration to be paid to the holders of RAI
common stock (other than the BAT Group) in the merger or with respect to the fairness of any
such compensation. J.P. Morgan expressed no opinion as to the price at which the RAI common
stock, BAT ordinary shares or BAT ADSs will trade at any future time.
The terms of the merger agreement, including the merger consideration, were determined
through arm’s-length negotiations between the Transaction Committee and BAT, and the
decision to enter into the merger agreement was solely that of the BAT board of directors and the
RAI board of directors, and, in the case of the decision of the RAI board of directors, based upon
the approval and recommendation of the Transaction Committee. J.P. Morgan’s opinion and
financial analyses were only one of the many factors considered by the RAI board of directors in
its evaluation of the merger and should not be viewed as determinative of the views of the RAI
board of directors or management with respect to the merger or the merger consideration.
In accordance with customary investment banking practice, J.P. Morgan employed
generally accepted valuation methodologies in rendering its opinion to the RAI board of
directors on January 16, 2017. The following is a summary of the material financial analyses
utilized by J.P. Morgan and contained in the presentation delivered to the RAI board of directors
on such date in connection with the rendering of such opinion. It does not purport to be a
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complete description of the analyses or data presented by J.P. Morgan. Some of the summaries of
the financial analyses include information presented in tabular format. The tables are not
intended to stand alone, and in order to more fully understand the financial analyses used by J.P.
Morgan, the tables must be read together with the full text of each summary. Considering the
data set forth below without considering the full narrative description of the financial analyses,
including the methodologies and assumptions underlying the analyses, could create a misleading
or incomplete view of J.P. Morgan’s analyses.
Analysis of RAI
Public Trading Multiples Analysis
Using publicly available information, J.P. Morgan compared selected financial data of RAI
with similar data for selected publicly traded companies engaged in businesses which J.P.
Morgan judged to be similar in certain respects to RAI’s business or aspects thereof. The
companies selected by J.P. Morgan were as follows:
• Altria Group Inc.;
• British American Tobacco p.l.c.;
• Imperial Brands p.l.c.;
• Japan Tobacco Inc.;
• Philip Morris International Inc.; and
• Swedish Match AB.
These companies were selected, among other reasons, because they are publicly traded
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be
considered similar in certain respects to those of RAI based on business sector participation,
financial metrics and form of operations, including product mix, end markets, customers and
size, of such companies. However, none of the selected companies reviewed is identical to RAI,
and certain of these companies may have characteristics that are materially different from those
of RAI. The analyses necessarily involve complex considerations and judgments concerning
differences in financial and operational characteristics of the companies involved and other
factors that could affect the companies differently than they would affect RAI.
For each company listed above, J.P. Morgan calculated and compared various financial
multiples and ratios based on publicly available information as of January 13, 2017, and in all
instances multiples were based on closing share prices on January 13, 2017. For purposes of this
analysis, J.P. Morgan obtained the amounts of earnings before interest, taxes, depreciation and
amortization estimated for calendar year 2017 (referred to in this section of the proxy
statement/prospectus as 2017E EBITDA) and earnings per share estimated for calendar year
2017, in the case of BAT, from publicly available research analysts’ consensus estimates and, in
the case of the other selected companies, from FactSet Research Systems. Other financial data
used for purposes of this analysis, including the market value of equity and stock price
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information for each selected company, were based on public filings and other publicly available
information. Among other calculations, the information J.P. Morgan calculated for each of the
selected companies included:
• the multiple of implied firm value, referred to in this section of the proxy
statement/prospectus as FV (calculated as the market value of equity plus total debt and
other adjustments, including minority interests, net of cash and cash equivalents) to
2017E EBITDA, referred to in this section of the proxy statement/prospectus as
FV/2017E EBITDA; and
• the multiple of stock price of its common equity to estimated earnings per share for
calendar year 2017, referred to in this section of the proxy statement/prospectus as
P/E 2017E.
Results of the analysis were presented for the selected companies, as indicated in the
following table:
Trading Multiples

Altria Group Inc.
British American Tobacco p.l.c.
British American Tobacco p.l.c.*
Imperial Brands p.l.c.
Japan Tobacco Inc.
Philip Morris International Inc.
Swedish Match AB

FV
(in billions)
$
124.5
$
135.4
$
93.9
$
57.1
$
64.1
$
166.7
$
6.2

FV/2017E
EBITDA
12.7x
11.7x
11.6x
11.4x
10.1x
13.5x
12.0x

P/E 2017E
20.3x
17.1x
17.1x
13.0x
16.5x
18.8x
17.3x

* Excludes BAT’s proportionate ownership in RAI and ITC Limited.
For the selected companies, J.P. Morgan’s analysis resulted in a range of FV/2017E
EBITDA multiples of 10.1x to 13.5x, an average FV/2017E EBITDA multiple of 11.9x and a
median FV/2017E EBITDA multiple of 12.0x. J.P. Morgan’s analysis also resulted in a range of
P/E 2017E multiples of 13.0x to 20.3x, an average P/E 2017E multiple of 17.2x and a median
P/E 2017E multiple of 17.3x for the selected companies.
Based on the results of this analysis of selected publicly traded companies and J.P.
Morgan’s professional judgment, J.P. Morgan derived a multiple reference range of 10.0x-13.5x
for FV/2017E EBITDA and a multiple reference range of 13.0x-20.5x for P/E 2017E. After
applying such ranges to 2017E EBITDA and estimated earnings per share for calendar year 2017
of RAI, in each case, as set forth in the RAI projections, the analysis indicated the following
ranges of implied equity value per share for RAI common stock, rounded to the nearest $0.25:
RAI Implied Equity Value Per Share

FV/2017E EBITDA

Low
$ 36.50

High
$ 51.75
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P/E 2017E

$

32.50

$

51.25

The ranges of implied equity value per share for RAI common stock were compared to
(1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the last
trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price
per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI
common stock prior to the announcement of the merger agreement on January 17, 2017, and
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which
was determined by valuing the BAT ADSs included in the merger consideration based on the
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on
January 13, 2017 divided by two (which was the number of BAT ordinary shares then
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per
BAT ordinary share of $57.61)).
Selected Transaction Multiples Analysis
Using publicly available information, J.P. Morgan examined selected transactions since
2001 involving businesses which, based on J.P. Morgan’s experience and familiarity with RAI’s
industry, J.P. Morgan judged to be similar in certain respects to RAI’s business or aspects
thereof, considering, among other reasons, business sector participation, financial metrics and
form of operations, including product mix, end markets, customers and size, of such businesses.
Using publicly available information, J.P. Morgan calculated, for each of the selected
transactions, the multiple of the target company’s FV implied by the consideration paid in such
transaction to the target company’s EBITDA for the twelve-month period prior to the
announcement date of the applicable transaction, referred to in this section of the proxy
statement/prospectus as LTM EBITDA.
The selected transactions, the month and year each such transaction was announced and the
results of the analysis for each such transaction are as indicated in the following table:
Announcement
Date
June 2015
February 2015
July 2014
July 2014
May 2011

June 2009

September
2008

Target
TDR d.o.o.
Souza Cruz SA
Lorillard, Inc.
Lorillard, Inc. and RAI
assets
Productora Tabacalera
de Colombia, S.A.S.
(Protabaco)
PT Bentoel
Internasional Investama
Tbk

Acquirer
BAT
BAT
RAI
Imperial Tobacco
Group p.l.c.

UST Inc.

FV
(in millions)
$
599
$
14,185
$
27,949

FV / LTM
EBITDA
12.5x
16.0x
13.8x

$

7,056

8.8x

BAT

$

452

11.3x

BAT

$

744

14.0x

Altria Group Inc.

$

11,681

12.0x
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July 2008
Rothmans Inc.
Skandinavisk
Tobakskompagni
February 2008 Tekel
November 2007 John Middleton Co.
July 2007
Altadis SA
February 2007 Commonwealth Brands
Inc.
January 2007
Lakson Tobacco Co.
Ltd.
December 2006 Gallaher Group plc
April 2006
Conwood LP
March 2005
PT HM Sampoerna Tbk
March 2002
Reemtsma
Cigarettenfabriken
GmbH
June 2001
Austria Tabak AG

Philip Morris
International Inc.

$

1,934

9.7x

$
$
$

4,141
1,720
2,900

11.2x
11.4x
15.8x

$

22,619

14.1x

$

1,900

10.9x

$
$
$

675
18,938
3,500

14.8x
13.0x
13.6x

$

5,082

13.9x

$
$

5,103
1,871

13.4x
7.4x

February 2008

BAT
BAT
Philip Morris USA
Imperial Tobacco
Group p.l.c.
Imperial Tobacco
Group p.l.c.
Philip Morris
International Inc.
Japan Tobacco Inc.
RAI
Philip Morris
International Inc.
Imperial Tobacco
Group p.l.c.
Gallaher Group plc

J.P. Morgan’s analysis resulted in a range of implied FV to LTM EBITDA multiples of 7.4x
to 16.0x for the selected transactions, a mean implied FV to LTM EBITDA multiple of 12.5x for
the selected transactions and a median implied FV to LTM EBITDA multiple of 13.0x for the
selected transactions.
Based on the results of this analysis and J.P. Morgan’s professional judgment, J.P. Morgan
derived a multiple reference range of 12.0x-16.0x for implied FV to LTM EBITDA. After
applying such range to the appropriate metric for RAI (which, in the case of LTM EBITDA of
RAI, was adjusted for certain cost synergies related to RAI’s acquisition of Lorillard at the
direction of the management of RAI) as set forth in the RAI projections, the analysis indicated
the following range of implied equity value per share for RAI common stock, rounded to the
nearest $0.25:
RAI Implied Equity Value Per Share

Implied FV/LTM Adjusted EBITDA

Low
$ 43.00

High
$ 60.00

For reference only and not as a component of its fairness analysis, J.P. Morgan also applied
the 12.0x-16.0x multiple reference range to the appropriate metric of RAI (without, in the case of
LTM EBITDA of RAI, giving effect to the adjustment described above) as set forth in the RAI
projections, and the analysis indicated the following range of implied equity value per share for
RAI common stock, rounded to the nearest $0.25.
RAI Implied Equity Value Per Share
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Implied FV/LTM EBITDA

Low
$ 42.00

High
$ 58.75

The ranges of implied equity value per share for RAI common stock were compared to
(1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the last
trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price
per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI
common stock prior to the announcement of the merger agreement on January 17, 2017, and
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which
was determined by valuing the BAT ADSs included in the merger consideration based on the
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on
January 13, 2017 divided by two (which was the number of BAT ordinary shares then
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per
BAT ordinary share of $57.61)).
Discounted Cash Flow Analysis
J.P. Morgan conducted a discounted cash flow analysis for the purpose of determining an
implied equity value per share for RAI common stock. A discounted cash flow analysis is a
method of evaluating an asset using estimates of the future unlevered free cash flows generated
by the asset, and taking into consideration the time value of money with respect to those future
cash flows by calculating their “present value.” The “unlevered free cash flows” refer to a
calculation of the future cash flows generated by an asset without including in such calculation
any debt servicing costs. “Present value” refers to the current value of the cash flows generated
by the asset and is obtained by discounting those cash flows back to the present using a discount
rate that takes into account macro-economic assumptions and estimates of risk, the opportunity
cost of capital and other appropriate factors. “Terminal value” refers to the present value of all
future cash flows generated by the asset for periods beyond the projections period. The
discounted cash flow analysis conducted by J.P. Morgan treated stock-based compensation as a
cash expense.
J.P. Morgan calculated the present value of unlevered free cash flows that RAI is expected
to generate during the period from calendar year 2017 through the end of 2021 using the RAI
projections. J.P. Morgan also calculated a range of terminal values for RAI at December 31,
2021 by applying a terminal growth rate ranging from 0.0% to 1.0% to the RAI projections
during 2021 to derive terminal period unlevered free cash flows for RAI. The unlevered free cash
flows and the range of terminal values were then discounted to present values using a range of
discount rates from 5.75% to 6.75%, which range was chosen by J.P. Morgan based upon an
analysis of the weighted average cost of capital of RAI, which included J.P. Morgan’s analysis of
the selected companies listed under “—Public Trading Multiples Analysis” described above.
This analysis indicated the following range of implied equity value per share for RAI
common stock, rounded to the nearest $0.25.
RAI Implied Equity Value Per Share
Low

High
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Discounted Cash Flow Analysis

$

47.50

$

68.75

The range of implied equity value per share for RAI common stock was compared to (1) the
closing price per share of RAI common stock of $47.17 on October 20, 2016, the last trading day
prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing price per share of
RAI common stock of $55.97 on January 13, 2017, the last trading day of the RAI common
stock prior to the announcement of the merger agreement on January 17, 2017, and (3) the
implied value of the merger consideration on January 13, 2017 of $59.74 per share (which was
determined by valuing the BAT ADSs included in the merger consideration based on the
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on
January 13, 2017 divided by two (which was the number of BAT ordinary shares then
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per
BAT ordinary share of $57.61)).
Other Information
Historical Trading Range. For reference only and not as a component of its fairness
analysis, J.P. Morgan reviewed the trading range of RAI common stock for the 52-week period
ended October 20, 2016, the last trading day prior to BAT’s announcement of a proposal to
merge with RAI, which was $43.50 per share to $54.50 per share (with a volume weighted
average price per share of $48.71 for the three months ended October 20, 2016), and compared
that to (1) the closing price per share of RAI common stock of $47.17 on October 20, 2016, the
last trading day prior to BAT’s announcement of a proposal to merge with RAI, (2) the closing
price per share of RAI common stock of $55.97 on January 13, 2017, the last trading day of the
RAI common stock prior to the announcement of the merger agreement on January 17, 2017, and
(3) the implied value of the merger consideration on January 13, 2017 of $59.74 per share (which
was determined by valuing the BAT ADSs included in the merger consideration based on the
exchange ratio in the merger of 0.5260 and the closing price per BAT ADS of $115.21 on
January 13, 2017 divided by two (which was the number of BAT ordinary shares then
represented by one BAT ADS and which calculation resulted in an implied hypothetical price per
BAT ordinary share of $57.61)).
Analyst Price Targets. For reference only and not as a component of its fairness analysis,
J.P. Morgan also reviewed certain publicly available equity research analyst share price targets
for RAI common stock as of October 20, 2016, the last trading day prior to BAT’s
announcement of a proposal to merge with RAI, and noted that the range of such price targets
was $47.00 per share to $62.00 per share, and compared that to (1) the closing price per share of
RAI common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s
announcement of a proposal to merge with RAI, (2) the closing price per share of RAI common
stock of $55.97 on January 13, 2017, the last trading day of the RAI common stock prior to the
announcement of the merger agreement on January 17, 2017, and (3) the implied value of the
merger consideration on January 13, 2017 of $59.74 per share (which was determined by valuing
the BAT ADSs included in the merger consideration based on the exchange ratio in the merger
of 0.5260 and the closing price per BAT ADS of $115.21 on January 13, 2017 divided by two
(which was the number of BAT ordinary shares then represented by one BAT ADS and which
calculation resulted in an implied hypothetical price per BAT ordinary share of $57.61)).
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J.P. Morgan noted that the analyses described above under “—Analysis of RAI” were
hypothetical, illustrative analyses only and were not a prediction as to future share trading.
Analysis of BAT
Public Trading Multiples Analysis
Using publicly available information, J.P. Morgan compared selected financial data of BAT
with similar data for publicly traded companies engaged in businesses which J.P. Morgan judged
to be similar in certain respects to BAT’s business or aspects thereof. The companies selected by
J.P. Morgan were the same companies listed under “—Analysis of RAI—Public Trading
Multiples Analysis” above.
These companies were selected, among other reasons, because they are publicly traded
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be
considered similar in certain respects to those of BAT based on business sector participation,
financial metrics and form of operations. However, none of the selected companies reviewed is
identical to BAT and certain of these companies may have characteristics that are materially
different from those of BAT. The analyses necessarily involve complex considerations and
judgments concerning differences in financial and operational characteristics of the companies
involved and other factors that could affect the companies differently than they would affect
BAT.
Based on the results of the analysis described under “—Analysis of RAI—Public Trading
Multiples Analysis” and J.P. Morgan’s professional judgment, J.P. Morgan derived a multiple
reference range of 10.0x-13.5x for FV/2017E EBITDA and a multiple reference range of 13.0x20.5x for P/E 2017E. After applying such ranges to 2017E EBITDA of BAT (adjusted to include
BAT’s proportionate ownership in RAI and ITC Limited, converted at unaffected exchange
rates) and estimated earnings per share for calendar year 2017 of BAT, in each case, as set forth
in the RAI projections for BAT, the analysis indicated the following ranges of implied equity
value per BAT ordinary share, rounded to the nearest £0.25:
BAT Implied Equity Value Per Share

FV/2017E EBITDA
P/E 2017E

Low
£ 39.25
£ 36.50

High
£ 56.25
£ 57.50

The ranges of implied equity value per BAT ordinary share were compared to (1) the
closing price per BAT ordinary share of £48.03 on October 20, 2016, the last trading day prior to
BAT’s announcement of a proposal to merge with RAI and (2) the closing price per BAT
ordinary share of £47.30 on January 13, 2017, the last trading day of the RAI common stock
prior to the announcement of the merger agreement on January 17, 2017.
Discounted Cash Flow Analysis
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J.P. Morgan conducted a discounted cash flow analysis for the purpose of determining an
implied equity value per BAT ordinary share, using the same methodology as described under
“—Analysis of RAI—Discounted Cash Flow Analysis,” except as noted below.
J.P. Morgan calculated the present value of unlevered free cash flows that BAT is expected
to generate during the period from calendar year 2017 through the end of 2021 using the RAI
projections for BAT. J.P. Morgan also calculated a range of terminal values for BAT at
December 31, 2021 by applying a terminal growth rate ranging from 0.0% to 1.0% to the RAI
projections for BAT during 2021 to derive terminal period unlevered free cash flows for BAT.
The unlevered free cash flows and the range of terminal values were then discounted to present
values using a range of discount rates from 6.75% to 8.0%, which range was chosen by J.P.
Morgan based upon an analysis of the weighted average cost of capital of BAT, which included
J.P. Morgan’s analysis of RAI and the selected companies listed under “—Public Trading
Multiples Analysis” described above.
This analysis indicated the following range of implied equity value per BAT ordinary share
(which includes the implied values of BAT’s minority interests and BAT’s proportionate
ownership in RAI and ITC Limited, applying, in the case of BAT’s proportionate ownership in
RAI, a GBP-U.S. dollar exchange rate of 1.2186 as of January 13, 2017), rounded to the nearest
£0.25.
BAT Implied Equity Value Per Share

Discounted Cash Flow

Low
£ 41.75

High
£ 58.75

The range of implied equity value per BAT ordinary share was compared to (1) the closing
price per BAT ordinary share of £48.03 on October 20, 2016, the last trading day prior to BAT’s
announcement of a proposal to merge with RAI and (2) the closing price per BAT ordinary share
of £47.30 on January 13, 2017, the last trading day of the RAI common stock prior to the
announcement of the merger agreement on January 17, 2017.
Other Information
Historical Trading Range. For reference only and not as a component of its fairness
analysis, J.P. Morgan reviewed the trading range of BAT ordinary shares for the 52-week period
ended October 20, 2016, the last trading day prior to BAT’s announcement of a proposal to
merge with RAI, which was £35.75 per share to £50.50 per share (with a volume weighted
average price per BAT ordinary share of £48.32 for the three months ended October 20, 2016),
and compared that to (1) the closing price per BAT ordinary share of £48.03 on October 20,
2016, the last trading day prior to BAT’s announcement of a proposal to merge with RAI and
(2) the closing price per BAT ordinary share of £47.30 on January 13, 2017, the last trading day
of the RAI common stock prior to the announcement of the merger agreement on January 17,
2017.
Analyst Price Targets. For reference only and not as a component of its fairness analysis,
J.P. Morgan also reviewed certain publicly available equity research analyst share price targets
for BAT ordinary shares as of October 20, 2016, the last trading day prior to BAT’s
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announcement of a proposal to merge with RAI, and noted that the range of such price targets
was £43.00 per share to £58.00 per share, and compared that to (1) the closing price per BAT
ordinary share of £48.03 on October 20, 2016, the last trading day prior to BAT’s announcement
of a proposal to merge with RAI, and (2) the closing price per BAT ordinary share of £47.30 on
January 13, 2017, the last trading day of the RAI common stock prior to the announcement of the
merger agreement on January 17, 2017.
J.P. Morgan noted that the analyses described above under “—Analysis of BAT” were
hypothetical, illustrative analyses only and were not a prediction as to future share trading.
Other Analyses
Illustrative Value Creation Analyses
Illustrative Market-Based Value Creation Analysis. For reference only and not as a
component of its fairness analysis, J.P. Morgan reviewed certain market-based analyses of the
potential illustrative value created by the merger for the existing holders of shares of RAI
common stock (other than the BAT Group) that compared the estimated implied equity value per
share of RAI common stock on a standalone basis based on the closing price per share of RAI
common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s announcement
of a proposal to merge with RAI to the sum of (1) the implied equity value per share of the
ownership of RAI shareholders (other than the BAT Group) in the pro forma combined company
and (2) the $29.44 cash per share included in the merger consideration.
J.P. Morgan determined the pro forma combined company implied equity value by
calculating: (1) the sum of (a) the implied equity value of BAT using an implied hypothetical
price per BAT ordinary share of $57.61 on January 13, 2017, the last trading day of the RAI
common stock prior to the announcement of the merger agreement, which was calculated based
on a GBP-U.S. dollar exchange rate of 1.2186 as of January 13, 2017, the last trading day of the
RAI common stock prior to the announcement of the merger agreement on January 17, 2017, and
a closing price per BAT ADS of $115.21 divided by two (which was the number of BAT
ordinary shares then represented by one BAT ADS and which calculation resulted in such
implied hypothetical price per BAT ordinary share of $57.61), (b) the implied equity value of
RAI common stock not owned by the BAT Group, using the closing price per share of RAI
common stock of $47.17 on October 20, 2016, the last trading day prior to BAT’s announcement
of a proposal to merge with RAI, (c) $500 million annual run-rate synergies estimated by the
management of RAI based in part on information provided by the management of the BAT
Group, capitalized by applying a blended implied FV/EBITDA multiple of 12.5x, and (d) the
present value of $140 million annual tax efficiencies estimated by the management of RAI based
in part on information provided by the management of the BAT Group, using a discount rate of
5.0% and a growth rate of 0.0%, less (2) the sum of (a) the estimated transaction fees and
expenses relating to the merger provided to J.P. Morgan by the management of RAI, and (b) the
aggregate amount of cash to be paid to the holders of RAI common stock (other than the BAT
Group) in the merger.
These analyses indicated that the merger would result in illustrative market-based value
creation of 25.8% for the holders of RAI common stock (other than the BAT Group) above the
standalone implied equity value of RAI. There can be no assurance, however, that the synergies,
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tax efficiencies, estimated transaction-related expenses and other impacts will not be
substantially greater or less than those estimated by the managements of RAI and the BAT
Group, as applicable, and described above.
J.P. Morgan noted that the market-based value creation analysis was a hypothetical,
illustrative analysis only and was not a prediction of future share trading.
Illustrative Intrinsic Value Creation Analysis. J.P. Morgan reviewed certain intrinsic
analyses of the potential illustrative value created by the merger for the existing holders of shares
of RAI common stock (other than the BAT Group) that compared the estimated implied equity
value per share of RAI common stock on a standalone basis based on the midpoint value
determined by J.P. Morgan’s discounted cash flow analysis described above under “—Analysis
of RAI—Discounted Cash Flow Analysis” to the sum of (1) the implied equity value per share of
the ownership of RAI shareholders (other than the BAT Group) in the pro forma combined
company and (2) the $29.44 cash per share included in the merger consideration.
J.P. Morgan determined the pro forma combined company implied equity value by calculating:
(1) the sum of (a) the implied equity value of BAT, using the midpoint value determined in J.P.
Morgan’s discounted cash flow analysis for BAT described above under “—Analysis of BAT—
Discounted Cash Flow Analysis” and a GBP-U.S. dollar exchange rate of 1.2186 as of
January 13, 2017, the last trading day of the RAI common stock prior to the announcement of the
merger agreement on January 17, 2017, (b) the implied equity value of RAI common stock not
owned by the BAT Group using the midpoint value determined in J.P. Morgan’s discounted cash
flow analysis for RAI described above under “—Analysis of RAI—Discounted Cash Flow
Analysis,” calculated by using a 6.25% discount rate and a terminal growth rate of 0.5%, (c) the
present value of $500 million annual run-rate synergies estimated by the management of RAI
based in part on information provided by the management of the BAT Group, using a 6.25%
discount rate and a growth rate of 0.0%, and (d) the present value of $140 million annual tax
efficiencies estimated by the management of RAI based in part on information provided by the
management of the BAT Group, using a discount rate of 5.0% and a growth rate of 0.0%, less
(2) the sum of (a) the estimated transaction fees and expenses relating to the merger provided to
J.P. Morgan by the management of RAI, and (b) the aggregate amount of the cash to be paid to
the holders of RAI common stock (other than the BAT Group) in the merger.
These analyses indicated that the merger would result in illustrative intrinsic value creation
of 9.6% for the holders of RAI common stock (other than the BAT Group) above the standalone
implied equity value of RAI. There can be no assurance, however, that the synergies, tax
efficiencies, estimated transaction-related expenses and other impacts will not be substantially
greater or less than those estimated by the managements of RAI and the BAT Group, as
applicable, and described above.
J.P. Morgan noted that the intrinsic value creation analysis was a hypothetical, illustrative
analysis only and was not a prediction of future share trading.
Historical Exchange Ratio Analysis
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For reference only and not as a component of its fairness analysis, J.P. Morgan reviewed the
per share daily closing market prices of RAI common stock and BAT ordinary shares from
July 14, 2014, the day prior to the announcement of the Lorillard merger, to January 13, 2017,
the last trading day of the RAI common stock prior to the announcement of the merger
agreement on January 17, 2017, and J.P. Morgan calculated the implied historical exchange
ratios for the periods specified below, including the implied historical exchange ratios after
adjusting the closing market prices of RAI common stock for the $29.44 cash per share included
in the merger consideration (referred to in this section of the proxy statement/prospectus as the
cash adjusted exchange ratio). Specifically, for each trading day, J.P. Morgan divided the daily
closing price per share of RAI common stock (in case of the cash adjusted exchange ratio, after
adjustment for the $29.44 cash per share included in the merger consideration) by the closing
price per BAT ordinary share. J.P. Morgan calculated the average of the implied historical
exchange ratios (including the cash adjusted exchange ratio) for the one-month, six-month and
one-year periods ended October 20, 2016, the last trading day prior to BAT’s announcement of a
proposal to merge with RAI, and the average for the period from June 11, 2015, the date the
Lorillard merger was completed, until October 20, 2016. J.P. Morgan also calculated the average
of the implied historical exchange ratios (including the cash adjusted exchange ratio) for the
period from October 21, 2016 until January 13, 2017, the last trading day of the RAI common
stock prior to the announcement of the merger agreement on January 17, 2017. The analysis
resulted in the following implied exchange ratios for the dates and periods indicated, all as
compared to the exchange ratio in the merger of 0.5260x:
Cash Adjusted Implied Historic
Exchange Rati
al
o
Exchange Ratio
1-Month Average Ended October 20, 2016
0.2897x

0.7680x

0.3298x

0.8046x

0.3299x

0.8287x

0.3001x

0.8071x

0.4582x

0.9864x

6-Month Average Ended October 20, 2016
1-year Average Ended October 20, 2016
Average for Period from June 11, 2015 to October 20, 2016
Average for Period from October 21, 2016 to January 13,
2017

J.P. Morgan also noted that the highest cash adjusted exchange ratio and the highest implied
historical exchange ratio for the period from June 11, 2015 to October 20, 2016 were 0.4027x
and 0.9538x, respectively.
Miscellaneous
The foregoing summary of certain material financial analyses does not purport to be a
complete description of the analyses or data presented by J.P. Morgan. The preparation of a
fairness opinion is a complex process and is not necessarily susceptible to partial analysis or
summary description. J.P. Morgan believes that the foregoing summary and its analyses must be
considered as a whole and that selecting portions of the foregoing summary and these analyses,
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without considering all of its analyses as a whole, could create an incomplete view of the
processes underlying the analyses and its opinion. As a result, the ranges of valuations resulting
from any particular analysis or combination of analyses described above were merely utilized to
create points of reference for analytical purposes and should not be taken to be the view of J.P.
Morgan with respect to the actual value of RAI or BAT. The order of analyses described does
not represent the relative importance or weight given to those analyses by J.P. Morgan. In
arriving at its opinion, J.P. Morgan did not attribute any particular weight to any analyses or
factors considered by it and did not form an opinion as to whether any individual analysis or
factor (positive or negative), considered in isolation, supported or failed to support its opinion.
Rather, J.P. Morgan considered the totality of the factors and analyses performed in determining
its opinion.
Analyses based upon forecasts of future results are inherently uncertain, as they are subject
to numerous factors or events beyond the control of the parties and their advisors. Accordingly,
forecasts and analyses used or performed by J.P. Morgan are not necessarily indicative of actual
future results, which may be significantly more or less favorable than suggested by those
analyses. Moreover, J.P. Morgan’s analyses are not and do not purport to be appraisals or
otherwise reflective of the prices at which businesses actually could be acquired or sold. None of
the selected companies reviewed as described in the above summary is identical to RAI or BAT,
and none of the selected transactions reviewed was identical to the merger. However, the
companies selected were chosen, among other reasons, because they are publicly traded
companies with operations and businesses that, for purposes of J.P. Morgan’s analysis, may be
considered similar in certain respects to those of RAI or BAT. The transactions selected were
similarly chosen because their participants, size and other factors, for purposes of J.P. Morgan’s
analysis, may be considered similar in certain respects to the merger. The analyses necessarily
involve complex considerations and judgments concerning differences in financial and
operational characteristics of the companies involved and other factors that could affect the
companies compared to RAI or BAT and the transactions compared to the merger.
As a part of its investment banking business, J.P. Morgan and its affiliates are continually
engaged in the valuation of businesses and their securities in connection with mergers and
acquisitions, investments for passive and control purposes, negotiated underwritings, secondary
distributions of listed and unlisted securities, private placements, and valuations for corporate
and other purposes. J.P. Morgan was selected to advise RAI with respect to the merger and
deliver an opinion to the RAI board of directors with respect to the merger on the basis of,
among other things, such experience and its qualifications and reputation in connection with such
matters and its familiarity with RAI, BAT and the industries in which they operate.
For services rendered in connection with the merger (including the delivery of its opinion),
RAI has agreed to pay J.P. Morgan a fee of 0.07% of the total consideration payable in the
merger, which includes the merger consideration to be paid to holders of RAI common stock
(other than the BAT Group) and equity awards at the closing of the merger, the value of any
equity awards of RAI to be assumed by BAT, any dividends or other distributions declared by
RAI with respect to its capital stock following October 30, 2016 (other than normal recurring
cash dividends in amounts not materially greater than then-currently paid) and amounts paid by
RAI to repurchase any securities of RAI outstanding on November 22, 2016 (other than in the
ordinary course of business). Based on the closing price per BAT ADS on June 8, 2017, J.P.
79

Morgan’s fee would be approximately $39.1 million of which $1.0 million became payable upon
the execution of the engagement letter with J.P. Morgan on November 22, 2016, $2.0 million
became payable upon the delivery by J.P. Morgan of its opinion, $1.0 million became payable on
January 30, 2017 and $1.0 million became payable on April 30, 2017 (and additional $1.0
million installments will subsequently become payable on each three-month anniversary of
April 30, 2017 until October 30, 2017 if the merger has not been completed before that date), and
the remainder of which will be due upon the completion of the merger. In addition, RAI may, in
its sole discretion, based on its assessment of J.P. Morgan’s performance of its services, pay J.P.
Morgan an additional fee of up to 0.01% of the total consideration payable in the merger
described above. Based on the closing price per BAT ADS on June 8, 2017, the maximum
amount of such additional fee would be approximately $5.6 million. In addition, RAI has agreed
to indemnify J.P. Morgan for certain liabilities arising out of J.P. Morgan’s engagement.
During the two years preceding the date of J.P. Morgan’s opinion, J.P. Morgan and its
affiliates have had commercial or investment banking relationships with RAI and BAT, for
which J.P. Morgan and such affiliates have received customary compensation. Such services
during such period have included acting as sole arranger and bookrunner on an amendment and
extension of RAI’s revolving credit facility in October 2015 and on an extension of such facility
in November 2016; as lead left arranger and bookrunner on RAI’s syndicated facility in June
2015; as bookrunner on an offering of debt securities by RAI in June 2015; as M&A financial
advisor to RAI on its sale of the international rights to the NATURAL AMERICAN SPIRIT
brand name and associated trademarks outside the United States in January 2016; as joint
bookrunner on an offering of debt securities by BAT in June 2015 and as joint bookrunner on an
offering of debt securities by BAT in September 2016. During such period, J.P. Morgan and its
affiliates have provided treasury and asset management services to RAI and asset management
services to BAT, in each case for customary compensation. In addition, J.P. Morgan’s
commercial banking affiliate is an agent bank and a lender under the outstanding revolving credit
facility of RAI, for which it receives customary compensation or other financial benefits. During
such two year period, the aggregate fees received by J.P. Morgan from RAI and BAT for such
services were approximately $54.0 million and $4.9 million, respectively. In addition, J.P.
Morgan and its affiliates hold, on a proprietary basis, less than 1% of the outstanding RAI
common stock and BAT ordinary shares (including BAT ordinary shares represented by BAT
ADSs). In the ordinary course of their businesses, J.P. Morgan and its affiliates may actively
trade the debt and equity securities or financial instruments (including derivatives, bank loans or
other obligations) of RAI or BAT for their own account or for the accounts of customers and,
accordingly, J.P. Morgan may at any time hold long or short positions in such securities or other
financial instruments.
Preliminary Financial Analyses by J.P. Morgan
In addition to the financial analyses utilized by J.P. Morgan and contained in its
presentation delivered to the RAI board of directors on January 16, 2017 in connection with the
rendering of its opinion, J.P. Morgan, in
its capacity as financial advisor to the RAI board of directors, conducted a series of preliminary
financial analyses. J.P. Morgan discussed these preliminary financial analyses with the RAI
board of directors on November 8, 2016, December 7, 2016, December 20, 2016, January 10,
2017 and January 14, 2017 (such preliminary financial analyses are collectively referred to in
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this section of the proxy statement/prospectus as the J.P. Morgan preliminary financial analyses).
Copies of the written materials containing the J.P. Morgan preliminary financial analyses have
been attached as exhibits to the Schedule 13E-3 filed by RAI and the Schedule 13E-3 filed by
BAT with the SEC. These written presentations will be available to any interested shareholder of
RAI (or any representative of a shareholder who has been so designated in writing) to inspect
and copy at RAI’s principal executive offices during regular business hours.
The J.P. Morgan preliminary financial analyses primarily addressed the continuing
negotiations of a potential transaction between RAI and BAT and included summaries of the
various proposals submitted by BAT and described above under “—Background of the Merger,”
various summary data, illustrative analyses and other information that J.P. Morgan utilized in
formulating its preliminary perspectives regarding a potential transaction. The J.P. Morgan
preliminary financial analyses were prepared for discussion purposes only and did not make any
recommendations or constitute, or form the basis or part of, its fairness analysis or J.P. Morgan’s
opinion dated January 16, 2017 with respect to the fairness, from a financial point of view, of the
merger consideration to be paid to holders of RAI common stock (other than the BAT Group) in
the proposed merger. Except for the assumptions and qualifications set forth in the materials
containing such preliminary analyses, the J.P. Morgan preliminary financial analyses were
substantially similar to, and were prepared using substantially the same methodologies as, the
financial analyses described above and contained in the presentation delivered to the RAI board
of directors on January 16, 2017 in connection with the rendering of J.P. Morgan’s opinion. A
summary of the written materials and the J.P. Morgan preliminary financial analyses is provided
below. The following summary, however, does not purport to be a complete description of these
materials or of the J.P. Morgan preliminary financial analyses included in these materials.
November 8, 2016 Materials
The November 8, 2016 materials discussed with the RAI board of directors included,
among other information, a summary of BAT’s October 20 Proposal, a summary of selected
news and commentary regarding a potential transaction between RAI and BAT, a summary of
certain preliminary financial forecasts for RAI prepared by the management of RAI and provided
to J.P. Morgan (referred to in this section of the proxy statement/prospectus as the preliminary
RAI projections), a summary of certain preliminary financial forecasts for BAT based on
publicly available equity analysts’ consensus estimates and extrapolations that had been
reviewed and approved for J.P. Morgan’s use by the management of RAI (referred to in this
section of the proxy statement/prospectus as the preliminary RAI projections for BAT), a
discussion of the potential synergies and tax efficiencies to be achieved in a potential transaction
as estimated by BAT and RAI and the implications thereof for a potential transaction, an
overview of certain considerations relating to the financing of the cash portion of the proposed
transaction consideration and a discussion of potential strategic alternatives for RAI.
The November 8, 2016 materials also included, among other information, public trading
multiples analyses, selected transaction multiples analyses, discounted cash flow analyses,
historical trading ranges and analyst price targets, illustrative value creation analyses, a historical
exchange ratio analysis and an illustrative accretion/dilution analysis (which analysis compared
certain financial metrics for BAT on a standalone basis to the corresponding financial metrics
implied for the pro forma combined company). Based on certain of these preliminary financial
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analyses and for purposes of discussing BAT’s October 20 Proposal with the RAI board of
directors, J.P. Morgan derived the ranges of implied equity values for RAI and BAT set forth
below:
Preliminary Analyses of RAI
• A preliminary public trading multiples analysis for RAI, using the preliminary RAI
projections and focusing on the same six companies identified above under “Opinion of
J.P. Morgan—Analysis of RAI—Public Trading Multiples Analysis,” indicated ranges of
implied equity value per share of RAI
common stock, rounded to the nearest $0.25, of (1) $38.75 to $52.00 applying a
FV/2017E EBITDA multiple range of 10.5x to 13.5x and (2) $37.50 to $50.00 applying a
P/E 2017E multiple range of 15.0x to 20.0x.
• A preliminary selected transaction multiples analysis for RAI, using the preliminary RAI
projections and focusing on the same nineteen transactions identified above under
“Opinion of J.P. Morgan—Analysis of RAI—Selected Transaction Multiples Analysis,”
indicated ranges of implied equity value per share of RAI common stock, rounded to the
nearest $0.25, of (1) $42.00 to $58.75 applying a FV/2016E EBITDA multiple range of
12.0x to 16.0x and (2) $43.00 to $60.00 applying a FV/2016E EBITDA multiple range of
12.0x to 16.0x (with 2016E EBITDA being adjusted, at the direction of the management
of RAI, for certain cost synergies related to RAI’s acquisition of Lorillard).
• A preliminary discounted cash flow analysis for RAI, using the preliminary RAI
projections and applying a terminal growth rate ranging from 0.0% to 1.0% and a range
of discount rates from 6.0% to 7.0%, indicated a range of implied equity value per share
of RAI common stock, rounded to the nearest $0.25, of $45.75 to $65.00.
Preliminary Analyses of BAT
• A preliminary public trading multiples analysis for BAT, using the preliminary RAI
projections for BAT and focusing on the same six companies identified under “Opinion
of J.P. Morgan—Analysis of BAT—Public Trading Multiples Analysis,” indicated ranges
of implied equity value per BAT ordinary share, rounded to the nearest £0.25, of (1)
£43.00 to £58.25 applying a FV/2017E EBITDA multiple range of 10.5x to 13.5x and (2)
£42.50 to £56.75 applying a P/E 2017E multiple range of 15.0x to 20.0x.
• A preliminary discounted cash flow analysis for BAT, using the preliminary RAI
projections for BAT and applying a terminal growth rate ranging from 0.0% to 1.0% and
a range of discount rates from 7.0% to 8.0%, indicated a range of implied equity value
per BAT ordinary share, rounded to the nearest £0.25, of £40.00 to £54.50.
December 7, 2016 Materials
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The December 7, 2016 materials discussed with the RAI board of directors included, among
other information, a summary of BAT’s October 20 Proposal and December 5 Proposal,
summaries of the preliminary RAI projections and the preliminary RAI projections for BAT and
a discussion of potential synergies and tax efficiencies to be achieved in a potential transaction as
estimated by RAI and BAT and the implications thereof for a potential transaction.
The December 7, 2016 materials also included, among other information, public trading
multiples analyses, selected transaction multiples analyses, discounted cash flow analyses,
historical trading ranges and analyst price targets, illustrative value creation analyses and an
analysis of historical premia paid by shareholders acquiring companies in which such
shareholders already owned a significant portion of the stock. Based on certain of these
preliminary financial analyses and for purposes of discussing BAT’s October 20 Proposal and
December 5 Proposal with the RAI board of directors, J.P. Morgan derived the ranges of implied
equity values for RAI and BAT set forth below:
Preliminary Analyses of RAI
• A preliminary public trading multiples analysis for RAI, using the preliminary RAI
projections and focusing on the same six companies identified above under “Opinion of
J.P. Morgan—Analysis of RAI —Public Trading Multiples Analysis,” indicated ranges of
implied equity value per share of RAI common stock, rounded to the nearest $0.25, of
(1) $36.50 to $49.75 applying a FV/2017E EBITDA multiple range of 10.0x to 13.0x and
(2) $36.25 to $48.75 applying a P/E 2017E multiple range of 14.5x to 19.5x.
• A preliminary selected transaction multiples analysis for RAI, using the preliminary RAI
projections and focusing on the same nineteen transactions identified above under
“Opinion of J.P. Morgan—Analysis of RAI —Selected Transaction Multiples Analysis,”
indicated ranges of implied equity value per share of RAI common stock, rounded to the
nearest $0.25, of (1) $42.00 to $58.75 applying a FV/2016E EBITDA multiple range of
12.0x to 16.0x and (2) $43.00 to $60.00 applying a FV/2016E EBITDA multiple range of
12.0x to 16.0x (with 2016E EBITDA being adjusted, at the direction of the management
of RAI, for certain cost synergies related to RAI’s acquisition of Lorillard).
• A preliminary discounted cash flow analysis for RAI, using the preliminary RAI
projections and applying a terminal growth rate ranging from 0.0% to 1.0% and a range
of discount rates from 5.75% to 6.75%, indicated a range of implied equity value per
share of RAI common stock, rounded to the nearest $0.25, of $47.75 to $69.00.
Preliminary Analyses of BAT
• A preliminary public trading multiples analysis for BAT, using the preliminary RAI
projections for BAT and focusing on the same six companies identified under “Opinion
of J.P. Morgan—Analysis of BAT—Public Trading Multiples Analysis,” indicated ranges
of implied equity value per BAT ordinary share, rounded to the nearest £0.25, of (1)
£40.50 to £55.75 applying a FV/2017E EBITDA multiple range of 10.0x to 13.0x and (2)
£40.75 to £55.00 applying a P/E 2017E multiple range of 14.5x to 19.5x.
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• A preliminary discounted cash flow analysis for BAT using the preliminary RAI
projections for BAT and applying a terminal growth rate ranging from 0.0% to 1.0% and
a range of discount rates from 6.75% to 8.0%, indicated a range of implied equity value
per BAT ordinary share, rounded to the nearest £0.25, of £40.25 to £57.00.
December 20, 2016 Materials
The December 20, 2016 materials discussed with the RAI board of directors included,
among other information, a summary of BAT’s October 20 Proposal, December 5 Proposal and
December 20 Proposal, an illustrative discussion of the effect of an increase in the stock portion
of the proposed transaction consideration to be paid by BAT on the implied offer price per share
of RAI common stock and an illustrative overview of the effect of different share prices for BAT
on the implied offer price per share of RAI common stock.
The December 20, 2016 materials also included, among other information, illustrative value
creation analyses, historical trading ranges and analyst price targets, an illustrative
accretion/dilution analysis and, for purposes of discussing BAT’s October 20 Proposal,
December 5 Proposal and December 20 Proposal, the same public trading multiples analysis,
selected transactions multiples analysis and discounted cash flow analysis with the same ranges
of implied equity values per share of RAI common stock that were included in the December 7,
2016 materials described above.
January 10, 2017 Materials
The January 10, 2017 materials discussed with the RAI board of directors included, among
other information, a summary of BAT’s October 20 Proposal, December 5 Proposal and
December 20 Proposal and an illustrative overview of the effect of different exchange ratios on
the implied offer price per share of RAI common stock.
The January 10, 2017 materials also included, among other information, an analysis of
historical premia paid by shareholders acquiring the remaining outstanding stock of U.S.
companies in which such shareholders already owned 30% to 49% of the target company’s
stock. For purposes of this analysis, J.P. Morgan reviewed the premia paid in 27 closed
transactions from 1995 until June 30, 2016, each with a total enterprise value of greater than $1.0
billion. Using information from Dealogic and Bloomberg, premia paid were calculated as a
percentage by which the per share consideration paid in each such transaction exceeded the
closing price per share of the relevant target company one week prior to the transaction
announcement. The analysis indicated a range of premia paid of (6.0)% to 80.1%, a median
premium of 20.5% and a mean premium of 24.0%.
January 14, 2017 Materials
The January 14, 2017 materials discussed with the RAI board of directors included, among
other information, a summary of BAT’s October 20 Proposal and January 10 Proposal.
Each of the J.P. Morgan preliminary financial analyses was subsequently updated and
refined by J.P. Morgan. Each of the J.P. Morgan preliminary financial analyses was based on
market, economic and other conditions as in effect on, and the information made available to J.P.
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Morgan as of, the dates on which J.P. Morgan performed such analyses. Accordingly, the results
of the J.P. Morgan preliminary financial analyses and other information differed due to changes
in those conditions. Among other things, the results of certain financial analyses changed as the
management of RAI revised or adjusted its financial forecasts for RAI and as the management of
RAI provided J.P. Morgan certain financial forecasts for BAT, which were based in part on
certain financial information for BAT prepared by the management of the BAT Group and
provided to RAI.
B.
ANNEX C TO PROXY STATEMENT, FAIRNESS OPINION OF JP
MORGAN
Annex C

January 16, 2017
The Board of Directors
Reynolds American Inc.
401 North Main Street
Winston-Salem, NC 27101
Members of the Board of Directors:
You have requested our opinion as to the fairness, from a financial point of view, to the holders
of common stock, par value $0.0001 per share (the “Company Common Stock”), of Reynolds
American Inc. (the “Company”) (other than the Acquiror or any Parent Subsidiaries (as defined
below)) of the consideration to be paid to such holders in the proposed merger (the
“Transaction”) of the Company with a wholly-owned subsidiary of British American Tobacco
p.l.c. (the “Acquiror”). Pursuant to the Agreement and Plan of Merger (the “Agreement”), among
the Company, the Acquiror, BATUS Holdings Inc. (the “US Acquiror”) and the Acquiror’s
subsidiary, Flight Acquisition Corporation (“Acquisition Sub” and, together with the Acquiror
and the US Acquiror, the “Acquiror Group”), the Company will become a wholly-owned
subsidiary of the Acquiror, and each outstanding share of Company Common Stock, other than
shares of Company Common Stock owned by the Acquiror or any Parent Subsidiaries (as
defined in the Agreement) and other than Dissenting Shares (as defined in the Agreement), will
be converted into the right to receive consideration per share equal to (i) $29.44 in cash (the
“Cash Consideration”) and (ii) a number of American depositary shares of the Acquiror (the
“Acquiror ADSs”) equal to 0.5260 divided by the number of ordinary shares, par value 25
British pence per share, of the Acquiror (the “Acquiror Ordinary Shares”) represented by one
Acquiror ADS as of the effective time of the Transaction (the “Stock Consideration” and,
together with the Cash Consideration, the “Consideration”).
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In connection with preparing our opinion, we have (i) reviewed a draft dated January 16, 2017 of
the Agreement; (ii) reviewed certain publicly available business and financial information
concerning the Company and the Acquiror and the industries in which they operate;
(iii) compared the proposed financial terms of the Transaction with the publicly available
financial terms of certain transactions involving companies we deemed relevant and the
consideration paid for such companies; (iv) compared the financial and operating performance of
the Company and the Acquiror with publicly available information concerning certain other
companies we deemed relevant and reviewed the current and historical market prices of the
Company Common Stock, the Acquiror Ordinary Shares and the Acquiror ADSs and certain
publicly traded securities of such other companies; (v) reviewed certain internal financial
analyses and forecasts prepared by the management of the Company relating to the businesses of
each of the Company and the Acquiror (which, in the case of the forecasts for the Acquiror, were
based in part on certain financial information for the Acquiror prepared by the management of
the Acquiror and provided to the Company), as well as the estimated amount and timing of the
cost savings and related expenses and synergies expected to result from the Transaction (the
“Synergies”); and (vi) performed such other financial studies and analyses and considered such
other information as we deemed appropriate for the purposes of this opinion.
In addition, we have held discussions with certain members of the management of the Company
and the Acquiror with respect to certain aspects of the Transaction, and the past and current
business operations of the Company and the Acquiror, the financial condition and future
prospects and operations of the Company and the Acquiror, the effects of the Transaction on the
financial condition and future prospects of the Company and the Acquiror, and certain other
matters we believed necessary or appropriate to our inquiry.
In giving our opinion, we have relied upon and assumed the accuracy and completeness of all
information that was publicly available or was furnished to or discussed with us by the Company
and the Acquiror or otherwise reviewed by or for us. We have not independently verified any
such information or its accuracy or completeness and, pursuant to our engagement letter with the
Company, we did not assume any obligation to undertake any such independent verification. We
have not conducted or been provided with any valuation or appraisal of any assets or liabilities,
nor have we evaluated the solvency of the Company or the Acquiror Group under any state or
federal laws relating to bankruptcy, insolvency or similar matters. In relying on financial
analyses and forecasts provided to us or derived therefrom, including the Synergies, we have
assumed that they have been reasonably prepared based on assumptions reflecting the best
currently available estimates and judgments by management as to the expected future results of
operations and financial condition of the Company and the Acquiror to which such analyses or
forecasts relate. We express no view as to such analyses or forecasts (including the Synergies) or
the assumptions on which they were based. We have also assumed that the Transaction and the
other transactions contemplated by the Agreement will have the tax consequences described in
discussions with, and materials furnished to us by, representatives of the Company, and will be
consummated as described in the Agreement, and that the definitive Agreement will not differ in
any material respects from the draft thereof furnished to us. We have also assumed that the
representations and warranties made by the Company and the Acquiror Group in the Agreement
and the related agreements are and will be true and correct in all respects material to our analysis.
We are not legal, regulatory or tax experts and have relied on the assessments made by advisors
to the Company with respect to such issues. We have further assumed that all material
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governmental, regulatory or other consents and approvals necessary for the consummation of the
Transaction will be obtained without any adverse effect on the Company or the Acquiror or on
the contemplated benefits of the Transaction.
Our opinion is necessarily based on economic, market and other conditions as in effect on, and
the information made available to us as of, the date hereof. It should be understood that
subsequent developments may affect this opinion and that we do not have any obligation to
update, revise, or reaffirm this opinion. Our opinion is limited to the fairness, from a financial
point of view, of the Consideration to be paid to the holders of the Company Common Stock
(other than the Acquiror or any Parent Subsidiaries) in the proposed Transaction and we express
no opinion as to the fairness of any consideration to be paid in connection with the Transaction
to the holders of any other class of securities, creditors or other constituencies of the Company or
as to the underlying decision by the Company to engage in the Transaction. Furthermore, we
express no opinion with respect to the amount or nature of any compensation to any officers,
directors, or employees of any party to the Transaction, or any class of such persons relative to
the Consideration to be paid to the holders of the Company Common Stock in the Transaction or
with respect to the fairness of any such compensation. We are expressing no opinion herein as to
the price at which the Company Common Stock, the Acquiror Ordinary Shares or the Acquiror
ADSs will trade at any future time.
We note that we were not authorized to and did not solicit any expressions of interest from any
other parties with respect to the sale of all or any part of the Company or any other alternative
transaction.
We have acted as financial advisor to the Company with respect to the proposed Transaction and
will receive a fee from the Company for our services, a substantial portion of which will become
payable only if the proposed Transaction is consummated. In addition, the Company has agreed
to indemnify us for certain liabilities arising out of our engagement. During the two years
preceding the date of this letter, we and our affiliates have had commercial or investment
banking relationships with the Company and the Acquiror, for which we and such affiliates have
received customary compensation. Such services during such period have included acting as sole
arranger and bookrunner on an amendment and extension of the Company’s revolving credit
facility in October 2015 and on an extension of such facility in November 2016, as lead left
arranger and bookrunner on the Company’s syndicated facility in June 2015, as bookrunner on
an offering of debt securities by the Company in July 2015, as M&A financial advisor to the
Company on its sale of Natural American Spirit in January 2016, as joint bookrunner on an
offering of debt securities by the Acquiror in June 2015 and as joint bookrunner on an offering of
debt securities by the Acquiror in September 2016. During such period, we and our affiliates
have provided treasury and asset management services to the Company and asset management
services to the Acquiror, in each case for customary compensation. In addition, our commercial
banking affiliate is an agent bank and a lender under outstanding credit facilities of the
Company, for which it receives customary compensation or other financial benefits. In addition,
we and our affiliates hold, on a proprietary basis, less than 1% of the outstanding Company
Common Stock and Acquiror Ordinary Shares (including Acquiror Ordinary Shares represented
by Acquiror ADSs). In the ordinary course of our businesses, we and our affiliates may actively
trade the debt and equity securities or financial instruments (including derivatives, bank loans or
other obligations) of the Company or the Acquiror for our own account or for the accounts of
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customers and, accordingly, we may at any time hold long or short positions in such securities or
other financial instruments.
On the basis of and subject to the foregoing, it is our opinion as of the date hereof that the
Consideration to be paid to the holders of the Company Common Stock (other than the Acquiror
or any Parent Subsidiaries) in the proposed Transaction is fair, from a financial point of view, to
such holders.
The issuance of this opinion has been approved by a fairness opinion committee of J.P. Morgan
Securities LLC. This letter is provided to the Board of Directors of the Company (in its capacity
as such) in connection with and for the purposes of its evaluation of the Transaction. This
opinion does not constitute a recommendation to any shareholder of the Company as to how such
shareholder should vote with respect to the Transaction or any other matter. This opinion may
not be disclosed, referred to, or communicated (in whole or in part) to any third party for any
purpose whatsoever except with our prior written approval. This opinion may be reproduced in
full in any proxy or information statement mailed to shareholders of the Company but may not
otherwise be disclosed publicly in any manner without our prior written approval.
Very truly yours,
J.P. MORGAN SECURITIES LLC
/s/ J.P. Morgan Securities LLC

LAZARD’S OPINION TO RAI’S BOARD

§ 1.1
C.

PROXY DISCUSSION OF OPINION OF LAZARD

Opinions of RAI’s Financial Advisors
RAI retained J.P. Morgan and Lazard as financial advisors to the RAI board of directors in
connection with the merger. In connection with this engagement, the RAI board of directors
requested that RAI’s financial advisors deliver the opinions described below. * * *
Opinion of Lazard
On January 16, 2017, at a meeting of the RAI board of directors held to evaluate the
merger, Lazard rendered to the RAI board of directors an oral opinion, which was confirmed by
delivery of a written opinion dated January 16, 2017, to the effect that, as of that date and based
upon and subject to the matters described in its opinion, the merger consideration per share of
RAI common stock, consisting of (1) a number of BAT ADSs representing 0.5260 of a BAT
ordinary share plus (2) $29.44 in cash to be paid to holders of shares of RAI common stock,
other than the BAT Group and excluded holders, was fair, from a financial point of view, to such
holders. For purposes of this section, excluded holders means holders of shares of RAI common
stock who have not voted, or caused or permitted to be voted, any shares of RAI common stock
in favor of the adoption of the plan of merger, as defined in the merger agreement, at the special
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meeting and who have properly asserted (and not lost or effectively withdrawn) their rights of
appraisal in accordance with Article 13 of the NCBCA.
The full text of Lazard’s written opinion, dated January 16, 2017, to the RAI board of
directors which sets forth, among other things, the procedures followed, assumptions made,
matters considered and limitations on the scope of review undertaken, is attached to this proxy
statement/prospectus as Annex D and is incorporated into this proxy statement/prospectus by
reference. The summary of Lazard’s opinion set forth in this proxy statement/prospectus is
qualified in its entirety by reference to the full text of Lazard’s written opinion attached as Annex
D. You are encouraged to read Lazard’s opinion and this section carefully and in their entirety.
Lazard’s opinion was for the benefit of the RAI board of directors (in its capacity as such)
and Lazard’s opinion was rendered to the RAI board of directors in connection with its
evaluation of the merger. Lazard’s opinion was not intended to and does not constitute a
recommendation to any RAI shareholder as to how such shareholder should vote or act
with respect to the merger or any matter relating thereto.
In connection with its opinion, Lazard:
• reviewed the financial terms and conditions of the merger agreement, dated as of
January 16, 2017;
• reviewed certain publicly available historical business and financial information relating
to RAI and BAT;
• reviewed certain internal financial analyses and forecasts prepared by the management of
RAI relating to the business of each of RAI and BAT (which, in the case of the forecasts
for BAT, were based in part on certain financial information for BAT prepared by the
management of BAT and provided to RAI), and the projected synergies and other
benefits, including the amount and timing thereof, anticipated by the management of RAI
to be realized from the merger;
• held discussions with members of the senior management of RAI with respect to the
businesses and prospects of RAI and BAT, respectively, and the projected synergies and
other benefits anticipated by the management of RAI to be realized from the merger;
• reviewed public information with respect to certain other companies in lines of business
Lazard believed to be generally relevant in evaluating the businesses of RAI and BAT,
respectively;
• reviewed the financial terms of certain business combinations involving companies in
lines of business Lazard believed to be generally relevant in evaluating the businesses of
RAI and BAT, respectively;
• reviewed historical stock prices and trading volumes of RAI common stock and BAT
ordinary shares;

89

• reviewed the potential pro forma financial impact of the merger on BAT based on the
financial forecasts referred to above relating to RAI and BAT; and
• conducted such other financial studies, analyses and investigations as Lazard deemed
appropriate.
Lazard assumed and relied upon the accuracy and completeness of the foregoing
information, without independent verification of such information. Lazard did not conduct any
independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of
RAI or BAT or concerning the solvency or fair value of RAI or BAT, and Lazard was not
furnished with any such valuation or appraisal. At the direction of the RAI board of directors, for
purposes of its analysis, Lazard utilized forecasts with respect to BAT and the synergies and
other benefits anticipated to result from the merger that were prepared by management of RAI
and were based, in part, on financial information provided by BAT to RAI and, as the RAI board
of directors knew, Lazard did not have discussions with management of BAT in connection with
the merger. With respect to the financial forecasts utilized in Lazard’s analyses, including those
related to projected synergies and other benefits anticipated by the management of RAI to be
realized from the merger, Lazard assumed, with the consent of RAI, that they have been
reasonably prepared on bases reflecting the best currently available estimates and judgments as
to the future financial performance of RAI and BAT, respectively, and such synergies and other
benefits. Lazard expressed no view as to any such forecasts or the assumptions on which they are
based.
Further, Lazard’s opinion was necessarily based on economic, monetary, market and other
conditions as in effect on, and the information made available to Lazard as of, the date of the
opinion. Lazard assumed no responsibility for updating or revising its opinion based on
circumstances or events occurring after the date thereof. Lazard did not express any opinion as to
the prices at which shares of RAI common stock, BAT ordinary shares or BAT ADSs may trade
at any time subsequent to the announcement of the merger. In connection with Lazard’s
engagement, Lazard was not authorized to, and Lazard did not, solicit indications of interest
from third parties regarding a potential transaction with RAI. In addition, Lazard’s opinion did
not address the relative merits of the merger as compared to any other transaction or business
strategy in which RAI might engage or the merits of the underlying decision by RAI to engage in
the merger.
In rendering its opinion, Lazard assumed, with the consent of RAI, that the merger would
be completed on the terms described in the merger agreement, without any waiver or
modification of any material terms or conditions. Lazard also assumed, with the consent of RAI,
that obtaining the necessary governmental, regulatory or third-party approvals and consents for
the merger would not have an adverse effect on RAI, BAT or the merger. Lazard did not express
any opinion as to any tax or other consequences that might result from the merger, nor did its
opinion address any legal, tax, regulatory or accounting matters, as to which Lazard understood
that RAI obtained such advice as it deemed necessary from qualified professionals. Lazard
expressed no view or opinion as to any terms or other aspects (other than the merger
consideration to the extent expressly specified in the opinion) of the merger, including, without
limitation, the form or structure of the merger or any agreements or arrangements entered into in
connection with, or contemplated by, the merger. In addition, Lazard expressed no view or
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opinion as to the fairness of the amount or nature of, or any other aspects relating to, the
compensation to any officers, directors or employees of any parties to the merger, or class of
such persons, relative to the merger consideration or otherwise. The issuance of Lazard’s opinion
was approved by the Opinion Committee of Lazard.
In preparing its opinion to the RAI board of directors, Lazard performed a variety of
financial and comparative analyses. The following is a brief summary of the material financial
and comparative analyses that Lazard deemed to be appropriate for this type of transaction and
that were reviewed with the RAI board of directors by Lazard in connection with rendering its
opinion. The summary of Lazard’s analyses described below is not a complete description of the
analyses underlying Lazard’s opinion. The preparation of a fairness opinion is a complex
analytical process involving various determinations as to the most appropriate and relevant
methods of financial analysis and the application of those methods to the particular
circumstances and, therefore, is not readily susceptible to partial or summary description. In
arriving at its opinion, Lazard considered the results of all of the analyses undertaken by it and
assessed as a whole and did not draw, in isolation, conclusions from or with regard to any one
factor or method of analysis considered by it. Rather, Lazard made its determination as to
fairness on the basis of its experience and professional judgment after considering the results of
all of the analyses. Accordingly, Lazard believes that its analyses must be considered as a whole
and that selecting portions of its analyses and factors or focusing on information presented in
tabular format, without considering all analyses and factors or the narrative description of the
analyses, could create a misleading or incomplete view of the processes underlying its analyses
and opinion.
In its analyses, Lazard considered industry performance, general business, economic,
market and financial conditions and other matters, many of which are beyond the control of RAI
or BAT. No company or business used in Lazard’s analyses is identical to RAI or BAT, and such
analyses may not necessarily utilize all companies or businesses that could be deemed
comparable to RAI or BAT. Accordingly, an evaluation of the results of those analyses is not
entirely mathematical. Rather, the analyses involve complex considerations and judgments
concerning financial and operating characteristics and other factors that could affect the public
trading or other values of the companies analyzed. The estimates contained in Lazard’s analyses
and the ranges of valuations resulting from any particular analysis are not necessarily indicative
of actual values or predictive of future results or values, which may be significantly more or less
favorable than those suggested by the analyses. In addition, analyses relating to the value of
businesses or securities do not purport to be appraisals or to reflect the prices at which businesses
or securities actually may be sold. Accordingly, the estimates used in, and the results derived
from, Lazard’s analyses are inherently subject to substantial uncertainty.
The merger consideration was determined through negotiations between the Transaction
Committee and BAT and was approved by the RAI board of directors, after unanimous
recommendation and approval by the Transaction Committee. Lazard was not requested to, and
it did not, recommend the specific merger consideration payable in the merger or that any given
merger consideration constituted the only appropriate consideration for the merger. The decision
to enter into the merger agreement was solely that of the RAI board of directors and the opinion
of Lazard was only one of many factors taken into consideration by the RAI board of directors in
its evaluation of the merger. Consequently, the analyses described below should not be viewed as
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determinative of the views of the RAI board of directors, the Transaction Committee or RAI’s
management with respect to the merger or the merger consideration.
The financial analyses summarized below include information presented in tabular
format. In order to fully understand Lazard’s financial analyses, the tables must be read
together with the text of each summary. The tables alone do not constitute a complete
description of the financial analyses. Considering the data in the tables below without
considering the full narrative description of the financial analyses, including the
methodologies and assumptions underlying the analyses, could create a misleading or
incomplete view of Lazard’s financial analyses. Except as otherwise noted, the following
quantitative information, to the extent that it is based on market data, is based on market
data as it existed on or before January 13, 2017, the last trading day for RAI common stock
and BAT ADSs before the public announcement of the merger, and is not necessarily
indicative of current market conditions.
Introduction
As more fully described below, Lazard performed (1) with respect to each of RAI and BAT,
discounted cash flow analyses on a stand-alone basis and selected comparable company
analyses, (2) with respect to RAI, selected precedent transactions analyses and (3) “has-gets”
analyses from the perspective of the holders of RAI common stock (other than the BAT Group
and excluded holders).
The merger consideration to be paid by BAT in the merger consists of (1) a number of BAT
ADSs representing 0.5260 of a BAT ordinary share plus (2) $29.44 in cash. Based on the closing
price of BAT ADSs of $115.21 (each BAT ADS then representing two BAT ordinary shares) on
January 13, 2017 ($57.61 after giving effect to the BAT ADS ratio change), the last trading day
of the BAT ADSs before the public announcement of the merger agreement, the merger
consideration represented approximately $59.74 in value per share of RAI common stock. For
purposes of these analyses, Lazard assumed a Sterling-Dollar exchange rate as of January 13,
2017 of 1.2186 $/£.
Discounted Cash Flow Analyses
Lazard performed the following discounted cash flow analyses with respect to each of RAI
and BAT. Financial forecasts and other data for RAI and BAT on a stand-alone basis were
provided by RAI. See “—RAI Unaudited Prospective Financial Information” beginning on page
108 of this proxy statement/prospectus.
Discounted Cash Flow Analysis. Lazard performed a discounted cash flow analysis to
calculate the estimated present value, as of December 31, 2016, of the unlevered, after-tax free
cash flows that each of RAI and BAT, on a stand-alone basis, were forecasted to generate during
the calendar years 2017 to 2021, based on an estimated range of weighted average cost of capital
of 5.0% to 6.0% for RAI and 6.0% to 7.0% for BAT. The unlevered, after-tax free cash flows
were calculated by taking the net operating profit after tax (representing earnings before interest
after tax), then adding depreciation and amortization, subtracting capital expenditures and
adjusting for changes in working capital and other cash flow items. Lazard then calculated the
estimated present value of the terminal values of RAI and BAT, respectively, as of December 31,
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2016, by selecting, based on its judgment and experience, a range of perpetuity growth rates of
(0.5)% to 0.5% (which implied exit EBITDA multiples ranging from 9.7x to 14.1x for RAI and
7.9x to 10.9x for BAT) and an estimated range of weighted average cost of capital of 5.0% to
6.0% for RAI and 6.0% to 7.0% for BAT. The weighted average cost of capital was derived by
application of the Capital Asset Pricing Model, taking into account certain metrics including
target capital structure, the cost of long-term Treasury debt, tax rates, unlevered and levered
betas for the selected comparable tobacco companies discussed below, including RAI and BAT
as appropriate, as well as certain financial metrics for the U.S. financial markets generally.
Lazard then calculated a range of implied per share values of RAI common stock and BAT
ordinary shares by subtracting the net debt of each of RAI and BAT as of December 31, 2016,
from the estimated enterprise value using the discounted cash flow method and dividing such
amount by the fully diluted number of outstanding shares of RAI common stock and BAT
ordinary shares, respectively. This analysis resulted in the following range of implied per share
values of RAI common stock and BAT ordinary shares, respectively:
Implied per share values
of RAI common stock
on a stand-alone basis
$50.03 – $73.38

Implied per share values
of BAT ordinary shares
on a stand-alone basis
£44.09 – £54.72
($53.73 – $66.68)

Lazard also calculated an implied exchange ratio reference range based on the discounted
cash flow analysis described above by dividing (1) the low end of the per share value range of
RAI resulting from the discounted cash flow analysis described above (less the $29.44 per share
of merger consideration to be paid in cash) by the high end of the per share value range of BAT
resulting from the discounted cash flow analysis described above and (2) the high end of the per
share value range of RAI resulting from the discounted cash flow analysis
described above (less the $29.44 per share of merger consideration to be paid in cash) by the low
end of the per share value range of BAT resulting from the discounted cash flow analysis
described above. This analysis resulted in an implied exchange ratio of 0.3088x to 0.8178x and
an implied pro forma ownership range for the holders of RAI common stock of 12.1% to 26.6%.
The exchange ratio provided for in the merger agreement is 0.5260x resulting in a pro forma
ownership for the holders of RAI common stock of 18.9%.
Selected Comparable Company Analyses
Lazard reviewed and analyzed certain financial information, valuation multiples and market
trading data related to selected publicly traded tobacco companies whose business and operations
Lazard believed, based on its judgment and experience, including with companies in the tobacco
industry, to be similar to each of RAI’s and BAT’s business and operations for purposes of these
analyses, considering, among other factors, business sector participation, financial metrics and
form of operations, including product mix, end markets, customers and size, of such companies.
The selected companies used in these analyses, which are referred to in this proxy
statement/prospectus as the selected comparable tobacco companies, were divided into two
categories as follows:
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Global Majors
• Philip Morris International;
• BAT;
• Japan Tobacco Inc.; and
• Imperial Brands.
US/European
• Altria Group;
• RAI;
• Swedish Match; and
• Scandinavian Tobacco.
Although none of the selected comparable tobacco companies (other than RAI and BAT)
included in the selected comparable company analyses is identical or directly comparable to RAI
or BAT, the selected comparable tobacco companies included were chosen because they are
publicly traded companies with certain operations, results, business mixes or product profiles
that, for the purposes of analysis, may be considered similar to certain operations, results,
business mixes or product profiles of the RAI Group and the BAT Group.
Lazard calculated and compared various financial multiples and ratios of each of the
selected comparable tobacco companies, including among other things, the ratio of each
comparable tobacco company’s (1) enterprise value as a multiple of 2017 calendar year
estimated EBITDA and (2) share price as a multiple of 2017 calendar year estimated earnings
per share, referred to as a P/E ratio. The earnings per share and EBITDA estimates for each of
the selected comparable companies listed above and used by Lazard in its analysis were based on
information from FactSet Research Systems, which represents publicly available consensus
estimates, and other public sources. All of these calculations were based on publicly available
financial data and closing share prices as of January 13, 2017. The results of this analysis are
summarized in the following table:

Global Majors
Philip Morris
International
BAT
Japan Tobacco
Inc.

Share Price
(as of
01/13/17)

EV
($ in
billions)

2017E
EBITDA
Multiple

2017E
P/E Ratio

$90.40
£47.30

$167
$86

13.5x
10.8x

18.9x
16.7x

JPY3,870

$65

10.1x

16.4x
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Imperial
Brands

£35.90

$57

High
Median
Mean
Low
US/European
Altria Group
RAI
Swedish
Match
Scandinavian
Tobacco

11.4x

13.1x

13.5x
11.1x
11.5x
10.1x

18.9x
16.6x
16.3x
13.1x

$67.58
$55.97

$124
$91

12.6x
14.2x

20.2x
21.9x

SEK285.10

$6

11.6x

17.2x

DKK121.50

$2

10.0x

12.2x

14.2x
12.1x
12.1x
10.0x

21.9x
18.7x
17.9x
12.2x

High
Median
Mean
Low

Based on its professional judgment after taking into account, among other things, such
observed multiples, Lazard selected a range of 2017E EBITDA multiples of 11.0x to 13.0x and a
range of 2017E P/E ratios of 17.0x to 20.0x for RAI and a range of 2017E EBITDA multiples of
10.0x to 13.0x and a range of 2017E P/E ratios of 16.0x to 19.0x for BAT. This analysis resulted,
when applied to corresponding information of RAI and BAT, in the following range of implied
per share values of RAI common stock and BAT ordinary shares, respectively:

Valuation Methodology
EBITDA Multiple-Based

Implied per share
values of RAI
common stock
$ 40.86 – $49.67

P/E Ratio-Based

$

43.08 – $50.68

Implied per share
values of BAT
ordinary shares
£41.79 – £52.04
($50.92 – $63.42)
£44.74 – £53.13
($54.52 – $64.74)

Lazard also calculated an implied exchange ratio reference range based on the selected
comparable company analyses described above by dividing (1) the low end of the implied RAI
per share value range resulting from the selected comparable company analyses described above
(less the $29.44 per share of merger consideration to be paid in cash) by the high end of the
implied BAT per share value range resulting from the selected comparable company analyses
described above and (2) the high end of the implied RAI per share value range resulting from the
selected comparable company analyses described above (less the $29.44 per share of merger
consideration to be paid in cash) by the low end of the implied BAT per share value range
resulting from
the selected comparable company analyses described above. This analysis indicated, on the one
hand, an EBITDA multiple-based implied exchange ratio of 0.1800x to 0.3972x and an implied
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pro forma ownership range for the holders of RAI common stock of 7.4% to 15.0%; and, on the
other hand, a P/E ratio-based implied exchange ratio of 0.2106x to 0.3896x and an implied pro
forma ownership range for the holders of RAI common stock of 8.5% to 14.7%. The exchange
ratio provided for in the merger agreement is 0.5260x resulting in a pro forma ownership for the
holders of RAI common stock of 18.9%.
Selected Precedent Transactions Analyses
Lazard performed selected precedent transactions analyses with respect to RAI on a standalone basis by reviewing selected transactions involving the acquisition of a tobacco company
announced since March 2005 and for which financial information was publicly available, and
which Lazard viewed, based on its judgment and experience, including with companies in the
tobacco industry, as generally relevant for purposes of these analyses.
Although none of the selected transactions included in the selected precedent transactions
analyses is identical or directly comparable to the merger, the selected transactions included were
chosen because they involve companies with certain operations, results, business mixes or
product profiles that, for the purposes of analysis, may be considered similar to certain
operations, results, business mixes or product profiles of the RAI Group.
For each of the selected transactions, Lazard reviewed, based on publicly available
information, the enterprise value, implied by each transaction purchase price, as a multiple of
EBITDA (measured as the most recently available or disclosed LTM EBITDA at the time of the
announcement of the relevant transaction), for each target company. The results of this analysis
are summarized in the following table:
Announcement
Date
June 2015
February 2015

Acquirer
BAT
BAT

July 2014

Imperial Brands

July 2014

RAI

May 2012

Japan Tobacco
Inc.
Japan Tobacco
Inc.

July 2011

May 2011

BAT

June 2009

BAT

Target

Enterprise Value
(dollars in millio EBITDA Multi
ns)
ple
$
603
12.5x

TDR
Souza Cruz (24.7 $
%)
$
RAI
$
Lorillard
$
Gryson
Haggar Cigarette $
&
Tobacco Factory
$
Protabaco
PT Bentoel
$
Internasional
Investama

13,741

15.1x

7,100

8.8x

27,387

13.1x

598

12.3x

450

9.9x

452

11.3x

744

14.0x
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September 2008

Altria Group

July 2008
February 2008

Philip Morris
International
BAT

February 2008

BAT

November 2007

Altria Group

July 2007

Imperial Brands

February 2007

Imperial Brands

January 2007

Philip Morris
International
Japan Tobacco I
nc.
RAI

December 2006
April 2006
March 2005

Philip Morris
International

$

11,655

12.2x

$

1,966

9.6x

Tekel (Cigarette $
business)
Skandinavisk
$
Tobakskompagni
$
John Middleton
$
Altadis
Commonwealth $
Brands
Larkson Tobacco $

1,720

11.4x

4,089

11.2x

2,900

15.7x

22,370

14.2x

1,899

10.9x

675

14.6x

$

19,036

12.8x

$

3,500

13.5x

$

5,120

14.0x

UST
Rothmans

Gallaher Group
Conwood
Company
PT HM
Sampoerna

—
High

15.7x

Median

12.5x

Mean

12.5x

Low

8.8x

Based on its professional judgment after taking into account, among other things, such
observed multiples, Lazard then applied a selected range of EBITDA multiples of 12.0x to 15.0x
to RAI’s last twelve months, referred to as LTM, EBITDA as of December 31, 2016, and to
RAI’s LTM adjusted EBITDA as of December 31, 2016, which included adjustments in the
amount of $113.6 million to reflect the run-rate synergies associated with the Lorillard merger.
This analysis resulted in the following ranges of implied per share values of RAI common stock,
respectively:
Implied per share values
of RAI common stock
(2016 EBITDA)

Implied per share values
of RAI common stock
(Adjusted 2016 EBITDA)
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$42.08 – $54.50

$43.03 – $55.69

“Has-Gets” Analyses from the Perspective of the Holders of RAI Common Stock (Other than
the BAT Group and Excluded Holders)
Lazard reviewed and analyzed certain financial information, multiples and ratios in order to
compare the stand-alone per share value of RAI common stock to the per share value of BAT
ordinary shares on a pro forma basis after giving effect to the merger from the perspective of the
holders of RAI common stock (other than the BAT Group and excluded holders). These
comparison analyses are referred to as the “has-gets” analyses.
Accordingly, Lazard performed (1) a discounted cash flow analysis, (2) selected
comparable company analyses based on EBITDA multiples and (3) selected comparable
company analyses based on P/E ratios, in each case for RAI on a stand-alone basis and for BAT
on a pro forma basis after giving effect to the merger. The pro forma analyses were conducted
assuming a merger consideration to be paid by BAT per share of RAI common stock in the
merger comprised of (1) a number of BAT ADSs representing 0.5260 of a BAT ordinary share
plus (2) $29.44 in cash. Financial forecasts and other data used for each of these analyses were
provided by RAI. Lazard factored into its analyses the present value of the illustrative projected
dividends to be received by the holders of RAI common stock, in each case over the relevant
time periods.
Discounted Cash Flow “Has-Gets” Analyses. Lazard performed a discounted cash flow
analysis to calculate the estimated present value, as of June 30, 2017, of the unlevered, after-tax
free cash flows that BAT on a pro forma basis after giving effect to the merger was forecasted to
generate during the calendar years 2017 to 2021, based on an estimated range of weighted
average cost of capital of 5.5% to 6.5% (which was calculated as the weighted average of BAT
and RAI standalone weighted average cost of capital, based on 2017E EBITDA). The unlevered,
after-tax free cash flows were calculated by taking the net operating profit after tax (representing
earnings before interest after tax), then adding depreciation and amortization, subtracting capital
expenditures and adjusting for changes in working capital and other cash flow items. Lazard then
calculated the estimated present value of the terminal values of BAT on a pro forma basis after
giving effect to the merger, as of June 30, 2017, by selecting, based on its judgment and
experience, a range of perpetuity growth rates of (0.5)% to 0.5% (which implied exit EBITDA
multiples ranging from 9x to 12.7x). Lazard then calculated a range of implied per share values
of BAT ordinary shares on a pro forma basis after giving effect to the merger by subtracting the
estimated projected net debt of BAT on a pro forma basis after giving effect to the merger as of
June 30, 2017, from the estimated enterprise value using the discounted cash flow method and
dividing such amount by the fully diluted number of outstanding shares of BAT ordinary shares
on a pro forma basis after giving effect to the merger. Lazard then discounted the implied
projected per share values of BAT ordinary shares on a pro forma basis after giving effect to the
merger as of June 30, 2017, back to December 31, 2016, using a cost of equity range of 6.09% to
7.27% underlying the estimated weighted average cost of capital of 5.5% to 6.5%, taking into
account the present value of the illustrative projected dividends to be received by the holders of
RAI common stock in the interim. This analysis resulted in the following range of implied per
share values of BAT on a pro forma basis after giving effect to the merger:
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“Has”—RAI (Stand-Alone)
“Gets”—BAT (Pro Forma after
giving effect to the merger)

Implied per share values
of common stock /
ordinary shares
$50.03 – $73.38
$56.31 – $70.14

EBITDA Multiple-Based “Has-Gets” Analyses. Lazard calculated the projected per share
values of BAT ordinary shares on a pro forma basis after giving effect to the merger by applying
a selected range of enterprise value to EBITDA multiples of 10.5x-13.0x (calculated as weighted
average of RAI multiples and BAT multiples, based on Lazard’s analysis of 2017E EV/EBITDA
of the selected comparable tobacco companies) to the next 12 months estimated EBITDA as of
June 30, 2017 of BAT on a pro forma basis after giving effect to the merger adjusted to include
full run-rate synergies. Lazard then discounted the implied projected per share values of BAT
ordinary shares on a pro forma basis after giving effect to the merger back to December 31,
2016, using an implied blended cost of equity, taking into account the present value of the
illustrative projected dividends to be
received by the holders of RAI common stock in the interim. This analysis resulted in the
following range of implied per share values of BAT ordinary shares on a pro forma basis after
giving effect to the merger:

“Has”—RAI (Stand-Alone)
“Gets”—BAT (Pro Forma after
giving effect to the merger)

Implied per share values
of common stock /
ordinary shares
$40.86 – $49.67
$53.51 – $62.40

P/E Ratio-Based “Has-Gets” Analyses. Lazard calculated the projected per share values of
BAT ordinary shares on a pro forma basis after giving effect to the merger by applying a selected
range of P/E ratios of 16.4x-19.4x (calculated as weighted average of RAI multiples and BAT
multiples, based on Lazard’s analysis of 2017E net income of the selected comparable tobacco
companies) to next 12 months estimated earnings per share of BAT on a pro forma basis after
giving effect to the merger as of June 30, 2017, adjusted to include full run-rate synergies.
Lazard then discounted the implied projected per share values of BAT ordinary shares on a pro
forma basis after giving effect to the merger back to December 31, 2016, using an implied
blended cost of equity, taking into account the present value of the illustrative projected
dividends to be received by the holders of RAI common stock in the interim. This analysis
resulted in the following range of implied per share values of BAT ordinary shares on a pro
forma basis after giving effect to the merger:

“Has”—RAI (Stand-Alone)

Implied per share values
of common stock /
ordinary shares
$43.08 – $50.68
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“Gets”—BAT (Pro Forma after
giving effect to the merger)

$60.82 – $66.98

Other Analyses
The analyses and data relating to RAI and BAT described below were presented to the RAI
board of directors for reference purposes only and did not provide the basis for, and were not
otherwise material to, the rendering of Lazard’s opinion.
Historical Stock Trading
Lazard reviewed historical data with regard to the range of trading prices of shares of RAI
common stock for the 52-week period to and including October 20, 2016, the last trading day
prior to BAT’s announcement of a proposal to merge with RAI. During this period, the intraday
share price of RAI common stock ranged from a low of $43.38 to a high of $54.48 per share.
Lazard also observed that, during such period, the intraday share price of BAT ordinary shares
ranged from £35.36 ($43.09) per share to £51.35 ($62.58) per share.
Lazard also calculated an implied exchange ratio reference range based on trading prices by
dividing the low end of the 52-week trading price per share range for RAI (less the $29.44 per
share of the cash portion of the merger consideration) by the high end of the 52-week trading
price per share range for BAT and by dividing the high end of the 52-week trading price per
share range for RAI (less the $29.44 per share of the cash portion of the merger consideration) by
the low end of the 52-week trading price per share range for BAT. This analysis indicated an
implied exchange ratio reference range of 0.2228x to 0.5811x and an implied pro forma
ownership range for the holders of RAI common stock of 9.0% to 20.5%.
Premiums Paid Analysis
Lazard reviewed a range of premiums paid in public company transactions closed (1) from
2011 to 2016, involving U.S. targets and transactions valued more than $500 million and
(2) from 2005 to 2016, in which significant shareholders with more than 20% ownership of the
target acquired the remaining shares of such
target. Using a 20%-35% premium range based on the median/mean of premiums paid in the
transactions referenced above and the RAI unaffected closing price per share as of October 20,
2016 of $47.17, resulted in an implied price per share range for shares of RAI common stock of
$56.60 to $63.68.
Analyst Price Targets
Lazard reviewed selected equity analyst stock price targets for RAI common stock based on
publicly available research analyst reports in Bloomberg, which indicated as of October 20, 2016
target prices that ranged from $47.00 to $62.00 per share.
Lazard also reviewed recently selected equity analyst stock price targets for BAT ordinary
shares based on publicly available research analyst reports in Bloomberg, which indicated as of
October 20, 2016 target prices that ranged from £43.00 ($52.40) to £60.00 ($73.12) per share.
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Lazard also calculated an implied exchange ratio reference range based on research analyst
price targets by dividing the low end of the share price target range for RAI (less the $29.44 per
share of merger consideration to be paid in cash) by the high end of the share price target range
for BAT and by dividing the high end of the share price target range for RAI (less the $29.44 per
share of merger consideration to be paid in cash) by the low end of the share price target range
for BAT. This analysis indicated an implied exchange ratio reference range of 0.2402x to
0.6214x and an implied pro forma ownership range for the holders of RAI common stock of
9.6% to 21.6%.
Miscellaneous
The RAI board of directors selected Lazard to act as its financial advisor in connection with
the merger based on Lazard’s qualifications, experience, reputation and familiarity with the RAI
Group and its business. Lazard is an internationally recognized investment banking firm
providing a broad range of financial advisory and securities services.
In connection with Lazard’s services as RAI’s financial advisor, RAI has agreed to pay
Lazard an aggregate fee of 0.02% of the merger consideration, of which $2.0 million was
payable on the date of the announcement of the merger and approximately $8 million of which is
contingent upon the closing of the merger. In addition, RAI may, in its sole discretion, based on
its assessment of Lazard’s performance of its services, pay Lazard an additional fee in an amount
to be determined by RAI in its sole discretion. RAI has also agreed to reimburse Lazard for
certain expenses incurred in connection with Lazard’s engagement and to indemnify Lazard and
certain related persons under certain circumstances against various liabilities that may arise from
or be related to Lazard’s engagement, including certain liabilities under U.S. federal securities
laws. The financial advisory business of Lazard in the past has provided certain investment
banking services to RAI for which Lazard has received compensation, including, during the twoyear period prior to the date of Lazard’s opinion, having acted as financial advisor to RAI in the
acquisition by RAI of Lorillard in June 2015 for which Lazard received fees of approximately
$29.5 million. In the two-year period prior to the date of Lazard’s opinion, the financial advisory
business of Lazard did not receive any other fees from RAI and was not engaged by BAT to
provide services for which it received compensation.
Lazard, as part of its investment banking business, is continually engaged in valuations of
businesses and securities in connection with mergers and acquisitions, negotiated underwritings,
secondary distributions of listed and unlisted securities, private placements, leveraged buyouts
and valuations for other purposes. In addition, in the ordinary course, Lazard and its affiliates
and employees may trade securities of RAI, BAT and certain of their respective affiliates for
their own accounts and for the accounts of their customers, may at any time hold a long or short
position in such securities, and may also trade and hold securities on behalf of RAI, BAT and
certain of their respective affiliates.

D.

ANNEX D TO PROXY STATEMENT, FAIRNESS OPINION OF LAZARD

101

Annex D

January 16, 2017
The Board of Directors
Reynolds American Inc.
401 North Main Street,
Winston-Salem, NC 27101
Dear Members of the Board:
We understand that Reynolds American Inc., a North Carolina corporation (“Company”),
British American Tobacco p.l.c., a public limited company incorporated under the laws of
England and Wales (“Parent”), BATUS Holdings Inc., a Delaware corporation and an indirect
wholly owned subsidiary of Parent and Flight Acquisition Corporation, a North Carolina
corporation and an indirect wholly owned subsidiary of Parent (“Sub”), propose to enter into an
Agreement and Plan of Merger, dated January 16, 2017 (the “Agreement”), pursuant to which
Parent will acquire Company (the “Transaction”). Pursuant to the Agreement, Sub will be
merged with and into Company and each outstanding share of the common stock, par value
$0.0001 per share, of Company (“Company Common Stock”), other than shares of Company
Common Stock (i) owned by Parent or any subsidiaries of Parent or (ii) owned by holders of
Company Common Stock who shall have not voted, or caused or permitted to be voted, any
shares of Company Common Stock in favor of adoption of the Plan of Merger, as defined in the
Agreement, at the Company Shareholders Meeting, as defined in the Agreement, and who shall
have properly asserted (and not lost or effectively withdrawn) his, her or its appraisal rights for
such Company Common Stock in accordance with Article 13 of the North Carolina Business
Corporations Act, as defined in the Agreement (such holders described in clause (ii),
collectively, “Excluded Holders”), will be converted into the right to receive (A) $29.44 in cash
(the “Cash Consideration”) and (B) the number of American depositary shares of Parent
(“Parent ADSs”) equal to (1) 0.5260 divided by (2) the ADS Ratio, as defined in the Agreement
(such number of Parent ADSs so issuable, the “Stock Consideration” and, together with the
Cash Consideration, the “Consideration”). The terms and conditions of the Transaction are
more fully set forth in the Agreement.
You have requested our opinion as of the date hereof as to the fairness, from a financial
point of view, to holders of Company Common Stock (other than Excluded Holders, Parent and
any subsidiaries of Parent) of the Consideration to be paid to such holders in the Transaction.
In connection with this opinion, we have:
(i) Reviewed the financial terms and conditions of the Agreement;
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(ii) Reviewed certain publicly available historical business and financial information relating
to Company and Parent;
(iii) Reviewed certain internal financial analyses and forecasts prepared by the management
of Company relating to the business of each of Company and Parent (which, in the case
of the forecasts for Parent, were based in part on certain financial information for Parent
prepared by the management of Parent and provided to Company), and the projected
synergies and other benefits, including the amount and timing thereof, anticipated by the
management of Company to be realized from the Transaction;
(iv) Held discussions with members of the senior management of Company with respect to
the businesses and prospects of Company and Parent, respectively, and the projected
synergies and other benefits anticipated by the management of Company to be realized
from the Transaction;
(v) Reviewed public information with respect to certain other companies in lines of business
we believe to be generally relevant in evaluating the businesses of Company and Parent,
respectively;
(vi) Reviewed the financial terms of certain business combinations involving companies in
lines of business we believe to be generally relevant in evaluating the businesses of
Company and Parent, respectively;
(vii)Reviewed historical stock prices and trading volumes of Company Common Stock and
the ordinary shares, par value 25 pence per share, of Parent (“Parent Ordinary
Shares”);
(viii)Reviewed the potential pro forma financial impact of the Transaction on Parent based on
the financial forecasts referred to above relating to Company and Parent; and
(ix) Conducted such other financial studies, analyses and investigations as we deemed
appropriate.
We have assumed and relied upon the accuracy and completeness of the foregoing
information, without independent verification of such information. We have not conducted any
independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of
Company or Parent or concerning the solvency or fair value of Company or Parent, and we have
not been furnished with any such valuation or appraisal. At your direction, for purposes of our
analysis, we utilized forecasts with respect to Parent and the synergies and other benefits
anticipated to result from the Transaction that were prepared by management of Company and
were based, in part, on financial information provided by Parent to Company and, as you know,
we did not have discussions with management of Parent in connection with the Transaction.
With respect to the financial forecasts utilized in our analyses, including those related to
projected synergies and other benefits anticipated by the management of Company to be realized
from the Transaction, we have assumed, with the consent of Company, that they have been
reasonably prepared on bases reflecting the best currently available estimates and judgments as
to the future financial performance of Company and Parent, respectively and such synergies and
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other benefits. We express no view as to any such forecasts or the assumptions on which they are
based.
Further, our opinion is necessarily based on economic, monetary, market and other
conditions as in effect on, and the information made available to us as of, the date hereof. We
assume no responsibility for updating or revising our opinion based on circumstances or events
occurring after the date hereof. We do not express any opinion as to the prices at which shares of
Company Common Stock, Parent Ordinary Shares or Parent ADSs may trade at any time
subsequent to the announcement of the Transaction. In connection with our engagement, we
were not authorized to, and we did not, solicit indications of interest from third parties regarding
a potential transaction with Company. In addition, our opinion does not address the relative
merits of the Transaction as compared to any other transaction or business strategy in which
Company might engage or the merits of the underlying decision by Company to engage in the
Transaction.
In rendering our opinion, we have assumed, with the consent of Company, that the
Transaction will be consummated on the terms described in the Agreement, without any waiver
or modification of any material terms or conditions. We also have assumed, with the consent of
Company, that obtaining the necessary governmental, regulatory or third party approvals and
consents for the Transaction will not have an adverse effect on Company, Parent or the
Transaction. We do not express any opinion as to any tax or other consequences that might result
from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting
matters, as to which we understand that Company obtained such advice as it deemed necessary
from qualified professionals. We express no view or opinion as to any terms or other aspects
(other than the Consideration to the extent expressly specified herein) of the Transaction,
including, without limitation, the form or structure of the Transaction or any agreements or
arrangements entered into in connection with, or contemplated by, the Transaction. In addition,
we express no view or opinion as to the fairness of the amount or nature of, or any other aspects
relating to, the compensation to any officers, directors or employees of any parties to the
Transaction, or class of such persons, relative to the Consideration or otherwise.
Lazard Frères & Co. LLC (“Lazard”) is acting as financial advisor to Company in
connection with the Transaction and will receive a fee for such services, a portion of which is
payable upon the rendering of this opinion and a substantial portion of which is contingent upon
the closing of the Transaction. We have in the past provided certain investment banking services
to Company, for which we have received compensation, including, during the past two years,
having acted as financial advisor to Company in the acquisition by Company of Lorillard, Inc. in
June 2015. In addition, in the ordinary course, Lazard and its affiliates and employees may trade
securities of Company, Parent and certain of their respective affiliates for their own accounts and
for the accounts of their customers, may at any time hold a long or short position in such
securities, and may also trade and hold securities on behalf of Company, Parent and certain of
their respective affiliates. The issuance of this opinion was approved by the Opinion Committee
of Lazard.
Our engagement and the opinion expressed herein are for the benefit of the Board of
Directors of Company (in its capacity as such) and our opinion is rendered to the Board of
Directors of Company in connection with its evaluation of the Transaction. Our opinion is not
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intended to and does not constitute a recommendation to any stockholder as to how such
stockholder should vote or act with respect to the Transaction or any matter relating thereto.
Based on and subject to the foregoing, we are of the opinion that, as of the date hereof, the
Consideration to be paid to holders of Company Common Stock (other than Excluded Holders,
Parent and any subsidiaries of Parent) in the Transaction is fair, from a financial point of view, to
such holders.
Very truly yours,
LAZARD FRERES & CO. LLC
By /s/ Maxence de Gennaro
Maxence de Gennaro
Managing Director
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